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CHAPTER 1 – INTRODUCTION
Six hundred million years ago, the first multicellular organisms, the earliest
metazoans, evolved from their unicellular ancestors, the colonial flagellate
eukaryotes. Development of multicellularity was attained when unicellular organisms
began to stick together, work together, and specialize. The presence of intercellular
junctions

partitioned

the

new

multicellular

organism,

generating

internal

compartments. Each newly created compartment would further evolve a unique
composition benefitting the organism, allowing it to adapt to different environments,
and evolve into more complex species. Intercellular junctions contribute to the
ascension, diversification, and transformation of unicellular organisms into the
diverse animal kingdom.
The primary purpose of early intercellular junctions in metazoans was to
protect the organism from the external environment. As multicellular organisms
increased in complexity, intercellular junctions developed specialized functions,
while retaining their most basic function of forming a barrier. Today, intercellular
junctions have evolved to adhere cells together, preserve structural integrity, allow
remodeling to occur in changing environments, and permit passage of select
molecules. Three main categories of intercellular junctions have evolved: adherens,
gap, and tight junctions.
Diversity of intercellular junctions permits functional specialization
Intercellular junctions, which are of four major categories, function to maintain
a physical association between cells, allow intercellular communication, and
participate in tissue organization. The first type of intercellular junction, the adherens
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junction, molds the shape of multicellular structures by indirectly linking their actin
cytoskeletons. All intercellular junctions are comprised of three basic structural
proteins: integral membrane proteins, cytoplasmic proteins, and cytoskeletal proteins.
The integral proteins of adherens junctions are largely comprised of the cadherin
family of type-1 transmembrane proteins (Yoshida and Takeichi, 1982; YoshidaNoro et al., 1984). The extracellular domains of cadherins interact with either trans
(opposing) or cis (neighboring) cadherins forming dimers or tetramers. The
cytoplasmic domains of cadherins bind to members of the catenin family of
cytoplasmic proteins. These protein complexes are anchored to actin filaments,
thereby stabilizing the junction in the membrane.
The second category of adhesive junction is the desmosome, which provides
focal mechanical strength to epithelial and endothelial cell layers by attaching the
plasma membrane to intermediate filaments. Desmosomes are comprised of
cadherins and integral membrane proteins known as desmogleins and desmocollins
(Buxton et al., 1993; Holton et al., 1990; Koch et al., 1990). These single-pass
transmembrane proteins interact in trans with neighboring desmogleins and
desmocollins at their extracellular domains. The cytoplasmic domains bind to
anchoring proteins such as plakoglobin, plakophilin, or desmoplakin, which in turn
are bound to intermediate filaments. While desmosomes function to adhere two cells
together, hemidesmosomes anchor each cell to the basement membrane or
extracellular matrix (Borradori and Sonnenberg, 1999).
Gap junctions are the third type of intercellular junctions that interact in trans
to form channels between cells and permit direct cell-to-cell communication. These
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junctions are comprised of the connexin family of polytopic four transmembrane
domain proteins. Connexins interact in cis to form hexamers known as connexons.
Opposing connexons form the characteristic gap junction, allowing small metabolites
and water to freely pass, thereby coupling the cells chemically and electrically
(Alberts et al., 2008).
The hypotheses developed and examined within this dissertation work
revolve around the function of tight junctions, which are the final category of
intercellular junctions. Tight junctions were first observed in the 1960s and form
circumferential bands between plasma membranes of apposing cells by interactions
in trans that focally fuse the cell membranes and eliminate the paracellular space
(Farquhar and Palade, 1963). Tight junctions are permeable to water and selectively
permeable to ions but otherwise seal the extracellular spaces between cells and
serve to generate two compartments, the contents of which can be independently
regulated (Angelow and Yu, 2007; Furuse and Tsukita, 2006; Van Itallie and
Anderson, 2004, 2006). Tight junctions are the principal component for establishing
and maintaining the apical and basolateral domains of polarized epithelial and
endothelial cell layers (Mugnaini and Schnapp, 1974; Shin et al., 2006). In addition
to the archival tight junctions between apposing cells, which are known as
heterotypic junctions, autotypic tight junctions are found between bilayers of a single
cell such as the membrane sheaths of myelinating cells in the central and peripheral
nervous systems (Dermietzel, 1974; Tetzlaff, 1978). The functional characterization
of autotypic tight junctions in CNS myelin sheaths is the foundation for this
dissertation work.
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Claudins constitute the principal integral membrane protein of tight junctions
Probing cultured rat fibroblasts, cardiac muscle, and epithelial cells from small
intestine and liver identified a candidate integral membrane protein of tight junctions.
The probe was comprised of a fusion protein containing cDNA of zonula occludens
(ZO-1). The ZO family of proteins comprises a major component of the cytoplasmic
proteins of tight junctions (Itoh et al., 1993). The fusion protein interacted with a
novel 65 kDa transmembrane protein designated occludin. Using immunoelectron
microscopy and freeze-fracture replica electron microscopy, occludin was localized
at tight junctions in epithelial and endothelial cells (Fujimoto, 1995; Furuse et al.,
1993). Transfection studies demonstrated that newly synthesized chick occludin can
be delivered and incorporated into existing human and bovine epithelial cell tight
junctions (Furuse et al., 1994) and increased transepithelial resistance (McCarthy et
al., 1996). However, knockout studies in mice show that occludin is not the main
integral membrane protein of tight junctions (Gow et al., 1999; Morita et al., 1999b).
Two key experiments extensively investigating the function of occludin refuted
the hypothesis that occludin is necessary for tight junction formation. First, when
peptides raised against occludin were transfected into epithelial cells, occludin was
excluded from tight junction strands. Interestingly, epithelial cell morphology
remained unaltered (Wong and Gumbiner, 1997). Second, deletion of the occludin
gene by homologous recombination in embryonic stem cells yielded a mouse with
morphological normal tight junctions in many tissues (Saitou et al., 1998).
Reassessing the original cell fraction in which occludin was identified, Furuse et al.
(1998) discovered a novel 22 kDa protein. When sequenced, the putative
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transmembrane protein had disparate sequence to occludin and was designated
claudin (Cldn), from the Latin word ‘to close.’ This protein was quickly found to be a
member of a large family of proteins with broad and overlapping expression patterns
in polarized cells (Fanning et al., 1998; Furuse et al., 1998; Morita et al., 1999a;
Morita et al., 1999c; Simon et al., 1999).
The claudin family of proteins has increased to at least 24 members in
mammals with similar structures, divergent sequences, and hallmark conserved
elements (Angelow et al., 2008; Furuse and Tsukita, 2006; Van Itallie and Anderson,
2006). Claudins are polytopic membrane proteins consisting of four transmembrane
domains with amino and carboxyl termini both located in the cytoplasm and two
extracellular domains. Conserved features include a GLWxxC (8 – 10 aa) motif
within the first cytoplasmic domain and a PSD95 / Dlgs1 / ZO-1 (PDZ) domain near
the carboxyl-terminus for binding the cytoplasmic tight junction proteins: ZO-1, -2,
and -3.
The expression of claudins is essential for tight junction function, whereas
occludin is considered an accessory protein (reviewed in Alberts et al., 2008; Nelson
and Fuchs, 2010). Evaluation of genetic knockout or mutations reiterates the
indispensible function of claudin family members, in vivo, for tight junction formation
(reviewed in Furuse, 2009). The loss of Cldn1 leads to an epidermal barrier deficit
resulting in water loss and neonate death (Furuse et al., 2002); altered ionic
permeability and subsequent hair cell degeneration and congenital deafness arise
from to the loss of Cldn14 (Ben-Yosef et al., 2003; Wilcox et al., 2001); the absence
of Cldn15 in produces megaintestine (Tamura et al., 2008); loss of Cldn16

5

(paracelllin-1) results in hypomagnesaemia, hypercalciuria and nephrocalcinosis
(Weber et al., 2000); and finally, renal magnesium wasting and renal failure are seen
in the absence of Cldn 19 (Konrad et al., 2006). The first claudin shown to
demonstrate dysfunction of tight junction in several tissues, Cldn11, is the primary
focus of this dissertation work.
Functional role of Claudin 11 homotypic tight junctions
Claudin11 forms parallel tight junction strands in several tissues including
Sertoli cells of the testis, basal cells of the stria vascularis, and CNS myelin sheaths
(Bronstein et al., 1997; Gow et al., 2004; Gow et al., 1999; Kitajiri et al., 2004; Morita
et al., 1999b). Functional analyses assessing the role of Cldn11 tight junctions has
been simplified by the tendency for Cldn11 to form single claudin tight junctions
(Gow et al., 1999).
Studies exploring the function of Cldn11 tight junctions were first completed in
Sertoli cells of the testis. The loss of Cldn11 results in disappearance of the
characteristic parallel tight junction intramembranous strands, hypogonadism and
azoospermia (Gow et al., 1999). Arrested spermatogenesis and abnormal
morphology of seminiferous tubules were excluded as the source for male sterility;
instead, the phenotype originates from disruption of the tightly controlled blood-testis
barrier, causing early spermatocyte death (Gow et al., 1999).
Within the inner ear, Cldn11 expression is restricted to basal cells of the stria
vascularis (Gow et al., 2004; Kitajiri et al., 2004). Claudin11 knockout (Cldn11-/-)
mice were characterized to elucidate the function of tight junctions on audition.
Cldn11-/- mice lack an endocochlear potential with minimal disruption to potassium
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ion homeostasis in the endolymph or perilymph. Morphometric analyses reveal mice
have normal inner ear cellular morphology, inner and outer hair cell organization,
and a normal compliment of spiral ganglion neurons. Psychoacoustic analysis
confirmed the critical function of the endocochlear potential on hearing sensitivity
and demonstrates that Cldn11-/- mice have increased hearing thresholds to
approximately 70 dB SPL by six weeks of age (Gow et al., 2004).
Structure and composition of CNS myelin membrane
The dissertation work herein centers on the function of Cldn11 tight junctions
within CNS myelin sheaths. Pre-myelinating oligodendrocytes extend numerous
processes that contact nearby axons, expand into large trapezoid membrane sheets,
and wrap segments of the axons in multiple layers (Figure 1.1A). Initially these
sheets contain cytoplasm (Figure 1.1A, light grey), which is extruded during
membrane compaction and confined to an outer channel (Figure 1.1A, dark grey).
The asymmetric trapezoid shape of the flattened myelin sheath generates distinct
compartments once myelination compaction has occurred (Figure1.1C). At the
lateral edges, membrane loops containing the cytoplasm comprise the paranodal
region. The compact myelin region, known as the internode, spans from paranode to
paranode (Figure 1.1A, dark grey). Lastly, unmyelinated segments between myelin
sheaths are known as nodes of Ranvier at which voltage-gated Na+ channels are
localized to propagate action potentials (Figure1.1C).
Myelin

sheaths

are

an

extension

of

the

plasma

membrane

of

oligodendrocytes. The composition of myelin is 40 % water; the dry mass is
comprised of 70 % lipids and cholesterol and 30 % protein, more than half of which
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is proteolipid protein (PLP) (Folch and Lees, 1951). The function of PLP within the
myelin membrane remains unknown, however it is thought to involve adhesion and
stabilization of compact myelin (Boison et al., 1995; Boison and Stoffel, 1994; Greer
and Lees, 2002). Myelin basic protein (MBP), accounts for 30 % of total myelin
protein, is localized to the major dense line (MDL) observed in transmission electron
micrographs of compact myelin and is thought to stabilize opposing membrane
layers (Omlin et al., 1982). The MDL is formed from the cytoplasmic faces of
apposing plasma membranes. The two external surfaces of the plasma membrane
form the minor dense line, or intraperiod line (IPL) in electron micrographs. The
protein with the third largest concentration in CNS myelin is Cldn11, comprises 7 %
of total protein. As extensively described above, Cldn11 forms autotypic in myelin
and comprises the diffusion barrier that forms the intramyelinic compartment (Figure
1.1, red) (Gow et al., 1999; Morita et al., 1999b). Remaining minor protein
components include 2’,3’-Cyclic Nucleotide 3’ Phosphodiesterase (CNP), myelin
associated glycoprotein (MAG), myelin oligodendrocyte basic protein (MOBP),
myelin oligodendrocyte glycoprotein (MOG), Nogo (Chen et al., 2000), OMGP,
Sirtuin 2 (SirT2), and stathmin.
Claudin 11 tight junctions in CNS myelin
For half a century, myelin tight junction were known morphologically as the
radial component which appears as rod-like thickenings within the intraperiod lines
(IPLs) of compact myelin has been documented from transmission and freeze
fracture electron microscopy (Peters, 1961, 1964; Reale et al., 1975; Staehelin,
1974; Tabira et al., 1978). Recently, Cldn11 was confirmed to comprise the only
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Figure 1.1 – Schematic illustrating key features of the myelin membrane

(A) A CNS myelin sheath is unraveled revealing the structure and organization of the
multilayered myelin membrane. Myelin begins as a flat trapezoid sheet filled with
cytoplasm extruded to an outer channel along the perimeter upon maturation and
compaction. (B) Cross section through the internode showing myelin wraps,
paranodal loops, and Cldn11 tight junctions (red) forming the electrically tight barrier
between successive layers of myelin. (C) Location of membrane domains on the
axon are also shown: node of Ranvier, paranodal myelin, juxtaparanodal region (JP),
and the remaining axon internode (Axon) The location of Cldn11 tight junctions are
indicated in red. This figure was modified and reprinted with permission from the
corresponding author (Gow, 2008)
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family member in the radial component (Gow et al., 1999). Claudin 11 tight junctions
are also present in the paranode, forming a continuous barrier between apposing
layers of myelin membrane. Elimination of Cldn11 in CNS myelin has revealed the
contribution of tight junctions to myelin sheath function.
Ultrastructural analyses indicate that the absence of Cldn11 tight junctions
neither perturbs compaction and thickness of myelin sheaths, nor disrupts axoglial
junctions. Phenotypic assessment reveals a slight tremor which does not arise from
neuronal loss or axonal degeneration (Gow et al., 1999). Interestingly, an increase in
latency of the visual evoked potentials (VEPs) from Cldn11-/- mice suggests slowed
conduction velocity (Michaelson et al., 1996; Strain and Tedford, 1993). These
findings recapitulate more recent studies in the auditory pathway.
The loss of Cldn11 in the stria vascularis of the cochlea accounts for the
observable increase in hearing threshold, however the well-differentiated waveforms
of the auditory brainstem response (ABR) suggest overall preservation of the
auditory pathway with dysfunction being limited to a delay in the latency of Wave V
latency. Wave V latency is a commonly used proxy for conduction velocity along
central myelinated fibers of the auditory pathway (Gow et al., 2004). Thus the ABR
data suggest slowed conduction in the auditory brainstem, data from visual and
auditory pathways demonstrate global dysfunction of myelinated axons within the
CNS of Cldn11-/- mice.
Function of CNS myelin
The high lipid and low water content of myelin generates a high resistance /
low capacitance structure that insulates axons. During axon depolarization, the
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electrically tight myelin membrane reduces current leakage into the compact myelin
region, restricting depolarization events to the nodes of Ranvier. Electrical signals
propagate from node to node, depolarizing the axonal membrane at these regions
compared to the entire axonal length in a process known as saltatory conduction.
Conduction velocity along myelinated fibers is proportional to the axonal diameter,
unlike unmyelinated axons, for which conduction velocity is proportional to the
square root of the diameter. The influence myelin has on conduction velocity is
functionally equivalent to increasing axonal thickness by100 (Kandel et al., 2000).
The passive properties of neurons, tau (time constant) and lambda (length
constant), specify action potential propagation. Lambda is the critical component
determining the distance along an axon a depolarizing event can travel and still
trigger a subsequent depolarizing event. Lambda is thought of as a safety factor
specifying the integrity of conduction along an axon in the absence of internodes or
presence of dysfunctional internode segments. If lambda is smaller than the distance
between

myelin

internodes,

signal

propagation

becomes

impaired.

This

consequence is commonly seen in multiple sclerosis (MS) when demyelination leads
to the absence of several internodes along an axon, reducing action potential
propagation.
The time constant, tau, is the calculated time it takes the membrane potential
of a neuron to reach 63 % of its steady state value. Tau regulates temporal
summation by dictating the time course of synaptic potentials. A shorter tau
represents a quicker change in membrane potential resulting from a stimulus.
Additionally, a shorter tau increases the likelihood that two consecutive inputs will
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summate and depolarize the cell membrane enough to fire an action potential
(Kandel et al., 2000).
Function of Claudin 11 tight junctions in CNS myelin membrane
Initial hypotheses from several studies posited that Cldn11 tight junctions in
CNS myelin stabilize the myelin membrane and generate an immune privileged
compartment (Mugnaini and Schnapp, 1974; Tabira et al., 1978). These hypotheses
have proved untenable, and more recent data indicate that Cldn11 tight junctions
preserve electrochemical gradients in similar fashion to epithelia (Devaux and Gow,
2008; Gow et al., 2004; Kitajiri et al., 2004). Noteworthy electrophysiology
experiments conducted in Cldn11-/- mice established the mechanism by which
Cldn11 tight junctions function in CNS myelin (Devaux and Gow, 2008; Gow et al.,
2004; Gow and Devaux, 2008).
Slowed conduction velocity in the visual and auditory pathways has been
demonstrated in Cldn11-/- mice (Gow et al., 2004; Gow et al., 1999; Kitajiri et al.,
2004). Compound action potentials (CAPs) measuring electrical potential from ex
vivo optic nerves of Cldn11+/+ and Cldn11-/- mice demonstrate the loss of tight
junctions significantly impacts CAP velocities along myelinated fibers (Figure 1.2)
(Devaux and Gow, 2008). Three components of the CAP are visible, corresponding
to large (1st), medium (2nd), and small (3rd) diameter fibers, respectively. The onset
delay in medium and small diameter fibers is unmistakable in Cldn11-/- mice
compared to controls, with significant reductions in conduction velocity of 20 and
50 %, respectively. Axon diameters of the medium and small components were
estimated to be approximately 1.2 and 0.7 µm. Conduction velocity along large
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diameter fibers, estimated at > 2 µm, are not significantly impacted (Devaux and
Gow, 2008).
The absence of Cldn11 tight junctions does not alter the ultrastructure of
myelin sheaths except for the absence of radial components. Detailed analyses
reveal myelin thickness, compaction, and internode length are preserved. The
distribution of voltage-gated ion channels within nodes, or underneath the myelin
sheaths remain normal (Devaux and Gow, 2008). In view of this preservation of
architecture, a novel computational model was developed to describe conduction
along small diameter myelinated fibers, accounting for the critical contribution of tight
junctions within the myelin membrane.
Early computational models describing saltatory conduction in myelinated
fibers are depicted as a double-cable circuit comprised of resistors (longitudinal
component of the fiber) and capacitors (axonal surface) (Brill et al., 1977; Halter and
Clark, 1991; Hartline and Colman, 2007; Waxman and Bennett, 1972). These
models were simple and predominantly based on large diameter myelinated axons
of the peripheral nervous system (PNS), rather than the vast number of small
diameter myelinated fibers of the CNS (Blight, 1985). Compared to such double
cable models (DCM) (Halter and Clark, 1991; McIntyre et al., 2002), the revised tight
junction model (TJM), specifies tight junctions as a series resistance with myelin
membrane to reduce capacitive charging of the membrane. Scaling the DCM to the
electrophysiological and morphological dimensions of optic nerve axons does not
yield a conducting model. However, the addition of tight junctions in the TJM better
reflects the experimental data obtained. This finding suggests that tight junctions
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Figure 1.2 – Compound action potentials from Cldn11-/- mice indicate slowed
conduction velocity in small diameter fibers

Representative compound action potentials (CAPs) collected from isolated optic
nerves in Cldn11+/+ and Cldn11-/- mice showing three components (arrows) elicited
by square voltage pulses with varied amplitudes. The components correspond to
large, medium, and small diameter axons, respectively, within the optic nerve fiber
bundles. This figure was modified and reprinted with permission from the
corresponding author (Devaux and Gow, 2008).
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play an important role in action potential propagation for small diameter fibers
(Devaux and Gow, 2008; Gow and Devaux, 2008).
Small diameter myelinated fibers are found throughout the brain, especially in
grey matter regions (Aboitiz et al., 1992). The majority of neural circuits require
signal information integration via small myelinated fibers, from multiple sensory
modalities, as well as refinement from feed forward / back networks. If slowed
conduction velocity occurs along these fibers, errors in information processing and
synchrony will likely arise and may lead to the development of behavioral
abnormalities. The disconnection hypothesis discussed in Chapter 2 is consistent
with disrupted communication along small diameter myelinated fibers as an etiology
of cognitive disease.
Cognitive diseases such as Schizophrenia (SZ) are thought to originate from
altered neural connectivity and disconnection of brain regions (Benes, 2000; Friston,
1999; Nuechterlein and Dawson, 1984). Reduced in white matter volume and
integrity are apparent from functional magnetic resonance imaging (fMRI) and
diffusion tensor imaging (DTI) scans, and in molecular analyses of post mortem
tissue (Camchong et al., 2011; Davis et al., 2003; Flynn et al., 2003; Lawrie and
Abukmeil, 1998). Surprisingly, reduced myelin protein and gene transcripts are the
most prominent changes detected in post mortem patients (Haroutunian et al., 2007;
Katsel et al., 2005; McCullumsmith et al., 2007; Tkachev et al., 2003). Not
surprisingly, many symptoms plaguing SZ patients are common in other neurological
disorders (Davis et al., 2003; Denier et al., 2007; Feinstein et al., 1992; Kopala et al.,
2000), which suggests a fundamental deficit.
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Investigating the consequence of dysfunctional myelin on neural processing
Many published studies suggest that white matter dysfunction, neural
processing deficits, and myelin gene misregulation may play a role in cognitive
diseases. However, because of the complex etiology of cognitive disorders, the
specific contribution of dysfunctional myelin cannot be determined from clinical
studies. Therefore, the overall goal of this dissertation is to elucidate the phenotype
associated with dysfunctional myelin in Cldn11-/- mice, focusing on neural processing
and the development of behavior abnormalities.
The second chapter of this dissertation examined anesthesia regimes needed
for subsequent experiments using evoked potentials to characterize a neural circuit
in the auditory brainstem. This circuit is employed as a model of neural processing
because it is a well-characterized system, easy to interrogate, and has been studied
in depth for decades. Information gained from this simple model system can be
extrapolated to higher order brain networks that are more challenging to investigate
directly. To obtain acoustic information from animal models, a straightforward
approach is to use an anesthetic cocktail, allowing for uninterrupted signal
measurement with minimal noise influence from awake activity.
Various anesthetics confer differing levels of sedation and alter recorded
brain wave activity. The potential for altering neural circuitry and interfering with
evoked responses is significant and is addressed in Chapter 2. Previous work in our
laboratory and others has determined that one of the oldest anesthetics, 2,2,2tribromoethanol, is a safe agent effective well below lethal doses and minimally
influences evoked brainstem responses (Gow et al., 1999; Zheng et al., 1999). The
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challenge in Chapter 2 was to develop a new anesthetic regime that increases
anesthesia time without sacrificing data quality or altering waveform characteristics.
Once established, the new anesthetic cocktail is used for more advanced
acoustic studies, which is the focus of Chapter 3. Here, the consequence of
dysfunctional myelin on neural processing is examined using the Cldn11-/-Tg+/mouse model. Using the auditory brainstem as a model, neural processing is
investigated by measuring sound lateralization in azimuth plane. Two primary
auditory features, intensity and timing, are relayed from each ear and are first
processed in the superior olivary complex (SOC). Due to the head size and position
of the ears in mice, sound intensity differences between left and right wars are
principally used for localization
The focus of Chapter 3 is to measure the output of the signal integrators in
the SOC when differing sound intensities are presented to each ear. Altering
intensity cues played to each ear simulates the lateralization of a sound source from
the perspective of neural processing in the LSO. Herein, we find that Cldn11-/-Tg+/respond abnormally to intensity differences suggesting altered in sound lateralization
circuitry. Unexpectedly, the output generated by LSO allow us to comment on a
debate in the auditory field regarding models that account for neural processing in
the SOC. Our data support the contemporary two-neuron hypothesis (Dingle et al.,
2012; Phillips, 2008; Phillips and Hall, 2005; Phillips et al., 2012; Yost, 1974), rather
than the classical Jeffress model (Jeffress, 1948). Because small diameter,
myelinated fibers are found along the auditory pathway, we hypothesize that slowed
conduction velocity along small diameter ipsilateral fibers between the cochlear
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nucleus and SOC can disrupt the integration of auditory signals. These data
demonstrate that dysfunctional myelin can alter neural processing which has
significant implications for higher order brain function in general.
If dysfunctional myelin alters neural processing in the auditory brainstem, then
probing higher order integration networks, such as those responsible for behavior,
should also reveal deficits. Chapter 4 explores this hypothesis in a quantifiable
manner through behavioral testing of Cldn11-/- Tg+/- mice. Behavior is the observed
response of an animal to an environmental cue or stimulation, typically through
integration of sensory signals. Because small diameter myelinated fibers are
prevalent in sensory integration networks, we hypothesize that Cldn11-/-Tg+/- mice
will exhibit abnormal behavioral phenotypes. Through anecdotal evidence and the
use of several behavioral tasks to assess behavior, we find that Cldn11-/-Tg+/- mice
are less anxious than controls. However this conclusion is somewhat uncertain
because of technical difficulties encountered during testing. The most unexpected
finding from Chapter 4 is the possibility that dysfunctional myelin may also perturb
neurotransmitter levels in the ventral hippocampus. These data, combined with the
neural processing abnormalities in the brainstem suggest that dysfunctional myelin
could underlie some behavioral disorders.
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CHAPTER 2– increased anesthesia time with low impact on
auditory evoked potentials using and avertin-chloral hydrate
cocktail
INTRODUCTION
In 1929, a German physiologist and psychiatrist, Hans Berger, published the
first-ever recorded spontaneous brain activity from a human (Berger, 1929). This
groundbreaking discovery and newly developed technique established the
fundamentals of electroencephalography (EEG) as we know it today. Further
progress was made when sensory stimulation of the brain during sleep was shown
to have consistent alterations to the EEG (Davis, 1939), however the magnitude of
baseline activity far exceeded that of the sensory evoked activity. To combat this,
the process known as signal averaging was introduced (Clark et al., 1961). The
premise of averaging uses the fact that sensory evoked responses have a temporal
relationship with the stimulus, whereas baseline neural activity is random and does
not. Thus, baseline EEGs could be mathematically removed from an averaged trace
and what remains was the neural response to a sensory evoked stimulus (Jacobson,
1994).
Evoked potentials can be induced using visual, somatosensory, and auditory
stimuli
There are three types of sensory stimuli that can be used to elicit an evoked
response: visual, somatosensory and auditory. Visual evoked potentials (VEPs) use
light stimulus to induce photic electroretinograms (Adrian and Matthews, 1934),
whereas somatosensory evoked potentials (SEPs) use electrical stimulation of
peripheral nerves and muscles to measure action potential volleys along sensory
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and motor fibers (Dawson, 1947). All three techniques of sensory evoked potentials
have been extensively studied and routinely used in clinical settings for diagnostic
purposes. The remainder of this chapter will focus on the use of auditory evoked
potentials (AEPs). Readers are directed elsewhere for excellent descriptions of the
two aforementioned evoked potentials (Chiappa, 1997; Niedermeyer and Lopes da
Silva, 2005).
The basis of AEPs is contingent on the ability to audiologically stimulate and
record electrical activity in the brain. As previously mentioned, the change a sensory
stimulus elicits in baseline EEGs is small. To enhance signal detection, a number of
techniques that modify the EEG have been employed. For instance, signal
averaging allows for subtraction of baseline neural activity, pre-amplification of
signals allows for enhanced detection when responses are small (microvolts), and
the use of a band pass filters can eradicate unwanted noise, optimizing collection
results.
To further enhance and define different types of auditory responses which
occur in the brain, AEPs can be divided into three categories based on the latency
each response occurs: short (0 – 10 msec), middle (10 – 40 msec) and long / late (>
50 msec). These are known as the auditory brainstem response (ABR), middle
latency response (MLR) and the long latency response (LLR) respectively.
Each of the three AEPs is not only defined by the latency of occurrence, but
also by the characteristic series of waves (or peaks) and troughs (valleys) elicited.
Waveforms of AEPs can be named based on the polarity of the wave, the latency of
occurrence, or sequential order (Jacobson, 1994). The ABR has five, sometimes six,
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distinct waves that present 0 to 10 msec post stimulus. Standard nomenclature used
to identify ABR waves comes independently from two groups in which Roman
numerals I through V (sometimes VI) were used to label positive waves, preventing
confusion if a waveform was either missing or altered in a disease state (Jewett and
Williston, 1971; Lev and Sohmer, 1972). The first wave occurs approximately 1.2 – 2
msec post stimulus, depending upon electrode placement. Each succeeding waves
occurs in approximately 1 msec intervals thereafter.
Contrasting nomenclature of the ABR, MLR wave identification is commonly
described by the polarity of the waves: N for negative and P for positive. Polarity is
combined with a lower case letter in alphabetical order. Earlier alphabetical letters
designate earlier wave latency (Goldstein and Rodman, 1967). At best, optimal filter
settings will differentiate six waveforms: V (retained from the ABR), P0, Na, Pa, Nb
and Pb. In contrast to the crisp, sharp waveforms of the ABR, MLR waves tend to be
broader, spanning a greater latency range, thus, naming waves based on the
latency they occur would become varied and problematic. The Na trough spans
approximately 15 – 30 msec, the Pa peak between 30 – 40 msec, and the Pb peak
between 46 – 55 msec (Hall, 1992).
Similar to MLRs, LLRs waveform nomenclature is based on the polarity of the
waveforms. To differentiate from MLRs, polarity is combined with numerical digits,
indicating wave order appearance (Williams et al., 1962). At the earliest latencies,
wave Pb from the MLR is sometimes present, followed by characteristic LLR waves
P1, N1, P2, N2 and P3 (sometimes referred to as P300 under certain stimulus
conditions). Wave P1 is typically present between 40 – 70 msec, followed N1
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ranging from 90 – 150 msec, P2 between 160 – 300 msec, N2 around 275 msec,
and finally P3 at approximately 300 msec (Hall, 1992). Of these waves, N1 and P2
are seen most reliably.
Auditory evoked responses waveforms are generated from nuclei along the
ascending auditory pathway
All three categories of auditory evoked responses have characteristic
waveforms that arise at somewhat predictable latencies post stimulus. Therefore, it
is reasonable to conclude that these signals are being generated from brain
structures along the ascending auditory pathway and cortical regions. Determination
of specific signal generators for the longer AEPs (MLRs and LLRs) are difficult to
assign because as nerve signals traverse along the ascending pathway, information
becomes widely dispersed within and between auditory cortices, integrated with
information from other sensory systems, and further processed in a more complex
manner, such as language recognition. What little information we do know about the
signal generators of these waveforms has come from examining patients with
auditory lesions, and yet, data is still controversial and discordant between patients.
Interrogating the auditory cortices experimentally is more challenging due to the
location of structures and the nature of auditory information integration. In contrast,
the ABR is the best characterized and most AEP and will be the focus of scrutiny for
this thesis.
A combination of techniques have allowed for the anatomical and
physiological characterization of ABR waveforms. Early studies employed far and
near field recordings in animals and humans. More recently, refined techniques such
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as surgical lesioning, single unit recordings, and targeted ablation of neurons has
uncovered the ABR waveform generators. Wave I in humans and animals is
generated from the distal portion of the auditory nerve as it leaves the cochlea and
enters the internal auditory canal (Hashimoto et al., 1981; Jewett and Williston,
1971; Moller and Jannetta, 1981, 1982, 1983a; Sohmer and Feinmesser, 1967).
Because of its long length in humans, the proximal portion of the auditory nerve
additionally gives rise to Wave II (Moller, 1985; Moller and Jannetta, 1981, 1982,
1983a; Moller et al., 1988; Moller et al., 1995).
In smaller animals commonly used in audiology studies (cats, bats, and
rodents), the short length of the auditory nerve cannot account for Wave II
generation, and thus, Wave II most likely arises from within the cochlear nucleus
(Fisch and Ruben, 1962; Moller and Jannetta, 1983b). As a consensus, the cochlear
nucleus also gives rise to Wave III of the ABR in humans, whereas MNTB principle
cells are responsible for Wave III generation in rodents (Jalabi et al., 2013).
The third-order neurons in the superior olivary complex are responsible for
the generation of Wave IV in both humans and small animals. Driving factors include
intracranial recordings, as well as consideration of wave amplitude, broadness of
waves, known orientation of neurons in major nuclei, and approximate relay times
along fiber tracts (Moore, 1987).
Wave V originates from the lateral lemniscus (LL) fibers terminating in the
inferior colliculus (IC) (Moller et al., 1995). Uncertainty still remains about the precise
signal generators of the occasional ABR waves (V – VI), due to the auditory
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pathway’s heavy contralateral trajectory and strong decussation of fibers across the
midline.
With a general consensus for the ABR signal generators in humans and
animals, more complex studies interrogating the auditory pathway and the resulting
changes to the ABR can be quite informative. One crucial element in the collection
and interrogation of AEPs that must be reviewed is the use of anesthesia during
acquisition.
Anesthesia drugs are frequently administered in AEP studies
The use of rodent models for AEP studies has increased markedly in recent
decades. In contrast to clinical and research studies of audition in humans using
surface electrodes, many simple animal experiments are performed using subdermal
electrodes under anesthesia. The least invasive method for examining the auditory
pathway is to administer a short-term anesthetic, which avoids more complex
surgical procedures involving the insertion of intracranial electrodes, and the
subsequent complications associated with recovery and postoperative infection.
Injectable anesthetics are typically administered via venous, peritoneal, muscular or
subcutaneous routes depending on the differing properties of the drugs and their
absorption rates (2008; Flecknell, 1996). The most commonly recommended
anesthetics for use in rodents include inhaled agents, barbiturates, and dissociative
agents.
Anesthetic drugs most commonly used for auditory studies in rodents have
been limited to a combination of a dissociative anesthetic with a powerful sedative /
analgesic such as ketamine / xylazine, which confers effective anesthesia over a
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period of 1 – 2 hrs. However, when compared with AEP measures in awake mice,
ketamine / xylazine anesthesia has been shown to alter waveform structure,
increase wave latencies by as much as 1 msec, and decrease wave amplitudes up
to 20 % (McGee et al., 1983; van Looij et al., 2004), Additionally, if injected at high
doses, it causes significant respiratory depression in rodents and requires prolonged
post-procedure recovery (2008). Similarly, volatile inhaled anesthetics such as
isoflurane have been also reported to alter ABR waveform morphology, decrease
wave amplitudes and increase wave latencies and hearing thresholds in rodents
(Santarelli et al., 2003; Stronks et al., 2010). The centrally derived waveforms
(Waves III – V) are predominantly affected in a dose dependent manner.
Alternatively, more mild fast acting drugs such as 2,2,2-tribromoethanol (TBE) have
also been employed (Forrest et al., 1996; Gow et al., 2004; Zheng et al., 1999).
Tribromoethanol is an effective anesthesia with rapid onset and recovery
times. A major advantage of this drug is its safety in rodents, with therapeutic doses
far below the lethal dose. Furthermore, it neither impairs ABR nor MLR evoked
responses nor significantly suppresses respiration (Gow et al., 2004). However, TBE
is a relatively short-acting drug at doses useful for AEPs, which confines auditory
experiments to 25 – 30 min in duration, thereby limits experimental complexity and
the extent of data collection.
The goal of this chapter has been to develop an anesthesia regimen that
increases the effective anesthesia time in mice, compared to a single dose of TBE,
without significantly compromising the quality of ABRs acquired using subdermal
electrodes. Accordingly, we compared our standard regimen of 375 mg / kg TBE
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with a drug combination comprising 375 mg / kg TBE followed after 5 min by 200 mg
/ kg chloral hydrate (CH). Our data show that we can increase effective anesthesia
almost two-fold without compromising ABR quality.
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MATERIALS AND METHODS
Mice
The Department of Laboratory and Animal Resources at Wayne State
University maintained all mice in this study. All experiments on mice were performed
in accordance with an Institutional Animal Care and Use Committee protocol
approved by the Wayne State University Animal Investigation Committee. The mice
used in this study were between six weeks and four months of age and were on a
randomly mixed background strain comprised of C57BL / 6J and 129. We observed
only mild age – dependent ABR threshold increases, which were consistent with
previous studies on this mixed background (Gow et al., 2004).
Chemicals
A 40 x stock solution of TBE (Sigma, St Louis, MO) (100 % weight / volume)
was prepared by dissolving 10 grams (g) of TBE in 6.2 ml of 2-methylbutan-2-ol
(Sigma, St Louis, MO) and adjusting to 10 milliliters (ml). The stock was aliquoted at
250 µl in 1.5 ml plastic tubes (Thermo Fisher Scientific, Waltham, MA) and stored at
- 20°C. Working solutions of 2.5 % TBE were prepared from a fresh aliquot of stock
dissolved by vortexing in 9.75 ml sterile PBS, pH 7.4 (Cellgro, Mannassas, VA).
Working solutions were stored away from light at 4°C up to two weeks.
Chloral hydrate (Sigma, St Louis, MO) was prepared as a 2 % working
solution by dissolving 0.5 g in 25 ml of sterile PBS. Working solutions were stored
sterile and away from light at 25°C. The PBS was filter – sterilized using a 10 ml
disposable syringe (Luer-Lok tip, BD Falcon, Franklin Lakes NJ) with a 0.22 µm filter
attachment (Millipore, Carrigtwohill, Ireland).
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Anesthesia
Mice were anesthetized by intraperitoneal (IP) injection with fresh TBE in
sterile PBS at a dose of 375 mg / kg (TBE cohort) as previously described (Gow et
al., 2004), and placed on a 39°C heating pad for experimentation. The mice were
monitored for the absence of tail, foot, and ear reflexes, as well as reduced
respiratory rate, which are all indications of effective anesthesia. Alternatively, mice
received a combination of fresh 375 mg / kg, IP, TBE in sterile PBS followed by 200
mg / kg, IP, CH in sterile PBS (TBE-CH cohort) five min after TBE anesthesia was
confirmed. After the completion of experiments, the mice were allowed to recover in
a separate cage on a 39°C heating pad until they regained normal activity and could
be placed back in their home cage. The mice were monitored periodically in their
home cage for 24 hrs to ensure they remained active and healthy.
Auditory brainstem response measurements
After confirming anesthesia, the fur along the top of the head and middle of
the back of each mouse was sterilized / moistened with alcohol prep pads (Triad
Group, INC, Hartland WI). Exposing the eyes to the alcohol pad was avoided.
Subdermal platinum electrodes (Grass Technologies, West Warwick, RI) were then
placed at the right and left mastoids (negative), vertex (reference) and hindquarters
along the midline (ground). Ten min post TBE injection, and at subsequent 10 min
intervals, mice were presented with 1,024 pure-tone stimuli in 10 dB SPL
decrements from 80 – 20 dB SPL at 32 kHz (102 µsec duration; Blackman envelope
– constant rise and fall similar to a Gaussian curve) and a stimulus rate of 29.1 / sec.
Both

right

and

left

ears

were

tested
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successively

and

ipsilateral

electroencephalography recordings were pre-amplified (100,000 x), band pass
filtered (0.3 – 3 kHz) and recorded for 12.5 msec (Sepwin software version 5.1,
Intelligent Hearing Systems, Miami, FL).
Amplitudes of the ABR waves were measured from the first derivative of the
wave peak to that of the following trough and latencies were measured from the
stimulus onset to the first derivative of each wave peak. Plots of ABR wave
amplitude or latency versus stimulus intensity exhibited negative slopes for all mice,
as expected. Hearing thresholds were approximated as the lowest stimulus intensity
that could evoke an ABR Wave I response.
To examine the amplitudes of Waves I, III and V as functions of anesthesia
time, we initially plotted absolute amplitudes. Although we observed low inter –
animal variability for Wave I data, there was significant stochastic variability for
Waves III and V that was not correlated with anesthesia time or stimulus intensity.
Alternate plots of sensation level (defined as SL = Astim – Athres, where Astim is the
stimulus amplitude and Athresh is the threshold amplitude) as a function of anesthesia
time did not resolve this variability (Wave III: Appendix B.1; Wave V: Appendix B.2).
Peritoneal cavity examination
Mice received two IP injections, one day apart, of sterile PBS, 375 mg / kg
TBE in sterile PBS or TBE followed by 200 mg / kg CH in sterile PBS. The
anesthetized mice were allowed to fully recover on a 39°C heating pad then placed
back in their home cages and monitored for 24 hrs. Three days after the second
injection, the mice were sacrificed and their peritoneal cavities were immediately
exposed and photographed (Coolpix 950, Nikon, Melville, NY) followed by a detailed
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analysis of the abdominal organs for signs of persistent anesthesia – induced
pathology. Two independent observers blinded to the injected agent evaluated the
organs using several criteria: general appearance, organ color and size relative to
one another, signs of inflammation, vasodilation and the presence or absence of
ascites. Eight mice were examined including two sterile PBS injected controls, three
TBE and three TBE-CH injected mice.
Statistics
Statistical analyses were performed using GraphPad Prism (version 5, La
Jolla, CA). The latency / intensity data comparing TBE and TBE-CH in Figure 2.3A
and B were fit with a one-phase exponential decay algorithm. Regression
coefficients, R2, were also calculated. The data for each 10 min interval were
analyzed using a one-way ANOVA with Bonferroni post-hoc testing to compare
matching intensities between the anesthetic treatments. For Figures 2.4 – 2.9,
normalized (to the 50 min time point) amplitudes or latencies of Waves I, III and V
from each animal, and the average values from the cohort, were fit using linear
regression constrained at (50,1). F-tests were used to identify significant deviances
of the regression line slopes from zero. In Figure 2.10, normalized (to the Day 0 data
point) average weights were fit using linear regression constrained at (0,1). F-test
was used to determine if the slope of the regression line differs from zero.
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RESULTS
Minimal differences in ABR thresholds and Wave latencies for TBE versus
TBE-CH anesthesia
To ascertain the impact of a TBE-CH anesthetic cocktail on mouse AEPs, we
verified several characteristic features of the ABRs (Figure 2.1A). First, the five
characteristic peaks and troughs of the ABR arising from generators are evoked
during anesthesia: spiral ganglion neurons, cochlear nucleus, MNTB, SOC, and
termination of lateral lemniscus fibers into the inferior colliculus (Buchwald and
Huang, 1975). Second, the latency of each of these waves occurs at characteristic
intervals. The first wave (Wave I) arises approximately 1.5 msec post-stimulus,
followed by Waves II – V at roughly one msec intervals thereafter. Third, the latency
of each wave increases slightly as the stimulus intensity is progressively decreased
(i.e. ABRs are right-shifted as stimulus intensity decreases).
Fourth, the lowest stimulus intensity that elicits an identifiable ABR Wave I
approximates the hearing threshold of the mice (Figure 2.1B), the time course of
which is not statistically different between mice anesthetized with TBE (ANOVA; F2,10
= 0.6410, p = 0.5471) or TBE-CH (ANOVA; F4,25 = 1.190 p = 0.3393). Regression
lines for these threshold series have positive slopes (p < 0.05); however, the
average threshold change is negligible at < 7 %. Finally, there are no statistical
differences in the Wave I latencies between the anesthesia groups at any stimulus
intensity (Table 2.1), indicating that both drug regimens have similar initial effects on
the ABRs. Moreover, we find no statistical differences from an ANOVA (Table 2.2,
Figure 2.2) between the cohorts for interpeak latencies of the total ABR (Waves V –
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I; F5,26 = 0.2966, p = 0.91), the peripherally derived ABR components (Waves III – I;
F5,25 = 0.8094, p = 0.55), or centrally derived components (Waves V – III; F5,25 =
0.4545, p = 0.81).
We also compared Wave I latencies as a function of stimulus intensity at 10
min intervals between 10 – 30 min for the TBE and TBE-CH cohorts (Figure 2.3A),
after which the TBE group regain consciousness. The average latencies of Wave I
for all intensities (80 – 30 dB SPL) are adequately described by a one-phase
exponential decay model using non-linear regression (0.66 < R2 < 0.83). The
regression lines for each group converge with time, but never differ by more than
4 % on the ordinate axis at any stimulus intensity or time point, and the ordinate
intercepts are not statistically significant at any time point (p > 0.37). Moreover, the
Wave I latencies between the 10 and 30 min time points differ by no more than 4 %
within each cohort. In addition, we examined the central Wave V latencies as a
function of stimulus intensity at 10 min intervals from 10 – 30 min between
anesthetic groups (Figure 2.3B, Table 2.3). The average latencies of Wave V for all
intensities (80 – 30 dB SPL) can be similarly described using a one-phase
exponential decay model using non-linear regression (0.41 < R2 < 0.63), similar to
Wave I. Taken together, these data indicate that there are negligible differences in
ABR waveforms, latencies or hearing thresholds between the treatment groups over
the time course of the experiment.
ABR amplitudes and latencies are modestly altered by TBE-CH
To determine the effects of TBE-CH on Wave I amplitudes with time, we
measured ABRs in anesthetized mice at 10 min intervals for 50 min at 32 kHz. Our
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Figure 2.1 – ABR threshold series from TBE and TBE-CH anesthetized mice

(A) Representative ABR intensity series from TBE (TBE) or TBE-CH (TBE-CH)
anesthetized mice measured at 10 min intervals post-injection anesthesia. (B) ABR
hearing thresholds from TBE (TBE) and TBE-CH (TBE-CH) anesthetized mice
measured at 10 min intervals post-anesthesia.
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Table 2.1 – F and p values for one-way ANOVAs comparing Wave I latencies
between the TBE and TBE-CH cohorts (Figure 2.3A).
Intensity
10 min
20 min
30 min
dB SPL

F11,48

p

F11,42

p

F11,42

p

80

1.524

>0.05

1.170

>0.05

1.016

>0.05

70

1.560

>0.05

1.170

>0.05

0.811

>0.05

60

1.923

>0.05

1.188

>0.05

0.982

>0.05

50

2.431

>0.05

1.476

>0.05

1.076

>0.05

40

1.742

>0.05

1.476

>0.05

1.529

>0.05

30

2.468

>0.05

1.257

>0.05

0.154

>0.05

Bonferroni post hoc reveals no statistically significant differences between
corresponding intensities.
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Figure 2.2 – Interpeak latencies from TBE and TBE-CH at 10 min intervals

Interpeak latencies were calculated for Waves V – I, V – III, and III – I at 10 min
intervals for 30 min comparing TBE and TBE-CH anesthesia affects. There are no
statistically significant changes for any interpeak latency (Table 2.3).
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Table 2.2 – Interpeak latencies of TBE (TBE) and TBE-CH (TBE-CH)
anesthetized mice at 10 min intervals.
Anesthesia
Time (min)

V–I

III – I

V – III

TBE

TBE-CH

TBE

TBE-CH

TBE

TBE-CH

10

3.75 ± 0.13

3.60 ± 0.14

1.64 ± 0.09

1.64 ± 0.10

2.11 ± 0.14

1.95 ± 0.19

20

3.70 ± 0.19

3.59 ± 0.20

1.67 ± 0.07

1.64 ± 0.11

2.03 ± 0.21

1.96 ± 0.22

30

3.68 ± 0.22

3.60 ± 0.16

1.64 ± 0.05

1.69 ± 0.07

2.04 ± 0.23

1.91 ± 0.07

40

3.63 ± 0.13

1.74 ± 0.10

1.89 ± 0.11

50

3.56 ± 0.14

1.65 ± 0.09

1.91 ± 0.16

36

Figure 2.3 – ABR Wave I and V latency / intensity graphs from TBE and TBECH anesthetized cohorts

(A) Quantified latency – intensity series of ABR Waves I under TBE (TBE) or TBECH (TBE-CH) anesthesia at 10 min post-injection intervals. Data are plotted as
mean ± SD for five mice per treatment. See Table 1 for corresponding one-way
ANOVA p values (B) Quantified latency-intensity series ABR Waves V under TBE
(TBE) or TBE-CH (TBE-CH) anesthesia at 10 min post-injection intervals. Data are
plotted as mean ± SD for five mice per treatment. See Table 2.2 for corresponding
one-way ANOVA p values.
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Table 2.3 – F and p values for one-way ANOVAs comparing Wave V latencies
between the TBE and TBE-CH cohorts (Figure 2.3B).
Intensity
10 min
20 min
30 min
dB SPL

F11,48

p

F11,42

p

F11,42

p

80

1.524

>0.05

1.170

>0.05

1.016

>0.05

70

1.560

>0.05

1.170

>0.05

0.811

>0.05

60

1.923

>0.05

1.188

>0.05

0.982

>0.05

50

2.431

>0.05

1.476

>0.05

1.076

>0.05

40

1.742

>0.05

1.476

>0.05

1.529

>0.05

30

2.468

>0.05

1.257

>0.05

0.154

>0.05

Bonferroni post hoc reveals no statistically significant differences between
corresponding intensities.
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previous studies have shown this to be the optimal stimulus frequency for hearing
experiments, providing greatest amplitudes and lowest thresholds (Gow et al., 2004).
Amplitudes of the waves were obtained from 80 dB SPL to approximately 30 dB SPL,
depending on the hearing threshold of individual mice. At a stimulus intensity of 80
dB SPL (Figure 2.4A), we observe consistent and statistically significant reductions
in Wave I amplitudes (α = 0.05; Table 2.4) at early time points during anesthesia, as
indicated by the positive slopes of the regression lines for all mice. Regression lines
at other stimulus intensities between 70 – 30 dB SPL also have positive slopes for
most of the mice (Figure 2.4B – F). Furthermore, the regression lines for the average
amplitudes differ statistically from zero (α = 0.05; Table 2.4).
Despite these non-zero slopes, the physiological effect of TBE-CH on Wave I
amplitudes is relatively small. Thus, the average amplitude we observe at 80 dB SPL
after 10 min of anesthesia is reduced by 19 %, compared to the 50 min time point
when the mice are beginning to regain consciousness. At lower stimulus intensities,
average reductions in amplitudes are 12 % at 70 dB SPL (Figure 2.4B) and at most
6 % for 60 – 30 dB SPL stimuli. Around the hearing threshold of 30 dB SPL, the
anesthesia has little affect on Wave I amplitudes.
Similar to Wave I amplitudes, the regression lines for normalized Wave I
latencies (Figure 2.5) are statistically non-zero for most individual mice (α = 0.05;
Table 2.5), and all of the averaged data down to the hearing threshold have negative
slopes. Nevertheless the absolute changes in the latencies, which are increased at
early time points, are minimal. Thus, for all stimulus intensities between 80 – 30 dB
SPL, we observe an increase of 3 % or less compared to the 50 min time point.
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Figure 2.4 – Normalized amplitudes of Wave I from TBE-CH anesthetized mice

ABR threshold series were obtained at 10 min intervals during anesthesia for 50 min.
Normalized Wave I amplitudes are plotted as a function of time for stimulus
intensities of 80 dB SPL (A), 70 dB SPL (B), 60 dB SPL (C), 50 dB SPL (D) 40 dB
SPL (E) and 30 dB SPL (F). The data for each mouse are normalized to amplitude at
50 min and the average linear regression line constrained at (50,1) is shown (solid
line) ± 95 % CI (dashed lines). See Table 2.4 for corresponding linear regression p
values.
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Table 2.4 – Tabulated p values of normalized Wave I amplitudes from TBE-CH
anesthetized mice (Figure 2.4).
Stimulus
p values, F1,3
(dB SPL)

Mouse 1

Mouse 2

Mouse 3

Mouse 4

Mouse 5

Group

80

0.006

0.004

0.001

0.001

<0.001

<0.001

70

0.030

0.005

0.054

0.006

0.009

0.003

60

0.542

0.005

0.732

0.112

<0.001

0.051

50

0.060

0.051

0.139

0.588

0.137

0.022

40

0.004

0.977

0.006

0.006

0.030

<0.001

30

0.127

0.009

0.090

1.000

0.010

0.239

F-tests were used to identify statistically significant differences between the null
hypothesis (m = 0), that regression line slopes do not differ from zero, for several
mice (bold, italicized).
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Together, these data demonstrate that the TBE-CH anesthesia causes at most,
minor reductions in Wave I ABR amplitudes and negligible changes in latencies.
The size and stability of Waves I provide the greatest sensitivity for measuring
changes in ABRs, but anesthetics typically have less impact on Wave I compared to
subsequent waves, particularly those derived from central signal generators. Thus,
to determine the effect of TBE-CH anesthesia on the major centrally derived
components, we examined normalized amplitudes and latencies of ABR Waves III
(Figure 2.6, Table 2.6 and Figure 2.7, Table 2.7) and Waves V (Figure 2.8, Table 2.8
and Figure 2.9, Table 2.9).
The Wave III amplitudes (Figure 2.6) are qualitatively similar to the Wave I
data in that the slopes of the regression lines are positive; however the rates of
change with time are much greater. Thus, maximal average amplitudes at 10 min
are 1.5 – 3 fold smaller than those at 50 min, which suggests that Wave III may be
strongly affected by TBE-CH. Unexpectedly, the magnitudes of the amplitude data
are independent of stimulus intensity, which suggests a stochastic effect of the
combination anesthesia. In contrast to the amplitude changes, the normalized
average Wave III latencies (Figure 2.7) are invariant with stimulus intensity or
anesthesia time and the slopes of the regression lines are zero (α = 0.05). Together,
these data suggest that the Wave III amplitudes vary in a stochastic rather than
systematic manner, which may argue against a strong suppression and more toward
increased amplitude variability during anesthesia. Indeed, this variability is reflected
in the large 95 % confidence intervals in the 80 – 30 dB SPL data.
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Figure 2.5 – Normalized latencies of Wave I from TBE-CH anesthetized mice

ABR threshold series were obtained at 10 min intervals during anesthesia for 50 min.
Normalized Wave I latencies are plotted as a function of time for stimulus intensities
of 80 dB SPL (A), 70 dB SPL (B), 60 dB SPL (C), 50 dB SPL (D) 40 dB SPL (E) and
30 dB SPL (F). The data for each mouse are normalized to the latency at 50 min and
the average linear regression line constrained at (50,1) is shown (solid line) ± 95 %
CI (dashed lines). See Table 2.5 for corresponding linear regression p values.
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Table 2.5 – Tabulated p values for normalized Wave I latencies from TBE-CH
anesthetized mice (Figure 2.5).
Stimulus
p values, F1,3
(dB SPL)

Mouse 1

Mouse 2

Mouse 3

Mouse 4

Mouse 5

Group

80

0.001

0.166

0.004

0.236

0.166

<0.001

70

0.001

0.001

0.002

0.670

0.689

0.002

60

0.005

0.166

0.001

0.261

0.099

0.004

50

0.001

0.010

0.112

0.193

0.001

0.005

40

0.046

0.004

0.003

0.052

0.014

0.148

30

0.004

0.031

0.002

0.501

0.166

<0.001

F-tests were used to identify statistically significant differences between the null
hypothesis (m = 0), that regression line slopes do not differ from zero, for several
mice (bold, italicized).

44

Figure 2.6 – Normalized amplitudes of Wave III from TBE-CH anesthetized mice

ABR threshold series were obtained at 10 min intervals during anesthesia for 50 min.
Normalized Wave V amplitudes are plotted as a function of time for stimulus
intensities of 80 dB SPL (A), 70 dB SPL (B), 60 dB SPL (C) 50 dB SPL (D) 40 dB
SPL (E) and 30 dB SPL (F). The data for each mouse are normalized to amplitude at
50 min and the average linear regression line constrained at (50,1) is shown (solid
line) ± 95 % CI (dashed lines). See Table 2.6 for corresponding linear regression p
values.
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Table 2.6 – Tabulated p values of normalized Wave III amplitudes from TBE-CH
anesthetized mice (Figure 2.6).
Stimulus
p values, F1,3
(dB SPL)

Mouse 1

Mouse 2

Mouse 3

Mouse 4

Group

80

<0.001

<0.001

<0.001

<0.001

<0.001

70

<0.001

0.662

0.025

0.701

0.002

60

<0.001

0.008

0.002

0.028

<0.001

50

0.002

0.132

0.010

0.619

0.874

40

<0.001

0.270

0.724

0.007

0.551

30

0.021

0.503

0.258

0.198

0.789

F-tests were used to identify statistically significant differences between the null
hypothesis (m = 0), that regression line slopes do not differ from zero, for several
mice (bold, italicized).
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Figure 2.7 – Normalized latencies of Wave III from TBE-CH anesthetized mice

ABR threshold series were obtained at 10 min intervals during anesthesia for 50 min.
Normalized Wave V latencies are plotted as a function of time for stimulus intensities
of 80 dB SPL (A), 70 dB SPL (B), 60 dB SPL (C) 50 dB SPL (D) 40 dB SPL (E) and
30 dB SPL (F). The data for each mouse are normalized to amplitude at 50 min and
the average linear regression line constrained at (50,1) is shown (solid line) ± 95 %
CI (dashed lines). See Table 2.7 for corresponding linear regression p values.
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Table 2.7 – Tabulated p values of normalized Wave III latencies from TBE-CH
anesthetized mice (Figure 2.7).
Stimulus
p values, F1,3
(dB SPL)

Mouse 1

Mouse 2

Mouse 3

Mouse 4

Mouse 5

Group

80

0.001

0.026

0.002

1

0.002

0.453

70

0.001

0.541

0.015

0.070

<0.001

0.644

60

0.002

0.566

0.015

0.010

<0.001

0.600

50

0.008

0.752

0.028

0.020

0.003

0.872

40

0.391

0.823

0.020

0.004

0.007

0.250

30

0.261

0.076

0.232

0.004

0.013

0.324

F-tests were used to identify statistically significant differences between the null
hypothesis (m = 0), that regression line slopes do not differ from zero, for several
mice (bold, italicized).
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Figure 2.8 shows normalized amplitudes of Waves V at 10 min intervals up to
50 min under combination TBE-CH anesthesia, and normalized amplitudes are
shown from 80 – 30 dB SPL. The regression lines of the averaged amplitude data
between 80 – 50 dB SPL have non-zero slopes (α = 0.05), with maximum amplitudes
of 10 – 21 % greater than the 50 min time point. At 40 and 30 dB SPL, average
Waves V regression line slopes was zero, attributable to the variable increase or
decrease of amplitudes as time progressed. However, in contrast to the Wave I
(Figure 2.4) and Wave III data (Figure 2.6), slopes of the regression lines in Figure
2.8 are negative, which indicates that Wave V amplitudes are supernormal at early
anesthesia time points and decrease as the mice approach consciousness. In
addition, the magnitudes of these changes are independent of stimulus intensity.
These data suggest that TBE-CH does not depress Wave V amplitudes but rather
enhances them, which differs from other common anesthetic combinations used in
the hearing field such as ketamine / xylazine. However, we cannot rule out the
possibility of stochastic anesthesia effects, similar to the Wave III amplitudes,
because of the large variability in the amplitudes between mice.
Wave V latencies for 80 – 30 dB SPL are shown in Figure 2.9. The average
regression line for the 80 – 30 dB SPL latencies have a zero slope (α = 0.05). The
greatest variation in Wave V latency occurs at 30 dB SPL, however the latencies are
2 % greater at 10 min than at 50 min. These data demonstrate that there is little
effect of TBE-CH on Wave V latencies even though the drug combination generally
increases the amplitudes of these waves in our study cohort.
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Figure 2.8 – Normalized amplitudes of Wave V from TBE-CH anesthetized mice

ABR threshold series were obtained at 10 min intervals during anesthesia for 50 min.
Normalized Wave V amplitudes are plotted as a function of time for stimulus
intensities of 80 dB SPL (A), 70 dB SPL (B), 60 dB SPL (C) 50 dB SPL (D) 40 dB
SPL (E) and 30 dB SPL (F). The data for each mouse are normalized to amplitude at
50 min and the average linear regression line constrained at (50,1) is shown (solid
line) ± 95 % CI (dashed lines). See Table 2.8 for corresponding linear regression p
values.
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Table 2.8 – Tabulated p values of normalized Wave V amplitudes from TBE-CH
anesthetized mice (Figure 2.8).
Stimulus
p values, F1,3
(dB SPL)

Mouse 1

Mouse 2

Mouse 3

Mouse 4

Group

80

0.006

0.787

0.002

0.197

0.026

70

0.001

0.053

0.011

0.073

0.417

60

0.097

0.021

0.094

0.729

0.089

50

0.152

0.099

0.168

0.658

0.009

40

0.100

0.325

0.290

0.009

0.700

30

0.065

0.118

0.004

0.005

0.716

F-tests were used to identify statistically significant differences between the null
hypothesis (m = 0), that regression line slopes do not differ from zero, for several
mice (bold, italicized).
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Figure 2.9 – Normalized latencies of Wave V from TBE-CH anesthetized mice

ABR threshold series were obtained at 10 min intervals during anesthesia for 50 min.
Normalized Wave V latencies are plotted as a function of time for stimulus intensities
of 80 dB SPL (A), 70 dB SPL (B), 60 dB SPL (C) 50 dB SPL (D) 40 dB SPL (E) and
30 dB SPL (F). The data for each mouse are normalized to amplitude at 50 min and
the average linear regression line constrained at (50,1) is shown (solid line) ± 95 %
CI (dashed lines). See Table 2.9 for corresponding linear regression p values.
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Table 2.9 – Tabulated p values of normalized Wave V latencies from TBE-CH
anesthetized mice (Figure 2.9).
Stimulus
p values, F1,3
(dB SPL)

Mouse 1

Mouse 2

Mouse 3

Mouse 4

Mouse 5

Group

80

0.001

0.178

0.006

0.477

<0.001

0.257

70

0.002

0.288

0.004

0.099

<0.001

0.180

60

0.003

0.145

0.006

0.448

0.001

0.095

50

<0.001

0.914

0.006

0.757

0.002

0.292

40

0.011

0.256

0.006

0.004

0.001

0.546

30

0.005

1

0.046

0.830

0.009

0.216

F-tests were used to identify statistically significant differences between the null
hypothesis (m = 0), that regression line slopes do not differ from zero, for several
mice (bold, italicized).
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Rapid recovery of mice from TBE-CH anesthesia and normal weight
maintenance
In addition to determining the effect of TBE-CH anesthesia on ABRs, we
examined post-anesthesia recovery times and the safety of the anesthesia in terms
of mouse weight over the subsequent two days. Consciousness was judged to
coincide with several coincident behavioral characteristics: the reappearance of tail
and ear pinch reflexes, an increase in respiratory rate and attempts to ambulate.
Normal activity coincided with the reacquisition of persistent exploring, foraging,
eating and drinking behaviors.
Figure 2.10B shows average times taken for six mice to regain consciousness
and resume normal activity in the cage following TBE or TBE-CH anesthesia.
Although the time to consciousness doubles from 30 min for TBE to 60 min for the
combination anesthetic, there is a modest 20 % increase in the time to regain normal
activity for the combination cocktail. Thus, the addition of choral hydrate extends
anesthesia but does not markedly increase recovery time from consciousness to
normal activity.
A useful indication of the short and medium term effects of anesthesia on
mouse health is obtained by monitoring changes in weight during the post
anesthesia period. Figure 2.10A shows the weights of six animals anesthetized with
TBE-CH normalized to the weight of the mice just prior to injection (Day 0). An
average weight gain of 5 % was observed for most mice after two days, and none of
them lost more than 1.2 % of their pre-anesthesia body weight in the post-
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anesthesia period. Accordingly, we conclude that the acute after effects of the TBECH combination is not detrimental to the normal behavior or health of the mice.
Mild peritoneal vasodilation following TBE-CH anesthesia
Finally, we examined the comparative medium term effects of two doses of
anesthetic, one day apart, on peritoneal cavity appearance in mice injected with PBS,
TBE, or TBE-CH. Figure 2.11 shows the peritoneal cavities of representative mice
before (Figure 2.11A, C, and E) and following (Figure 2.11B, D, and F) detailed
examination of the abdominal organs. Both observers were in agreement that the
superficial appearance of the abdominal organs from the TBE and TBE-CH cohorts
are indistinguishable from the controls at three days post-injection and gut content
and color indicates that all three cohorts were actively feeding. Further, ascites is
absent in all three cohorts, which suggests there is little or no inflammation, and the
organs have normal size, shape and color.
The observers identified several areas of apparent vasodilation in the
intestinal vasculature for both TBE and TBE-CH cohorts compared to the controls,
but the anesthesia cohorts were indistinguishable from each other. Accordingly, we
observe persistent damage to the peritoneal cavity of mice following a single dose of
TBE or the TBE-CH cocktail, although the pathology is mild and non-inflammatory.
This vasodilation likely stems from mild irritation caused by TBE and / or the solvent
2-methylbutan-2-ol because of the similarity of the changes in both anesthetized
cohorts.
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Figure 2.10 – Post anesthesia effect on recovery time and weight

(A) Average times for mice to become conscious from anesthesia and resume
normal activity. Averages are for six mice (mean ± SD) for awake and fully
recovered states. TBE-CH (TBE-CH) anesthetic combination persists for 60 min with
full recovery observed by two hrs, where as TBE alone persists for 30 min with full
recovery by an hr and a half. (B) The weights of six mice are normalized to their
weight on the day of anesthesia. There is no statistically significant change in weight
for this cohort over three days following anesthesia (ANOVA; p = 0.272).
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Figure 2.11 – Mild acute vasodilation in TBE-CH injected abdomens

Saline injected (A and B), TBE injected (C and D) and TBE-CH injected (E and F)
abdominal cavities post sacrifice indicate normal coloration, morphology and shape
of abdominal structures. Control (B), TBE injected (E), and TBE-CH injected (F)
intestines upon further examination highlight differences in vasodilation along
intestines and septum. Black arrowheads indicate increased vasodilation in the
peritoneal cavity.
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DISCUSSION
For decades, studies in rodents have employed TBE anesthesia for AEPs
because of its ease of preparation and use; TBE is not a controlled substance
subjected to State and Federal regulations, is readily available, easily prepared, is
safe and rapid-onset anesthetic that can be used over a wider dosage range
(Gaertner et al., 2008; Papaioannou and Fox, 1993; Weiss and Zimmermann, 1999).
Anesthesia with this drug causes loss of righting reflexes, absence of responses to
tail and ear pinching, muscle relaxation and decreased skeletal respiratory activity
within 1 – 2 min (Gaertner et al., 2008; Norris and Turner, 1983; Papaioannou and
Fox, 1993).
Concerns about the use of TBE have arisen in the past because this drug has
been associated with contradictions including intestinal ileus, peritonitis, muscle
necrosis, serositis of abdominal organs, and death (Tarin and Sturdee, 1972; Zeller
et al., 1998). Detailed examination of previous studies lacked crucial information
regarding the preparation, monitoring, and storage conditions of both the stock and
working solutions (Buetow et al., 1999; Gaertner et al., 2008; Weiss and
Zimmermann, 1999). TBE has a short half-life and can break down into hydrobromic
acid and dibromoacetaldehyde. These compounds are hypothesized to decrease the
pH of the solution below 5 and likely cause the aforementioned contradictions
(Lieggi et al., 2005; Nicol et al., 1965; Norris and Turner, 1983; Papaioannou and
Fox, 1993). To minimize complications and increase the efficacy of the anesthetic,
TBE should be dissolved in 2-methylbutan-2-ol, stored at 4°C and away from light for
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no longer than two weeks, and the pH of the solution checked before use (Lieggi et
al., 2005; Weiss and Zimmermann, 1999).
Nevertheless, a single dose of TBE provides only 25 – 30 min of anesthesia,
which limits the scope of experiments that can be performed. Our interest in
characterizing binaural hearing in mice prompted a search for anesthetics that
increase anesthesia time to one hr. Rather than a major change to different drugs,
which would yield results that may be difficult to compare with our previous studies,
we opted to test a novel cocktail using TBE as a base anesthetic overlaid with low
dose CH to extend effective anesthesia time while minimally changing the
fundamental characteristics of the centrally derived ABR waveforms.
The routine dose of TBE that is used for AEP studies in our lab is 375 mg / kg
(Gow et al., 2004). We have previously observed that significantly increasing the
dose to 500 mg / kg, as used by other groups, extends anesthesia time, but at the
cost of significant reductions in ABR amplitudes (Zheng et al., 1999). Repeated IP
injections of 375 mg / kg within the same testing period are impractical considering
the sensitivity of electrode and sound tube placement and lingering anesthesia from
the initial dose of TBE can alter the level of overall anesthesia affecting waveforms.
Chloral hydrate has been used as a reliable sedative for more than a century
(Gaertner et al., 2008; Hetzler and Dyer, 1984). It is often considered to be a
suboptimal anesthetic for rodents because it has poor analgesic properties and,
indeed, most contemporary surgical procedures involve anesthetics with strong
analgesic properties (Flecknell, 1996). Typical doses of CH for rodents with which a
surgical level of anesthesia is induced ranges from 300 – 400 mg / kg and confers
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effective anesthesia for 1 – 2 hrs. Numerous studies have demonstrated that the
dose of CH has a linear relationship to anesthesia time (Field et al., 1993; Flecknell,
1996; Smith and Kraus, 1987). At greater dosages, above 350 mg / kg, or with
repeat injections, CH has been shown to have a proportional impact on various
electroencephalography recordings by increasing waveform latencies and altering
amplitudes (Field et al., 1993; Smith and Kraus, 1987). However, at low to moderate
doses, ≤	
 300 mg / kg, CH preserves the electroencephalography waveforms in rats,
which is an important consideration for psychoacoustic studies (Sisson and Siegel,
1989).
The least invasive method to collect AEP measurements is via short-term
anesthesia. Surgical implantation of a recording device is not required, thus
alleviating any deleterious effects from surgery, data collection can begin without
delay, and a greater number of data points (animals) can be gathered more
efficiently. One compromise by using an acute anesthetic versus a surgically
implanted device is the inherent decrease in the signal-to-noise ratio (SNR).
Classically defined as SNR = Signal / Noise, this ratio relates the detectability of
desired signal in background noise where a greater numerical SNR value indicates
increased detectability of signal. To compensate for low SNR in anesthetized
animals arising from the use of subdermal electrodes rather than implants, a greater
number of recordings can be averaged together.
All forms of anesthesia have their advantages and disadvantages that must
be taken into account for specific applications. Herein, our goal was to extend
anesthesia time in mice without compromising AEP measurements, however, this
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did not seem attainable with the aforementioned alternative anesthetic compounds.
Barbiturates tend to increase hearing thresholds, variably affect amplitudes, or
strongly suppress EEG waveforms compared to awake animals (Feng et al., 2007;
Shaw, 1986; Smith and Kraus, 1987). Likewise, the dissociative agent cocktail
ketamine / xylazine, although most commonly employed has been shown to
suppress ABR amplitudes by 20 % and increase wave latencies by 1 msec in
rodents when compared to awake recordings (McGee et al., 1983; Santarelli et al.,
2003; Stronks et al., 2010; van Looij et al., 2004). Using the combination TBE-CH
anesthesia, we observe negligible changes in wave latencies and non-systematic
changes in amplitude, when compared to TBE alone.
Herein, we demonstrate that 375 mg / kg TBE followed after five min by 200
mg / kg CH is safe for mice, roughly doubles the anesthesia time to around 60 min,
and has non-systematic effects on the ABR amplitudes (Maheras and Gow, 2013). A
more reliable measure of these waves is to examine latencies as shown in Figures
2.5, 2.7 and 2.9. The regression lines for the averaged latencies have slightly
negative or zero slope indicating consistency throughout anesthetic time. Because of
the tight relationship between ABR wave amplitudes and latencies, it is reasonable
to conclude that variability in amplitude we observe stem from inter-subject effects,
such as technical placement of the subdermal electrodes, rather than systematic
suppression of the ABRs by the anesthetic combination.
In light of our data, TBE-CH anesthesia is superior to other commonly used
anesthetics in AEP studies. Amplitudes and latencies of ABRs measured from
awake mice are similar to the values we observed under TBE anesthesia alone (van
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Looij et al., 2004). Using the combination TBE-CH anesthesia, we observe negligible
increases in wave latencies and non-systematic changes in amplitude, which is a
preferable and more consistent method for collecting and analyzing AEPs.
We find that the timing for the administration of TBE and CH to mice is
important. Initial experiments involved injecting these anesthetics in quick
succession, first TBE then CH. However, this protocol leads to acute gasping and
body twitching in some mice and occasionally a failure to induce effective anesthesia.
However, administration of TBE to rapidly induce unconsciousness at a level where
reflexes are absent, followed by CH, yields no adverse effects. Typically, we use a
time delay between TBE and CH injections of approximately 5 min.
The most common side effects from IP injected anesthetics include transient
weight loss and peritoneal irritation or inflammation (Gaertner et al., 2008). In Figure
2.10A, we demonstrate using ANOVA that there are no statistically significant
changes in weight for TBE-CH injected mice over the three days following
anesthesia (p = 0.272). Figure 2.11 shows that the peritoneal cavities of these mice
sacrificed three days post injection with TBE-CH (Figure 2.11E and F), TBE alone
(Figure 2.11C and D) and even saline injected controls (Figure 2.11A and B) exhibit
mild signs of vasodilation around the intestines and normal abdominal organ color
and morphology. The similar extent of vasodilation between the TBE and TBE-CH
cohorts suggests that CH contributes minimally to peritoneal irritation. Finally, there
is no evidence of ascites in the peritoneal cavity of the anesthetized mice, which
indicates that inflammatory responses are minimal.
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CHAPTER 3 – slowed conduction velocity impacts neural
processing
INTRODUCTION
Sensory perception is governed through five classic modalities: vision,
hearing, taste, touch, and smell. All five senses begin as a physical event that
stimulates receptors, transforming stimulation into electrical impulses that travel to
the brain. As a result, the brain forms a perception or conscious experience from the
initial stimuli event. When triggered, each sensory modality encodes four elemental
characteristics of the stimulus: modality, location, intensity, and timing. Combined
with diverse receptors and a fine-tuned network, complex experiences develop in
each modality (Kandel et al., 2000). For instance, vivid images can be envisaged, a
classical symphony perceived, a delicate touch felt, and bold flavors entertained.
This chapter focuses on audition detailing and interrogating key features of sound
utilized within this modality.
The auditory pathway differentiates characteristics of sound for processing
Sound perception relies on the ability to localize the spatial positioning of a
sound source. Being able to isolate the necessary cues and eliminate redundant or
irrelevant sound information improves clarity and aids in the survival instinct, such as
the fight or flight response. Sound cues are non-redundant and provide spectral,
timing, and intensity information about the sound source. These features have
differing levels of importance depending upon the species.
Critical factors determining which sound features are optimally exploited
include head shape and relative ear location. The auricle, or outer ear, and shape of
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the head filter incoming stimuli that must then be dissociated from the actual spectral
information emitted. These physical features are advantageous: the size of the head
can cause a shadowing effect, distorting sounds and creating a perceivable intensity
difference between ears, and the difference in path length between ears can
generate delays in the arrival of a sound to each ear. These physical attributes of an
animal generate non-redundant sound cues and increase resolution of the spatial
location for a sound source (Schnupp et al., 2011).
There are two major axes pertaining to the head and the location of a sound
source: the vertical plane (front / back, above / below) and the horizontal plane, or
azimuth (left / center / right). Auditory cues used to isolate the origin of a sound
along the vertical axis originate from the frequency and phase of the sound, together
with interference patterns generated by the head, torso, and auricle. These physical
outer structures produce differential stimulating patterns on inner ear structures, and
thereby preserving sound cue information.
The representation of location for the origin of a sound source along the
azimuth plane must be computed from the input of signals from both ears. First
proposed in the late 1800s, the duplex theory of binaural hearing states that the
primary acoustic cues used to lateralize sounds (pure tones) are discrepancies in
the arrival (timing) and level (intensity) of signals that reach each ear. As proposed,
differences in sound intensity are best discriminated at higher frequencies, whereas
timing disparities are best differentiated at lower frequencies (Rayleigh, 1907).
These features are known as interaural level differences (ILDs) and interaural timing
differences (ITDs) respectively. The generation of intensity and timing differences
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arises from the shielding effect of the head, altering the physical dimension of the
auditory cue. The head creates a shadowing effect upon the ear farthest away from
the sound source, diminishing the sound intensity and delaying its arrival.
Sound information is encoded and relayed through the auditory pathway
The earliest encoding of timing and intensity cues begins in the peripheral
auditory pathway with the basilar membrane, which, like most regions of the auditory
pathway, is tonotopically structured. Its tapered structure generates a stiffer
membrane near the narrow base, and a more relaxed, wider structure near the apex.
High frequency sounds cause maximal deflection of the membrane near the base,
and low frequency sounds maximally deflect near the apex. Resting on the basilar
membrane is the organ of Corti in which inner hair cells reside. These cells further
promote the encoding of auditory cues by electrically depolarizing at their best
characteristic frequency, or frequency which elicits the greatest response. When an
inner hair cell depolarizes, it stimulates the spiral ganglion neurons that innervate
each hair cell. The axons of spiral ganglion neurons carry the frequency specific
stimulus information established in the periphery to the central auditory pathway via
their collective axons, known as the auditory or VIIIth nerve. When the auditory nerve
enters the cochlear nucleus, it bifurcates and innervates each division: dorsal (DCN),
posteroventral (PVCN), and anteroventral (AVCN) along their tonotopic axes.
Within the AVCN, there are two main cells types that preserve encoded
information: stellate and bushy cells (Kandel et al., 2000; Webster and Trune, 1982).
As
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electrophysiological properties differentiate these two populations (Oertel, 1983;
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Oertel et al., 1990; Webster and Trune, 1982; Wu and Oertel, 1984). Stellate cells
have several asymmetrical dendrites and regularly spaced action potentials. They
are thought to be the origin of the chopper response by which auditory nerve inputs
cause the cells to fire at regular rates despite noise and variations in stimulus
frequency. Conversely, bushy cells have a single dendrite with modest branching
and elicit only one action potential. Bushy cells receive direct input from the auditory
nerve fibers forming the sizeable, quick-response synapse known as the endbulb of
Held (Cant and Morest, 1979; Fekete et al., 1984; Tolbert and Morest, 1982). Two
classes of bushy cells, spherical and globular, have distinct physiological properties
and projections to the pons for binaural processing. Helping to preserve auditory
stimulus information, the bushy cells have a unique ability to phase lock with high
precision, causing increased synchronization for auditory nerve fibers with similar
characteristic frequencies (Joris et al., 1994; Smith et al., 1991; Smith et al., 1993).
From the AVCN, afferents from both the spherical and globular bushy cells
innervate principle cells in three key nuclei of the superior olivary complex (SOC):
the medial nucleus of the trapezoid body (MNTB), the medial superior olive (MSO)
and the lateral superior olive (LSO). Principle cells in the MSO and LSO act as
coincidence detectors and process the preserved sound encoded electrical signals
from each ear to represent the sound source location on the azimuth plane; the
MNTB principle cells act as a signal relay and sign inverter for signals being relayed
to the LSO.
The MSO is specialized to process minute differences in the timing of signals
arriving from each ear to aid in sound lateralization in the azimuth plane. Three
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different cells types are known to exist in the MSO: multipolar, marginal and principle
cells. The principle cells are most likely to be the coincidence detecting cell because
of a vast dendritic arbor extending in the medial / lateral direction (coronal view), as
well as along the rostral / caudal axes (Kiss and Majorossy, 1983). The principle
cells receive excitatory glutamatergic input from spherical bushy cells of both the
ipsilateral and contralateral AVCN. Ipsilateral spherical bushy cell axons synapse
onto the lateral side of the dendritic arbor, whereas contralateral axons synapse
towards the midline (Lindsey, 1975; Stotler, 1953). Termed EE (for excitatoryexcitatory) cells, the principle cells in the MSO process incoming signals by
summation; if the added depolarization from both ears is great enough, the principle
cells will fire.
Lateral superior olive principle cells receive ipsilateral information directly
from the ipsilateral AVCN (Cant and Benson, 2003; Doucet and Ryugo, 2003), but
information from the contralateral cochlea is relayed through afferents that first
synapse in the MNTB (Cant and Casseday, 1986; Kandler and Friauf, 1993; Kil et al.,
1995; Kuwabara and Zook, 1991). To help preserve the temporal accuracy of
contralateral signal transmission to the LSO, giant specialized synapses known as
calyces of Held are located within the MNTB (Guinan and Li, 1990; Held, 1893;
Kopp-Scheinpflug et al., 2008; Morest, 1968; Smith et al., 1991; Wu and Kelly, 1993).
These synapses form between the presynaptic axon terminals of globular bushy
cells in the contralateral AVCN and principle cell perikarya in the ipsilateral MNTB.
The afferents form a giant cup-like structure with finger-like processes, which
surround over half of the principle cell area. Additionally, principle cells of the MNTB
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are approximately five times the size of other cells in the mammalian brain. These
unique features enable the rapid transmission of signals, with precision, for sound
processing in the LSO.
The LSO is specialized to process differences in intensity for sound
localization in the azimuth plane. Detection of intensity differences is complimentary
to timing differences (MSO specialty), both of which are utilized for sound
discrimination in the form of electrical signals from each cochlea arriving onto
principle cells. Lateral superior olive principle / binaural cells receive direct,
excitatory, intensity encoded, ipsilateral information from spherical bushy cell axons
originating in the ipsilateral AVCN (Cant and Benson, 2003; Doucet and Ryugo,
2003). Information from globular bushy cells in the contralateral AVCN starts out
glutamatergic when synapsing in the MNTB, however MNTB principle cells invert the
signal to inhibitory when projecting onto the LSO. Thus, LSO principle cells are EI
(excitatory-inhibitory) in nature and depolarization and subsequent firing depends
upon overcoming the inhibitory hyperpolarization of these neurons.
Binaural sound information in the azimuth plane is processed by SOC nuclei
To determine the spatial directionality of a sound source in the azimuth plane,
incoming electrical signals from both ears that synapse on SOC principle cells are
processed. Two main hypotheses describe how neurons differ in their azimuth
coding frequencies and are known as the population and hemifield models (Phillips,
2008). First characterized in barn owls, the population model posits that individual
neurons are focally tuned to narrow ranges of ITDs or ILDs, spanning the relevant
frequency range for that animal. Responsiveness or sensitivity arises from the
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differing path lengths between the two ears and the selective neurons that respond
to sound stimuli. This hypothesis supports a coincidence detection model to describe
the arrival and processing of sound in MSO principle neurons and is known as the
Jeffress model for neural processing (Jeffress, 1948). The model relies on a series
of coincidence detecting cells (principle cells) and neural delay lines to these cells,
comprised of serial connections of each axon to adjacent coincidence-detecting cells.
Coincidence detecting cells receive excitatory neural signals from both the left and
right ears and uses the delay lines to equalize the differing distances signals must
traverse from each ear. Based on this output, the location of the sound in the
azimuth plane can be determined. Importantly, depolarization of a principle cell only
occurs when inputs from both neural pathways arrive in near coincidence. Excitatory
information synapsing from a single delay line axon from one side is insufficient to
generate action potentials; signals must arrive from both ears almost coincidently to
depolarize the principle cell.
The Jeffress model is the generally accepted model for neural processing in
birds and mammalian MSO, however this hypothesis is controversial. For example,
McAlpine and colleagues (2001) used single neuron recordings in guinea pigs to
show that some tuning frequencies of the ITD were inconsistent with the Jeffress
model and many of the calculated best ITDs were beyond the physiological range of
detection. The authors hypothesized this may stem from uncharacterized inhibitory
projections that were targeting the MSO neurons. Additional studies that blocked
these inhibitory projections from the MNTB and the lateral nucleus of the trapezoid
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body (LNTB) were shown to alter ITD tuning curves, once again, shifting peaks
outside of their physiological range (Brand et al., 2002).
Modeling how binaural information is processed in the LSO has been more
challenging than the MSO. Lateral superior olive principle neurons have a chopperlike response in which a highly regular discharge pattern of repetitive firing is seen.
Due to the extensive dendritic arborization of principal cells and diffuse synaptic
inputs from the AVCN, MNTB and other nuclei, a simple linear relationship between
bilateral inputs and subsequent output is implausible. Rather than passive
membrane properties, LSO principle neurons are thought to have active membrane
properties allowing for rapid temporal firing patterns (Adam et al., 2001). Thus, the
specification of a universal principle cell binaural model for lateralizing sound in
space is misleading. An alternate hypothesis, the hemifield model, appears to be
more suited for describing binaural information processing in the LSO.
Auditory evoked potential studies in humans and animals have demonstrated
that interaural level and timing differences are major determinants for high fidelity
acoustic perception near the midline (McAlpine and Grothe, 2003; Mills, 1958;
Phillips and Brugge, 1985). In humans, this relationship is linear for small and
medium level and timing differences but is non-linear for larger differences (Yost,
1974, 1981). Such data suggest neuronal subpopulations capable of precise
acoustic perception along the midline and distinguishing broad hemifield level and
timing differences more laterally.
In contrast to the narrow range of intensity differences proposed by the
Jeffress model, the hemifield model posits that neurons are tuned to a broad range
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of interaural timing and intensity variations, but a subset of neurons are also
specialized for sound detection near the midline, or medial boarder between
hemifields. A sound source emanating from the midline of the azimuth plane will
activate two distinct channels of neurons, in either the left or right hemifield, and
those spanning the medial boarder. Contrasting the Jeffress model, where the timing
or spike rate of neuronal firing encodes the magnitudes of timing and intensity
differences between left and right ears, the responsiveness or sensitivity of neurons
in the hemifield model arises from the distribution of firing activity across a small
number of neural channels. (Dingle et al., 2012; Phillips, 2008; Phillips and Hall,
2005). A number of recent psychoacoustic studies support the hemifield model of
neural processing with two populations of neurons.
Inaccuracies in the perceptual representation of a sound source can be
elicited under specific conditions. For example, a phenomenon known as the
auditory saltation illusion occurs when the processing of sound from one side of the
head interferes with a subsequent sound on the opposite side, causing signal
contamination. The perceived sound source is neither from the left nor the right, but
along the midline (Bremer et al., 1977; Phillips and Hall, 2005; Shore et al., 1998).
Further, a similar illusion is evoked during selective adaptation when a population of
neurons within the LSO adapts to a tone at a specific frequency. Once saturated,
further stimulation with the adapter tone and frequency causes a shift in perception
(Phillips et al., 2006; Phillips and Hall, 2005). Additional support for the hemifield
model comes from studies employing gap detection (Boehnke and Phillips, 1999)
and spatial release from masking (Phillips et al., 2003) paradigms.
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The classic Jeffress model of neural processing posits that neurons are
focally tuned to narrow ranges of timing and intensity delays that span the relevant
frequency range for that animal. The spatial location in the azimuth can be
determined depending upon which principle cells fire maximally. Single cell
electrophysiological recordings of MSO principle cells support this population model
of neural processing; however firing patterns of LSO principle cells is drastically
different. Auditory evoked response recordings from humans and animals propose a
two-neuron model to describe how LSO principle cells process differences in level
intensities. This model describes two different populations of neurons: those
optimized for firing when sound originates from the left or right hemifield, and a
second population that spans the midline between the hemifields.
In both models of sound processing, the transmission of auditory signals from
both ears to integration centers in the SOC is critical. To achieve temporal fidelity of
signal transmission, fibers in the auditory brainstem are myelinated, increasing
propagation speed and accuracy of dissemination. Herein, we investigate the
consequence of dysfunction myelin on sound lateralization. A decrease in myelin
membrane resistance due to the absence of electrically sealing Claudin11 tight
junctions produces dysfunctional myelin, most notably for small diameter myelinated
fibers. Larger diameter fibers have a greater number of wraps, increasing resistance
and offsetting the tight junctions (Devaux and Gow, 2008). Using the Cldn11-/-Tg+/mouse model, we conclude that sound lateralization mirrors a two-neuron
hypothesis. Stimulating sound near the midline elicits a steep, linear pattern neural
response, whereas and a non-linear gradual response is perceived as sound is
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lateralized to a hemifield. Data collected from dysfunctional myelin mutant mice
highlight the importance of small diameter myelinated axons in the auditory pathway.
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MATERIALS AND METHODS
Generation of transgenic mice
The Osp20 transgene construct (GS605) comprises a 22 kb Sau3A I
fragment of genomic sequence from 5 kb upstream of the transcription start site in
exon 1 to 1.9 kb downstream of the first polyadenylation site in exon 3. The unique
Acc65 I site near the 5’ end of intron 1 was blunted – out distinguishing the
transgene from the endogenous Cldn11 gene during qPCR analysis. The genomic
fragment was cloned between two Not I sites in a pUC18 – based vector (Gow et al.,
1992) and was excised and phenol : chloroform – purified from an agarose gel slice
for male pronuclear injection. This allele is referred to as Tg(Cldn11)605Gow
(MGI:5306245), and for the purposes of this dissertation as Tg+/-. Transgene
expression was demonstrated for the testis and inner ear, but not brain (Wu et al.,
2012). Additionally, this transgene restored the known male sterility phenotype in
Cldn11-/- mice (Gow et al., 1999) and the premature hearing loss stemming from
diminished endocochlear potential (Gow et al., 2004) (unpublished data).
Double mutant F1 Cldn11+/-:Tg(Cldn11)605GowTg/+ (Cldn+/-:Tg+/-) mice were
generated by breeding males from Tg(Cldn11)605Gow with Cldn11-/- females. These
mice were sib-mated to generate F2 (and beyond) Cldn11-/-Tg+/- mice (as well as
control Cldn11+/-Tg+/-) for experiments. These mice were used for all experiments
except where noted.
Auditory brainstem responses (ABRs) and interaural level delays (ILDs)
Mice were anesthetized by intraperitoneal (i.p.) injection of freshly prepared
2,2,2-tribromoethanol in sterile phosphate buffered saline (PBS) (Cellgro, Manassas,
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VA) at a dose of 375 mg / kg. Mice were monitored for the absence of tail, foot, and
ear reflexes, as well as reduced respiratory rate, all of which are indicative of
effective anesthesia. Once confirmed, mice were injected i.p. with 200 mg / kg
chloral hydrate (Sigma, St Louis, MO) in sterile phosphate buffered saline to
maximize anesthesia time (Chapter 1), and placed on a 39°C pad (Maheras and
Gow, 2013). The fur along the top of the head and middle of the back of each mouse
was sterilized / moistened with alcohol pre pads (Triad Group, INC, Harland WI) and
subdermal platinum electrodes (Grass Technologies, West Warwick, RI) were
positioned at the left and right mastoids (negative), vertex (reference) and
hindquarters along the midline (ground) for recording.
For auditory brainstem responses (ABR), mice were presented with 512 puretone stimuli in 10 dB SPL decrements from 80 – 20 dB SPL at 32 kHz (102 µsec
duration; Blackman envelope) at a stimulus rate of 29.1 / sec. Both right and left ears
were tested successively and ipsilateral EEGs were pre-amplified (x 100,000), band
pass filtered (0.3 – 3 kHz), and recorded for 12.5 msec (Sepwin software version 5.1,
Intelligent Hearing Systems, Miami, FL). Interaural level delay (ILD) measurements
were collected once a symmetrical hearing threshold of ≤	
 40 dB SPL was confirmed.
For ILDs, mice were presented with 2,048 pure-tone stimuli at 32 kHz (102
µsec duration; Blackman envelope) and a stimulus rate of 29.1 / sec. All EEGs were
pre-amplified (x 200,000), band pass filtered (10 – 3000 Hz), and recorded for 25
msec (Sepwin software version 5.1, Intelligent Hearing Systems, Miami, FL). The
advanced module was utilized to present ipsilateral and bilateral stimuli of differing
intensities to each ear. First, midline level delays were obtained by playing 70 dB
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SPL to either the left ear or right ear, then simultaneously. Subsequently, left ear
stimulus intensity was decreased to 68, 65, 60, 50, then 40 dB SPL in conjunction
with and without a 70 dB SPL stimulus presented to the right ear. This process was
reversed and right ear stimuli were reduced to 68, 65, 60, 50, then 40 dB SPL in
conjunction with and without a 70 dB SPL stimulus presented to the left ear. See
Table 3.1 for clarification.
To obtain binaural interaction components (BICs), we determined that postfiltering traces from 10 – 500 Hz was optimal. First, a midline BIC was acquired by
summing monaural left and right ipsilateral traces (µV weighted) obtained at 70 dB
SPL, then subtracting this summed trace from the binaural trace obtained when 70
dB SPL was presented bilaterally. Two midline BIC traces were obtained, one from
each ear. Subsequent ILD BIC traces were generated in a similar fashion. Left ear
BIC were generated by adding the monaural left ipsilateral trace obtained at <70 dB
SPL to the monaural right ipsilateral trace obtained at 70 dB SPL. The resulting
summed monaural trace was then subtracted from the corresponding binaural trace
(See Figure 3.1). This process was repeated for the right ear. After the completion of
experiments, the mice were allowed to recover in a separate cage on a 39°C heating
pad (Delta phase isothermal pad, Braintree Scientific, Braintree, MA) until they
regained normal activity and could be placed back in their home cage.

76

Figure 3.1 – Schematic for calculation of the BIC

A Binaural traces were obtained by simultaneously stimulating both ears with
differing sound intensities and the response recorded. Left and right ear monaurals
were obtained by individual stimulation with corresponding sound intensity and
traces recorded. The binaural interaction component was generated by summating
the two monaural traces and subtracting from the binaural.
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Dextran Labeling
CD – 1 female mice (Crl:CD1(ICR) Charles River, Wilmington, MA) were
perfused with 10 ml of freshly oxygenated artificial cerebral spinal fluid (aCSF:
126mM NaCl, 3mM KCl, 2mM CaCl2, 2mM MgSO4, 1.25 mM NaH2PO4, 26 mM
NaHCO3, 10mM dextrose, pH 7.4) at a rate of 2 ml / min (PHD 22/2000 Syringe
Pump Infusion, Harvard Apparatus, Holliston, MA). Brains were promptly removed
and 2 ml coronal sections isolating the lower auditory brainstem nuclei were
harvested extending from interaural -1 to -3 using a mouse anodized aluminum
matrice (BS-AL 5000C, Braintree Scientific, Braintree, MA). Coronal sections were
allowed to rest for an hr in a 60 x 60 millimeter petri dish (BD Falcon, Franklin Lakes,
NJ) filled with aCSF and perfused continuously with carbox gas (95% O2, 5% CO2).
Custom microinjection needles 10 – 20 µm in diameter were pulled from glass
capillary tubes using a puller (Narishige, Tokyo, Japan). Needles were back-filled
with 3 µl of a 50 mg / ml solution containing Alexa488 labeled dextran dye
(CAT#:D22910, 10000MW, Molecular Probes, Eugene, OR) then attached onto a
digital microdispensor (CAT#:53506-121, VRW International, Radnor, PA) clamped
onto a micromanipulator (Narishige, Tokyo, Japan).
Mouse brain slices were transferred, one-by-one from the resting dish to a
separate 60 mm dish containing freshly carbox-perfused aCSF under a
stereomicroscope (Leica Zoom 2000, Leica, Solms, Germany). Approximately 30 to
50 nl of dextran dye was quickly injected into a single location and the brain slice
was immediately returned to the resting dish for four hrs to allow sufficient time for
endocytosis of the dye and transport along axons. During this time, the carbox-

78

perfused aCSF was replaced every hr and pH monitored. After labeling, brains were
immersion-fixed overnight with shaking at 4°C in a fresh 60 mm dish containing 4 %
PFA in phosphate buffer, pH 7.2. The following day, brains underwent five x 15 min
washes in PBS in preparation for vibratome sectioning.
Vibratome
Dextran dye-labeled coronal mouse brain sections were removed from PBS,
blotted dry, placed into a 15 x 15 mm cryomold (Electron Microscopy Science,
Thermo Fisher Scientific, Waltham, MA), and overlaid with 4 % low-melt agarose
(Agarose Products, Nesbit, MS). The agarose was allowed to solidify at room
temperature for 10 min before being moved to 4°C for 20 min. Molds were removed
from 4 C, the gel excised, trimmed, and superglued to a vibratome chuck. Coronal
sections of approximately 70 µm thick were cut at room temperature and transferred
using an artist brush into individual wells of a 24-well dish (Fisher) containing PBS.
Immunofluorescence staining of vibratome sections
Individual 70 µm vibratome sections were stained in separate wells of a 24well plate using a minimum of 200 microliters solution during each step. Sections
were permeabilized in blocking solution comprised of TBSGBA (1X TBS pH 7.5,
0.1 % gelatin, 1 % BSA, 0.05 % sodium azide, 2 % goat serum) and 0.5 % triton X100 for one hr. Blocking solution was removed and replaced with primary antibody
(See Table 3.2) diluted fresh in blocking solution. Primary antibody incubation was
carried out for three overnight periods with gentle agitation at 4 C. Primary antibody
liquid was removed and washed with PBS plus 0.5 % triton X-100, twice, for 30 min.
Wash solution was removed and replace with the secondary antibody (See Table
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3.3) diluted in blocking solution. Slices were incubated with secondary antibody for
six hrs at room temp with gentle agitation. The secondary antibody liquid was
removed and replaced with DAPI solution diluted in PBS plus 0.5 % triton X-100 for
ten min. DAPI solution was removed and the sections washed with PBS plus 0.5 %
triton X-100, twice, for thirty min. Sections were free-floated in PBS and carefully
mounted to slides using a paintbrush. Sections were covered with Vectashield
mounting medium (Vector Labs, cat#H1000), coverslipped, and sealed with nail
polish.
Confocal microscopy and axon diameter measurements
Confocal fluorescence image stacks of dextran-labeled axons were captured
using a Leica DM5500B microscope equipped with a Plan Apo 63x lens, Yokogawa
spinning disk confocal with Argon/He/Ne lasers (QLC100, Visitech International,
Sunderland, United Kingdom) and a Hamamatsu Orca ER2 digital camera. Confocal
image stacks were acquired using a 63x Plan Apo oil-immersion objective lens (n.a.
= 1.4) in 0.2 µm increments through 70 µm vibratome sections.
After collection, stacks were quantified using Image J software. The location
of each fiber within a stack was determined and mini stacks were flattened into
single through-focus images for analysis of individual fibers. Axons were analyzed
only if the entire length could be followed with confidence throughout the image
stack. Axon diameters were manually drawn at random along the length of the axon,
resulting in 20 – 30 measurements per fiber. To discern contralateral auditory fibers
from pyramidal fibers, only axons attached to a calyx of Held were analyzed.
Average axon diameters from multiple mice were used to generate the histograms
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shown in Figures 3.5 and 3.6 using 0.2 µm as the binning factor and fit with a
Gaussian distribution (Graphpad).
Cryostat sectioning of PFA-perfused brain
Cldn11-/-Tg+/- mice were injected i.p. with 400 mg / kg avertin, and monitored
for the absence of reflexes, signifying deep anesthesia. The chest cavity was
exposed using scissors, and mice were perfused transcardially with 4 % PFA (Sigma
Aldrich, St Louis, MO) in 0.1 M phosphate buffer pH for 15 min. Brains were
immediately removed and place in a 25 % sucrose solution over night at 4 C.
Sucrose solution was changed the next morning and brains prepped for embedding
that afternoon. Brains were removed from the sucrose solution, blotted dry on a
Kimwipe (Kimberly-Clark Corp, Roswell, GA) placed in a plastic cryomold (Tissuetek, cat #4557, Torrance, CA), and covered with OCT (Tissue-tek OCT, Andwin
Scientific, Schaumburg, IL). Blocks were gradually frozen using ice-cold 2-methyl
butane and stored at - 80°C until cutting.
Frozen blocks were cut using a Shandon Electric Cyrotome (Pittsburgh, PA).
Sagittal 10 µm sections were collected on charged superfrost slides (Fisherbrand,
Thermo Fisher Scientific, Waltham, MA) beginning at the midline and progressing
laterally. Every fifth section (50 µm) was collected and stored at - 80°C until staining.
Immunofluorescence staining for cryostat sections
Superfrost slides were removed from the - 80°C and immediately thawed in a
glass vial containing PBS and washed twice for five min. Slides were permeabilized
with methanol for 20 min at 4°C. Slides were washed in PBS, excess liquid removed,
outlined brains using a pap pen, and immersed with blocking solution (TBSGBA +
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2 % goat serum) for an hr. Blocking solution was removed and replaced with primary
antibodies (Table 3.4), diluted in blocking solution. Primary antibodies were
incubated over night at room temperature while rocking. Primary antibody was
removed and slides washed with PBS. Secondary antibodies (Table 3.5) diluted in
blocking solution were placed onto sections for three hrs while rocking at room
temperature. Slides were washed once more in PBS, the pap pen removed using a
cotton bud soaked with chloroform, a drop of Vectashield mounting medium added
over the section and coverslipped. Slides rested overnight, excess mounting
medium removed, and edges of the coverslip sealed with clear nail polish the
following day.
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RESULTS
Cldn11-/-Tg+/- mice have altered ABRs
Evoked potentials can be elicited using a number of sensory modalities, but
our interest lies in the well-characterized ascending auditory pathway. Figure 3.2A
shows representative ABR threshold series traces from Cldn11+/-Tg+/-and Cldn11-/Tg+/- mice and demonstrates several characteristics of an ABR threshold series. First,
the five characteristic peaks and troughs of the ABR are discernable for both groups
of mice with Wave I arising approximately 1.5 – 2 msec post stimulus and each
subsequent waveform in approximate one msec intervals thereafter. Second, the
latency of each wave increases slightly as stimulus intensity is progressively
decreased. Finally, the lowest stimulus intensity that elicits an identifiable Wave I is
regarded as the hearing threshold of the mouse. Figure 3.2B shows that the hearing
thresholds between Cldn11+/-Tg+/- and Cldn11-/-Tg+/- mice are indistinguishable.
One detectable difference in the ABR trace of Cldn11-/-Tg+/- mice compared to
controls is the increased Wave V latency, indicated by the red ‘X’ along the x-axis
(Figure 3.2A). The latencies of Waves I – IV in Cldn11-/-Tg+/- mice are normal at the
level of both the absolute ABR and interpeak latencies (Figure 3.2C). Absolute
interpeak latency, Wave V – Wave I latency, is calculated to correct for variability in
Wave I onset. Figure 3.2C shows the absolute interpeak latency for Cldn11+/-Tg+/and Cldn11-/-Tg+/- mice, illustrating a significant increase in Cldn11-/-Tg+/- mice: F9,100
= 25.25, p < 0.0001. Post hoc testing using Bonferroni’s multiple comparisons test
indicates significant differences are present at every intensity level (80 – 40 dB SPL)
stimulated. When frequency of the stimulus is varied, the delay in Wave V persists
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(data not shown). These data suggest the delay in Wave V is not a function of
stimulus parameters, but a consequence of eliminating Cldn11 tight junctions.
The absolute interpeak latency can be separated into two components based
on location of signal generators: central (V – II) or peripheral (II – I) nervous system.
Similar to absolute interpeak latency, central interpeak latency of Cldn11-/-Tg+/- mice
is significantly increased compared to controls: F9,100 = 21.42, p < 0.0001. Bonferroni
post hoc tests reveal significant increases for all intensity levels. Contrasting
absolute and central interpeak latencies, peripheral interpeak latency was significant
(F9,100 = 2.938, p = 0.0039), however post hoc analysis comparing individual
intensities is not significant. Together, these data demonstrate that Cldn11-/-Tg+/mice have an in increase Wave V latency and elongated central interpeak latency,
suggesting slowed conduction along central components of the lower auditory
brainstem.
Cldn11-/-Tg+/- mice have altered neural processing in the auditory brainstem
The characteristic waveform traces of the ABR are evoked when auditory
information is rapidly transmitted to the generators, persevering the temporal
accuracy of signal transmission are myelinated fibers along the auditory brainstem.
The function of myelin is to increase the speed of signal transmission, preserving
temporal accuracy and increasing long-range signal fidelity. The repetitive delay in
central components of the ABR in Cldn11-/-Tg+/- mice suggests that small diameter
myelinated fibers are present in the lower auditory brainstem and are associated
with the transmission of electrical signals between these components. Because
preserving temporal transmission is imperative for the processing of sound
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Figure 3.2 – ABRs reveals delayed Wave V latency in Cldn11-/-Tg+/- mice

(A) Representative ABR traces collected from Cldn11+/-Tg+/- and Cldn11-/-Tg+/- mice
at 32 kHz, 80 – 20 dB SPL. Characteristic Waves I, III, and V are indicated in the 80
dB SPL trace with dotted vertical lines drawn down to convey latencies. The delay in
Wave V latency for Cldn11-/-Tg+/- mice is discernible at all intensities. (B) Threshold
quantification for Cldn11+/-Tg+/- and Cldn11-/-Tg+/- mice are identical. (C) Total
interpeak latency, Waves V – I, is significantly different between Cldn11+/-Tg+/- and
Cldn11-/-Tg+/- mice at all intensities. Upon further examination, central interpeak
components (Waves V – II) remain significantly latent, whereas peripheral
components (Wave II – I) are not. Cldn11-/-Tg+/- data points in II – I are right-shifted
about the abysses for clarification. Data values are plotted as mean + SD; 10 ≤	
 n ≤
12; ****p < 0.0001.
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localization cues, we explored the ramification of slowed conduction on neural
processing.
One method to non-invasively interrogate neural processing is to measure the
binaural interaction component (BIC) computed from processed ABR traces (Figure
3.1). Binaural ABR traces contain three pieces of information: ipsilateral transmitted
from the ipsilateral ear, contralateral relayed via the MNTB, and finally binaural
information. Binaural interaction component information is extracted from binaural
ABR traces by summing each monaural component (ipsi- and contra- lateral) and
subtracting from the binaural signal. The resulting BIC traces represents the output
from LSO principle cells where bilateral information has converged from ipsilateral
and contralateral pathways.
Figure 3.3A shows representative BIC traces generated via interaural level
delays (ILDs) using difference stimulus intensities for each ear of 0, 2, 5, 10, 20, and
30 ΔdB SPL. The corresponding ABR trace at 70 dB SPL is shown above the BIC
trace series is, and is labeled for Waves I, III and V. The characteristic BIC trough,
known as the DN1 trough, is indicated by a black dot for each BIC generated. The
DN1 trough represents the measured interaction component; the computed output
from LSO principle cells to which bilateral sound information has synapsed. The
latency of the BIC occurs between Waves IV and V of the ABR trace, indicating the
trough is generated immediately after the information reaches the SOC, but
precedes termination of lateral lemniscus fibers into the inferior colliculus (Wave V)
(Appendix C.1).
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The interaction component, DN1, contains two pieces of information reflecting
neural processing in the SOC, the amplitude and the latency. Appendix C.2
illustrates the raw latency and amplitude values of the DN1 trough for Cldn11+/-Tg+/and Cldn11-/-Tg+/- mice. To control for initial waveform onset, each variable between
groups, data values are normalized to either the respective latency or amplitude
recorded when simulated sound was directly in front of the animal at the midline (Δ0
dB SPL). Figure 3.3B shows the normalized latency of the DN1 trough for Cldn11+/Tg+/- and Cldn11-/-Tg+/- mice. A one-way ANOVA comparing normalized latency of
the DN1 trough to intensity difference indicates a significant difference between
Cldn11+/-Tg+/- and Cldn11-/-Tg+/- mice: F11,120 = 8.334, p < 0.0001. Bonferroni post
hoc testing reveals a significant increase in latency when sound intensity varies by
20 or 30 dB SPL for Cldn11-/-Tg+/-.
The second feature examined was the amplitude of the DN1 trough. Figure
3.3C shows normalized amplitude of the DN1 trough for Cldn11+/-Tg+/- and Cldn11-/Tg+/- mice. Unlike latency values, amplitude is highly variable, indicated by the large
deviations present at all ILD intensities stimulated for both groups of animals. There
are several strategies for measuring amplitude of a waveform. First, the conventional
approach measures amplitude from the bottom of the trough to the tip of the
subsequent waveform peak or to the preceding waveform peak. In the BIC, both
bounding peak waveforms are inconsistent in both Cldn11+/-Tg+/- and Cldn11-/-Tg+/mice. The best approach was to measure amplitude from the base of the DN1
trough to the - 5 msec baseline recording prior to sound stimulus presentation (0
msec). This region was unbiased during waveform manipulation. A one-way ANOVA
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indicates normalized amplitude of the DN1 trough was similar between Cldn11+/-Tg+/and Cldn11-/-Tg+/- mice, F11,120 = 0.6553, p = 0.7778.
With neurophysiology data, latency is the stronger parameter measurement
compared to amplitude. It is well known that amplitude values, regardless of
calculation method, are highly variable in nature. In addition, when a sound source is
located in the lateral hemifields (increased intensity difference), amplitude is
imprecise in specifying a sound source due to ILDs having a maximal response over
a broad lateral azimuth (Makous and Middlebrooks, 1990). This variability is seen
between and within mice of both groups, indicated by raw (Appendix C.2) or
normalized (Figure 3.3C) amplitudes. Combined, these data sound show that
lateralization measured by the DN1 trough is significantly different between Cldn11+/Tg+/- and Cldn11-/-Tg+/- mice, suggesting a difference in sound lateralization ability.
The auditory brainstem in mice contains myelinated small and large diameter
fibers
The significant increase in Wave V of the ABR in Cldn11-/-Tg+/- mice is
indicative of slowed conduction velocity along the auditory pathway. Interpeak
latency calculations show a significant increase in central, but not peripheral
interpeak latencies. These findings corroborate previous studies examining
compound action potentials (CAPs) of ex vivo optic nerves from Cldn11-/- mice
indicating that conduction velocity is severely slowed along small diameter fibers (<
1.2 µm). Furthermore, the difference in sound lateralization ability between
CLdn11+/-Tg+/- and Cldn11-/-Tg+/- mice suggests a functional consequence to
slowed conduction within the auditory brainstem. The literature has eluded to the
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Figure 3.3 – Computed DN1 interaction trough indicates abnormal latency in
Cldn11-/-Tg+/- mice

(A) Representative BIC traces calculated for intensity differences ranging from 0 –
30 dB SPL for Cldn11+/-Tg+/- and Cldn11-/-Tg+/- mice. BIC traces are aligned with
corresponding ABR trace to substantiate BIC emergence between Waves IV and V.
Crosshatch indicates the binaural trough, DN1. (B) Normalized latency of DN1
trough for varying intensity differences. (C) Normalized amplitude of DN1 trough for
varying intensity differences. Grey circles represent the normalized value for both
Cldn11+/-Tg+/- and Cldn11-/-Tg+/- mice. Data values plotted as mean + SD; 10 ≤	
 n ≤
12; **p < 0.01, ****p < 0.0001.
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presence of myelinated large diameter contralateral and small diameter ipsilateral
fibers, however direct quantitation is lacking (Doucet and Ryugo, 2003; Wu and Kelly,
1991, 1992b; Wu and Oertel, 1984).
Figure 3.4A illustrates the size of key brainstem nuclei using calbindin
staining, highlighting the extent to which information must be relayed for neural
processing. The simplified schematic in Figure 3.4B depicts the three fiber tracts are
responsible for relaying auditory information from each ear for neural processing in
the SOC along the contralateral pathway: between the CN and contralateral MNTB,
the MNTB and LSO, and from the CN to the LSO along the ipsilateral pathway (blue,
pink, and green fiber tracts respectively. Because electrophysiology data alludes to
small diameter myelinated fibers within this relay network, methodological studies
were undertaken to measure axon diameters between relay nuclei within this
network.
Contralateral fibers relaying information from the CN to the contralateral
MNTB must be speedy, preserving temporal accuracy of signal transmission
(Guinan and Li, 1990; Kopp-Scheinpflug et al., 2008; Wu and Kelly, 1993). Two
features important for rapid transmission, and subsequent relaying of information,
are the giant calyx of Held synapse and myelination of axons. Figure 3.5 confirms
myelination of contralateral fibers by immunofluorescence staining of sagittal
sections through the trapezoid body tract. Axons are stained with neurofilament light
(NFL, red), myelin is indicated with myelin basic protein (MBP, green), and nuclei
identified with DAPI (blue).
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Figure 3.4 – Auditory brainstem schematic illustrating key fiber tracts
transmitting binaural information

(A) Calbindin staining was used to identify key brainstem nuclei associated with
binaural interaction. Principle cells of the MNTB (outlined in blue) are pronounced,
as well as their axonal projections. Moreover, the PON (outlined in green) and LSO
(outlined in pink) are observable, presumably from MNTB priciple cell innervation.
Scale bar = 200 µm. (B) Lower brainstem schematic depicting three necessary fiber
tracts and their nuclei relays that transmit binaural information to priciple cell
integrators in the LSO. The blue trajectory represents contralateral information
transmitted from the AVCN to the contralateral MNTB; pink trajectory portrays the
subsequent relay of contralateral information from the MNTB to LSO; green
trajectory illustrates ipsilateral sound information transferred from the AVCN directly
to the LSO.
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Figure 3.5 – Myelinated axons are present in the auditory pathway

Representative sagittal brainstem section of the trapezoid body fiber tract (see
insert). NFL (red) is used to illustrate all axons present, myelin (green) is illustrated
with MBP, and nuclei (blue) are visible with DAPI staining. Distinct fiber bundles are
evident, interspersed with transverse pyramidal fibers. Scale bar = 20 µm.
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Appendix C.3 quantifies the proportion of myelinated axons within the
trapezoid body and pyramidal fiber tracts, prior to synapsing with, and in the
presence of, MNTB, principle cell innervation. Because axons of AVCN bushy cells
(forming the trapezoid body fiber tract) decussate at the midline before innervating
contralateral MNTB principle cells, direct midline sagittal sections will contain
trapezoid body fiber bundles in the absence of MNTB principle cells. Analyzing
sagittal brainstem sections indicates a conservative 98.7 ± 0.64 % of axons are
myelinated.
A labeled fluorescent dextran conjugate dye was injected laterally to the
MNTB, allowing axonal uptake, transport, and subsequent labeling of contralateral
fibers forming calyces of Held. Figure 3.6A illustrates a representative calyx of Held
synapse, complete with contralateral fiber labeling from the dextran conjugated dye
(green) and co-stained for MNTB principle cells (Calbindin+, red) and nuclei (DAPI,
blue). The histogram in Figure 3.6B shows contralateral axon diameters measured
from dextran labeled fibers forming a calyx. The distribution was normally distributed,
indicated by Gaussian curve fitting, with average diameter 3.33 ± 0.59 µm and
ranging 2.22 – 5.13 µm. Figure 3.6C shows variability along individual contralateral
axons, consisting of 20 – 25 measurements per fiber. As expected, and implicated
for other species from published studies, these data confirm that contralateral fibers
diameters are greater than a micron and conduction velocity along contralateral fiber
would be minimally affected in Cldn11-/-Tg+/- mice.
Ipsilateral fibers relaying information directly from the CN to the LSO have
been alluded to in the literature as being small in diameter, however obtaining a
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Figure 3.6 – Morphometric analysis of contralateral trapezoid body fibers
reveals axons are large in diameter

(A) Dextran injected vibratome sections were visualized using spinning disk confocal
microscopy. A contralateral dextran labeled fiber (green, arrow) is seen forming the
characteristic calyx of Held synapse around a Calbindin+ MNTB principle cell (red,
arrow head). Nuclei are stained using DAPI (blue). (B) Quantitation of axon
diameters from contralateral fibers labeled with dextran dye. Histogram is fit with a
Gaussian distribution. (C) Variation along individual contralateral fibers, labeled with
dextran dye and seen forming a calyx of Held. Data values are plotted as mean +
SD; n = 3 mice; 59 total axons, 20 – 25 measurements / axon. Scale bars = 20 µm.
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numerical value for small is critical for analysis of Cldn11-/-Tg+/- mice. Previous
studies using ex vivo optic nerves of Cldn11-/- mice indicates a predictable
relationship between axon diameter and impact on conduction velocity. Measuring
ipsilateral fibers diameters would allow us to build a mathematical model of neural
processing in the auditory brainstem, taking into account distance of the fiber tract
and axon diameter size.
In a similar fashion to contralateral fibers, ipsilateral fibers were labeled with
dextran dye by injecting coronal brainstem slices dorsal and lateral to the LSO.
Figure 3.7A illustrates presumed ipsilateral fibers entering the LSO (green),
accompanied by labeling of phosphorylated and non-phosphorylated neurofilament
(SMI 31 / 32, red) and nuclei (DAPI, blue). The histogram in Figure 3.7B shows
ipsilateral axon diameters measured from dextran labeled fibers that entered the
LSO. The frequency is normally distributed, as indicated by a Gaussian curve, with
average diameter 0.87 ± 0.37 µm and ranging 0.41 – 2.03 µm. Figure 3.7C shows
variability along individual ipsilateral axons, consisting of 20 – 25 measurements per
fiber. These ipsilateral fibers are less than a micron in diameter and conduction
velocity along ipsilateral fibers would be significantly slowed in Cldn11-/-Tg+/- mice,
and the likely the cause for the observed abnormal neural processing.
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Figure 3.7 – Morphometric analysis of ipsilateral fibers reveals axons are small
in diameter

(A) Dextran injected vibratome sections were visualized using spinning disk confocal
microscopy. Presumed ipsilateral dextran labeled fibers (green, arrowheads) are
seen entering and terminating in the LSO. Insert depicts site of picture in relation to
the LSO structure. Contrasting visualizations include all axons using SMI 31 / 32 for
phosphorylated and non-phosphorylated neurofilament (red) and nuclei using DAPI
(blue). (B) Quantitation of axon diameters from presumed ipsilateral fibers entering
the LSO and labeled with dextran dye. Histogram of averages is fit with a Gaussian
curve. (C) Axon diameter variation along individual ipsilateral fibers, labeled with
dextran dye and seen entering the LSO. Data values are plotted as mean + SD; n =
3 mice; 25 total axons. Scale bars = 20 µm.
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DISCUSSION
Over the past few decades, the mouse has emerged as an important model
organism to investigate AEPs and auditory perception (Liu, 2006; Ohlemiller, 2006).
With recent advances in molecular genetic manipulation in mouse models producing
deletions, duplications, and mutations by homologous recombination and transgene
technologies, researchers can explore the contribution of individual abnormalities on
audition, aiming to better understand human disease. The lower auditory brainstem
is an excellent model to study neural processing because signal transmission along
the ascending auditory pathway and their connections are highly conserved and
homologous across species, and well-characterized (Christensen-Dalsgaard and
Carr, 2008). Direct stimulation and measurement of processing in such an isolated
circuit allows extrapolation to higher brain networks that are less accessible to
manipulation and more difficult to isolate. Herein, we use auditory brainstem neural
circuitry to explore the consequence of dysfunctional myelin on neural processing
and its potential ramifications.
Characteristics of the Cldn11-/-Tg+/- ABR
The most well studied auditory evoked potential is the ABR. Elicited within 10
msec following auditory stimulation, the ABR is composed of five, sometimes six
waveforms, beginning with Wave I around 1.5 – 2 msec post stimulus. Waves II – V
appear in succession at 1 msec intervals thereafter (Willott, 2001). Chapter 2
discusses more extensively the signal generators along the ascending auditory
brainstem responsible for the production of each waveform.
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The persistent delay in Wave V latency of Cldn11-/-Tg+/- mice suggests
conduction velocity is slowed in the auditory brainstem below the level of the inferior
colliculus. These findings recapitulate electrophysiological data collected from ex
vivo optic nerves of Cldn11-/- mice computing a slowing of 50 % in myelinated fibers
< 0.7 µm and 20 % for those between 0.7 and 1.2 µm (Devaux and Gow, 2008).
These quantitative data suggest that within the auditory brainstem, small diameter
myelinated fibers < 1.2 µm are responsible for transmission and innervation of ABR
signal generating nuclei along the ascending auditory pathway below the level of the
inferior colliculus.
Binaural sound processing in the auditory brainstem
Sound is first processed in the lower auditory brainstem at the level of the
SOC. Two key nuclei, the MSO and LSO, integrate neural signals arriving from each
ear to localize the origin of a sound source on the azimuth plane. Principle cell
integrators located in the MSO are responsible for processing the temporal
difference in the arrival of signals to each ear. The principle cells are most sensitive
for sounds resonating at lower frequencies. In mice, higher frequencies dominate the
hearing range resulting from a small head size which lacks the ability to deflect lower
frequency sounds. The functional consequence to mice is an underdeveloped MSO,
comprised on only 200 neurons (Irving and Harrison, 1967; Ollo and Schwartz,
1979; Wu and Kelly, 1991, 1992a). Accordingly, the examination of binaural
processing using interaural timing differences would lack sensitivity, regardless of
frequency.
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In contrast to the MSO, LSO principle cell integrators discriminate sound
intensity, or level, differences arriving at each ear to localize a sound source on the
azimuth plane. Principle cells in the LSO are specialized to discriminate higher
frequency sounds, which is more appropriate for rodents that have poor hearing
below 10 kHz. Equal sound intensities played to each ear simultaneously mimics a
sound originating from directly in front, or back, of the animal. As intensity is
decreased to one ear and held constant in the other, sound is perceived to be
lateralized toward the ear exposed to the louder tone.
The classic Jeffress model for neural processing outlining coincidence
detectors and delay lines primarily describes neural processing in the MSO and
using those principles to interpret the data presented herein may be incorrect. The
measured response from Cldn11+/-Tg+/- and Cldn11-/-Tg+/- mice is similar to humans
where a linear response was measured for small and medium disparities of level
differences, but continued in a non-linear fashion for larger differences (Yost, 1981).
This idea developed into the hemifield model where two populations of neurons are
postulated to be responsible for sound localization. Each population / channel of
neurons responds broadly across the left or right (ipsilateral versus contralateral)
acoustic hemifield, and shares an overlapping boarder along the midline (Boehnke
and Phillips, 1999; Phillips, 2008). Each auditory hemifield (left and right) also
contains cells that respond to a sound source stemming from the ipsilateral and
contralateral hemifield.
The overall shape of the normalized DN1 latency curves for Cldn11+/-Tg+/- and
Cldn11-/-Tg+/- mice reflect a two-neuron hypothesis of neural processing. When a
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sound source is emulated near the midline, Δ0 – 10 dB SPL (Figure 3.3B), a steep
linear increase in latency is evident. These data are similar to those measured in
humans and reflect a distinct midline population of neurons that are responding.
Because sound lateralization along the azimuth is best near the midline, responding
neurons have a steeper response and this is reflected in both Cldn11+/-Tg+/- and
Cldn11-/-Tg+/- data collected.
As intensity differences are increased to Δ20 – 30 db SPL, the latency
response of Cldn11+/-Tg+/- mice continues to increase while flattening out. These
data reflect the hemifield neurons responding to a lateralized sound source.
Responding neurons in the lateral hemifields are less precise, generating a broader
response as compared to midline neurons. In Cldn11-/-Tg+/- mice, the response from
lateral hemifield neurons remains steady with unchanging latency. These data are
significantly different from Cldn11+/-Tg+/- mice suggesting that small myelinated fibers
either transmit bilateral information for processing, or small myelinated fibers refine
the output of the principle cells. These data are important in two ways. First, they
support the two-neuron hypothesis of sound lateralization, and second, they
highlight the importance of myelin on neural processing
Recent evidence from humans postulates a third group of neurons may aid in
sound localization. Located along the midline, this third group is specialized for
spatial tuning (Dingle et al., 2010, 2013). The initial jump in latency (Δ0 – 2 dB SPL)
may reflect a third population of integrating neurons, however this portion of the
curve Is generated from two data points and further resolution is not be plausible
using far field recording techniques.
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Morphometric analysis of auditory brainstem fiber tracts
Several unique features are evident in the auditory pathway, allowing for
robust temporal accuracy of signal relaying, as well as fidelity of signal transmission
for processing. First, two large synapses, measuring five times the diameter of
normal synapses, preserve and ensure the temporal features of signal transmission:
the endbulbs of Held (within the CN) and the calyces of Held (in the MNTB). One
understated attribute is the presence of myelinated fibers throughout the auditory
pathway (Anniko and Arnesen, 1988; Dinh et al., 2014; Spoendlin and Schrott, 1989,
1990; Wu and Kelly, 1991). Without myelin, signal transmission would be slowed by
as much as 10-fold. Our data confirm the presence of myelinated fibers in the
auditory pathway (Figure 3.5) and highlight their critical role in neural processing by
demonstrating abnormal responses when slowed conduction occurs along
myelinated fibers < 1.2 µm.
The electrophysiology data presented suggest Cldn11-/-Tg+/- mice have small
diameter myelinated fibers present within the lower auditory brainstem, as indicated
by the significant delay in Wave V latency and differential output of LSO signal
integrators. The morphometric studies presented in this chapter are the first to
quantify axon diameters along the auditory pathway in mice, despite the widespread
use of these animals in auditory experiments over the past few decades.
Studies in chick show contralateral axons transmitting information from the
AVCN to the MNTB are large in diameter, approximately 2 µm, and small diameter
fibers of approximately 1 µm, that relay information from the ipsilateral AVCN directly
to the LSO (Seidl et al., 2010). For mice, several published studies make mention of
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large diameter myelinated contralateral and small diameter ipsilateral fibers, but
quantitative data have not been presented (Doucet and Ryugo, 2003; Wu and Kelly,
1991, 1992b; Wu and Oertel, 1984). Figures 3.6 demonstrates that large
contralateral fibers are approximately 3.3 µm in diameter, and Figure 3.7 suggests
that the ipsilateral fibers are small, at approximately 0.87 µm in diameter. The
significant delay in Wave V latency suggests that small diameter myelinated fibers
are found in the auditory brainstem of mice and we confirm the presence of small, as
well as large diameter fibers.
There are several caveats associated with the current analysis of the
ipsilateral fibers. Unlike the contralateral fiber analysis, where we directly confirmed
the identity of axons giving rise to calyces of Held, direct verification of ipsilateral
fibers synapsing with the LSO principal neurons has not been possible. These
technical difficulties arose in the current study because of our inability to detect
synapsing fibers. While it has been shown that LSO principle cells are aligned along
the long axes of the nuclei (into and out of the image) (Brown and Liu, 1995; Guinan
et al., 1972), the trajectory of ipsilateral fibers is unknown. If fibers enter the LSO, as
seen in Figure 3.7, turn 90 degrees to synapse with a principle cell out of the plane
of section; a confirmed synapse would not be detectable. What we can verify is a
healthy brain slice during, and subsequent to dextran injections, robust labeling of
healthy fibers, and correct location within the LSO. These caveats aside, these data
suggest that all detectable ipsilateral fibers entering the LSO are small in diameter (<
1 µm), refuting the possibility of large diameter ipsilateral fibers.

102

Morphometric data confirm the observations that contralateral fiber diameters
are large and ipsilateral fibers are small (less than a micron) in diameter. These data
are critical for interpreting neural processing the Cldn11-/-Tg+/- mice. Previous studies
have extensively detailed and modeled the consequence of ablating Cldn11 tight
junctions on conduction velocity along myelinated axons. When Cldn11 tight
junctions within myelin sheaths are ablated, conduction velocity along small
diameter fibers, (~0.7 µm) is severely reduced by 50 % and medium diameter fibers
(~ 1.2 µm) by 20 %, whereas large diameter fibers (>2.1 µm) are minimally affected
(< 5 %) (Devaux and Gow, 2008).
In summary, Cldn11-/-Tg+/- mice have dysfunctional myelin in which resistance
of the myelin membrane is decreased, severely affecting conduction velocity along
small diameter myelinated fibers. Neurophysiological evidence collected in the
auditory brainstem of Cldn11-/-Tg+/-- mice confirms a decrease in conduction velocity
via an increase in Wave V latency of the ABR. This demonstrates the presence of
small diameter myelinated fibers along the ascending auditory brainstem. When
neural processing is probed using ILDs, the resulting response differs from Cldn11+/Tg+/-, suggesting alterations in sound lateralization. Interestingly, the response curve
from both groups of animals lends to a newly emerged model of neural processing
known as the two-neuron model. This model posits that the lateral position of a
sound source cannot be encoded by which particular neurons are discharging
maximally (population model). Instead, lateral sound is encoded by the relative
activation of two channels of neurons: those that are activated maximally by sources
favoring the contralateral or ipsilateral side, but both contain a steep boarder
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towards the midline (Boehnke and Phillips, 1999; Dingle et al., 2010; McAlpine et al.,
2001; Phillips, 2008; Phillips and Hall, 2005; Yost, 1981). Data collected within the
chapter supports a hemifield model, as opposed to the classic Jeffress model of
population neural processing for sound lateralization.
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CHAPTER 4 – slowed conduction velocity can alter behavior
INTRODUCTION
Behavioral disorders are simplistically defined as conduct that deviates from
the socially accepted normal. These abnormalities range from internal conflicts to
outward expressions of defiant episodes, both of which adversely affect and impinge
upon daily functioning. Behavioral abnormalities are present in children and adults
and

are

influenced

by

environmental

stimuli

and

experiences.

Common

abnormalities include anxiety, depression, and cognitive impairments. An estimated
half of adults will be diagnosed with a behavioral abnormality at some point in their
lifetime (Kessler et al., 2005). This translates to an increased annual encumbrance,
ranging in the tens of millions of dollars spent annually in the United States alone
(W.H.O., 2001).
Behavioral disorders result from a disconnection between brain regions
The etiologies for many behavioral disorders are uncharacterized, however
the leading hypothesis is that different parts of the brain do not effectively
communicate, known as the disconnection hypothesis. Proponents of this
hypothesis contend that behavior is the result of temporal integration of sensory
signals; abnormal behavior results when there is a disconnection between brain
regions or neural circuits (Friston, 1998, 1999). The disconnection hypothesis was
originally proposed by Karl Friston to describe the etiology of schizophrenia, but
more recently, a number of researchers have promoted and broadened this
hypothesis to include numerous neurological illnesses including Alzheimer (Bell and
Claudio Cuello, 2006; Bokde et al., 2009; Hof and Bouras, 1991; Reid and Evans,
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2013), autism spectrum disorders (Frith, 2004; Just et al., 2007; Melillo and Leisman,
2009), Parkinson disease (Cilia et al., 2011; Cronin-Golomb, 2010; Fogelson et al.,
2013) and bipolar disorder (Mahon et al., 2010). To understand the how neural
circuits become disconnected and cause behavioral abnormalities, researchers have
developed and investigated two main hypotheses for disconnection: altered
neurotransmitters and aberrant neurogenesis or neuron biology.
Disconnection can originate from altered neurotransmitters
Neurotransmitters are small molecules that nerve cells (neurons) use to
communicate with their targets. They extend across numerous biological categories
including cholines, monoamines, amino acids, peptides and purines (Kandel et al.,
2000; Webster, 2001). There are several, highly regulated stages involved in
neurotransmission. First, a molecule is synthesized from precursors in the axon
terminal of the presynaptic neuron, or in rare cases, transported from elsewhere in
the cell. After synthesis and before release, a neurotransmitter is packaged and
stored in vesicles near the presynaptic terminal (De Camilli and Jahn, 1990;
Holtzman, 1977). Upon stimulation, vesicles dock to the presynaptic membrane and
release the neurotransmitters into the synaptic cleft (Kelly et al., 1979; Miller and
Racker,

1976;

Papahadjopoulos

et

al.,

1977;

Sudhof,

2004).

Finally,

neurotransmitters bind to receptors on the postsynaptic membrane, which pass
current across the membrane to depolarize or hyperpolarize the postsynaptic
terminal.
Evidence of altered neurochemical levels in patients with behavioral
abnormalities is evident throughout the literature. In recent years, researchers have
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developed molecular imaging techniques to measure neurotransmitters levels in the
brains of humans in real time. Using radiolabeled ligands, the binding of a
radiolabeled substrate can be measured using positron emission tomography (PET).
The amount of ligand binding is proportional to the number of unoccupied receptors
and thus, act as a proxy for the amount of native neurotransmitter present
(Badgaiyan, 2011). Several human and animal studies have used this technique to
investigate diseases in which an onerous behavioral component is evident, including
Alzheimer (Jacobs et al., 2003; Wengenack et al., 2008), Parkinson (Elsinga et al.,
2006) and schizophrenia (Andreasen et al., 1996; Davis et al., 1991). Moreover,
behavioral abnormalities, such as anxiety, have been directly studied using PET
demonstrating abnormal neurochemical compositions (Reiman, 1997).
Recently, proton magnetic resonance spectroscopy (H1MRS) has allowed for
a direct quantitation of neurochemical levels in select brain regions associated with
behavioral abnormalities including anxiety (Mathew et al., 2004; Pollack et al., 2008),
depression (Hasler et al., 2007; Sanacora et al., 1999) and neuropsychiatric
disorders (Stanley, 2002). Thus, the advancement of medical imaging techniques
has demonstrated altered brain neurochemistry in behavioral disorders suggesting
disconnection between brain networks and the emergence of atypical behavior.
Literature advocating for neurochemical alterations as the probable etiology
for behavioral abnormalities has lead to the development of drug therapies targeted
to correct neurochemical levels in patients. Neural transmission is a highly regulated
process in which the timing of release, amount of information (quanta), and precision
of targeting is closely monitored. If any stage in the chemical transmission process
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becomes modified, the proper information fails to be communicated and
subsequently relayed. Drug design has optimization signal transmission through
compounds that reduce clearance from the synaptic cleft (Haenisch and Bonisch,
2011; Philip et al., 2010) or inhibit removal (Feighner, 1999; Stahl, 1998; Stahl et al.,
2005), thereby modulating signal transmission. With available drug treatments, the
major disadvantage is the significant proportion of patients whose symptoms and
behaviors are not alleviated.
Selecting the appropriate therapeutic treatment for a behavioral abnormality is
complex. Longitudinal epidemiological data are not available for many therapies and
predictions for relapse / remitting phases are complicated by factors including
comorbid illnesses and traumatic events, which can substantially alter effectiveness.
Data collected over a five year period are often used to project the proportion of
patients expected to experience full remission with drug therapy. The forecasted
level is around 40 % for most behavioral abnormalities (Foa et al., 1983; Yonkers et
al., 2000) and, consequently, the majority of patients will struggle to find relief,
advocating for alternative etiologies for behavioral abnormalities.
Abnormal neuron biology generates disconnection between neural networks
In addition to aberrant levels of neurotransmitters, abnormal neuron biology
can be a driving factor for behavioral abnormality. Neurons are the main
communication cell responsible for receiving, processing, and transmitting electrical
and chemical encoded information (Waxman et al., 1995). There are different
subtypes of neurons (motor, sensory, interneuron), totaling over 200 billion neurons
in the adult human brain, and on average each neuron is connected to 5,000 –
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200,000 other neurons. Altering the expansive connections established can perturb
normal signal processing, modify integration, and conceivably disconnect neural
circuitry. Neural connections also can be reshaped by increases or decreases in the
number of neurons in a network.
The most widely studied mechanism for reductions in neurons is death
through diffuse axonal injury related to a traumatic event. Axonal injury, in its many
forms, has a similar pattern of disruption that ultimately leads to the degeneration of
the axon and death of the cell. In brief, an expansion of the axonal membrane is
seen, followed by an increase in Na+ and Ca2+ ion permeability. Next, damaging
intracellular cascades attributable to the Ca2+ influx causes swollen and ruptured
mitochondria, and finally, potential indirect effects due to disruption of the axoglial
interaction necessary to maintain homeostasis (Buki and Povlishock, 2006;
Marmarou et al., 2005; Medana and Esiri, 2003).
It has been assumed that axonal injury impairs brain function, reflecting the
extent of damage and the number of neurons injured (Waxman et al., 1995). Axonal
damage can be translated to deafferentation, yielding target cell dysfunction as
illustrated by presynaptic degeneration; however, the functional significance remains
unclear (Erb and Povlishock, 1991). On the opposite end of the spectrum, increasing
the number of neurons may lead to dysfunctional neural circuitry via improper
signaling cascades and competing signal information. This supposition has been
suggested for the etiology of autism where hyperconnectivity has been
demonstrated (Belmonte et al., 2004a; Belmonte et al., 2004b). Similarly, increasing
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the activity of a neuron can also render circuitry dysfunctional, most notably with
illnesses such as epilepsy (McNamara, 1999).
White matter integrity is a key component of properly functioning neural
circuitry
There is clear evidence that behavioral abnormalities may arise from
mechanisms including aberrant neurotransmitter levels, or other abnormal neuron
biology, however, patients receiving treatments to correct these deficits do not
always respond. Thus, there may be additional mechanisms by which behavioral
abnormalities arise. We know from the clinical literature that white matter diseases,
such as leukodystrophies and multiple sclerosis (MS) have known alterations to
white matter along with prominent behavioral abnormalities (Baumann et al., 2002;
Garside et al., 1999; Hyde et al., 1992; Petersen and Kokmen, 1989; Schiffer and
Babigian, 1984; Schubert and Foliart, 1993). We also know that myelin is
functionally important in temporal communication, increasing the speed and fidelity
at which impulses propagate along a neuron and improving long-range
communication between brain regions (Hodgkin, 1964; Hodgkin and Huxley, 1952;
Tasaki, 1952). Dysfunctional myelin can cause a disconnection between brain
regions, altering the processing of sensory information and contribute to behavioral
abnormalities. To better elucidate the link between dysfunctional myelin and
behavioral

abnormalities;

we

investigated

the

Cldn11-/-

mouse

model

of

dysfunctional myelin.
Animal models play an essential role in understanding the pathophysiological
mechanism by which behavioral abnormalities arise (Petters and Sommer, 2000;
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Phillips et al., 2002; van der Staay et al., 2009). Modeling abnormalities, whether in
their simplest form or a prominent attribute of an illness, is quite challenging due to
the complexity of human behavior. Genetic, pharmacological, environmental, or
direct manipulation of neural circuitry has been employed to study behavior (Nestler
and Hyman, 2010). We can ascertain the anthropomorphic characteristics of human
behavior in animal models by quantitative measurements via behavioral testing.
Numerous tests have been developed to interrogate behavioral abnormalities such
as anxiety, depression, and cognitive ability and we will use such tests to determine
if dysfunctional myelin can cause behavioral changes, indicating a potential etiology
for these disorders.
Because of the numerous proportions of patents unresponsive to current
behavioral drug therapies targeting neurotransmitters and neurons, there must be an
alternate hypothesis describing how brain regions become disconnected leading to
behavioral abnormalities. Herein, we investigate the Cldn11-/- mouse model of
dysfunctional myelin to explore the possibility that myelin is critical for the proper
functioning of neural circuitry and dysfunction can arise when the integrity of myelin
is altered. Our animal model provides the first direct evidence that dysfunctional
myelin can contribute to the development of behavioral abnormalities, and can alter
brain neurochemistry. These data provide evidence indicating dysfunctional myelin
can contribute to the etiology of behavioral abnormalities.
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MATERIALS AND METHODS
Mice
The Department of Laboratory and Animal Resources at Wayne State
University maintained all mice in this study. All experiments on mice were performed
in accordance with an Institutional Animal Care and Use Committee protocol
approved by the Wayne State University Animal Investigation Committee. Up to four
mice were housed in group I rodent polycarbonate cages (19.05 X 29.21 X 12.7 cm3,
Ancare, Bellmore, NY), or up to nine mice housed in groupII polycarbonate cages
(26.67 X 48.26 X 15.56 cm3, Bellmore, NY). Each cage was given a 2 X 2 in nestlet
square (Ancare, Bellmore, NY) to promote nesting behavior and aid in
thermoregulation. Food and water were available ad labium. Breeding mouse trios or
pairs were provided mouse diet (#5015, LabDiet, St. Louis, MO) to support healthy
pups and non-breeding mice were provided laboratory rodent chow (#5001, LabDiet,
St. Louis MO). All polycarbonate cages, water bottles, and food pellets were
changed weekly and as needed.
The Osp20 transgene construct (GS605) comprises a 22 kb Sau3A I
fragment of genomic sequence from 5 kb upstream of the transcription start site in
exon 1 to 1.9 kb downstream of the first polyadenylation site in exon 3. The unique
Acc65 I site near the 5’ end of intron 1 was blunted-out distinguishing the transgene
from the endogenous Cldn11 gene during qPCR analysis. The genomic fragment
was cloned between two Not I sites in a pUC18 – based vector (Gow et al., 1992)
and was excised and phenol : chloroform-purified from an agarose gel slice for male
pronuclear injection. This allele is referred to as Tg(Cldn11)605Gow (MGI:5306245),
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and for the purposes of this dissertation as Tg+/-. Transgene expression was
confirmed in testis and inner ear, but not brain (Wu et al., 2012). Additionally, this
transgene restored the known sterility (Gow et al., 1999) and premature hearing loss
resulting from a loss in endocochlear potential in Cldn11-/- mice (Gow et al., 2004)
(unpublished data). Double mutant mice were generated by breeding males from
Tg(Cldn11)605Gow

with

Cldn11-/- female

mice

to

generate

F1

Cldn11+/-

:Tg(Cldn11)605GowTg/+ mice, referred to as Cldn11+/-Tg+/-. These mice were sibmated to generate F2 (and beyond) Cldn11-/-Tg+/- mice (as well as control Cldn11+/Tg+/-) for experiments. These mice were used for all experiments unless noted.
Open Field
The open field arena consisted of a 61 x 61 x 31 cm black plexiglass box with
a matted finish (FT Plastics, Oak Park, MI). The bottom of the arena was lined with
white bench top paper (Whatman™ Benchkote™, cat#: 12-007-182B, ThermoFisher,
Waltham, MA) and a clear plexigalss insert panel (61 x 61 x 1 cm3) placed over top
for added contrast and ease of cleaning. All mice were habituated to the behavior
room one hr before testing. Standard open field protocol consisted of two
consecutive days in which mice were placed in the center of the arena, facing the
same wall, and video recorded for five min (Samsung SC-MX20L/XAA). Videos were
uploaded and the center point of the mouse was post – tracked using Ethovision
software (version 8.5, Noldus, Leesburg, VA) to obtain various center square activity,
total distance traveled, average velocity, and time spent in each quadrant. All
variables for the two days were averaged for each animal.
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Conventional center square (CS) analysis designates 50 % of the total area
as the center portion, however we find this parameter uncommunicative. To convey
practical criteria and a more detailed analysis, we used the average body length of a
mobile mouse (7.5 cm) as the determinant for CS boundaries. Half a mouse body
length away from the periphery computed to be 83 % of the total area, and thus,
designated as 83 % CS. A similar pattern was followed to generate concentric
squares of the OF environment, resulting in the following: 66 % (one body length
away from the periphery), 48 % (one and a half body lengths), and 32 % (two body
lengths).
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Figure 4.1 – Open field schematic

Open field schematic detailing size and location of the various different center
square (CS) % used for analysis, location of quadrants and light sources. Schematic
is drawn with respect to the mouse in the top right hand corner
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Marble Burying
All mice were habituated to the behavior room one hr prior to testing. Marble
burying test was carried out in a clean home cage (19.05 X 29.21 X 12.7 cm3,
Ancare, Bellmore, NY) layered with 2 cm of bedding (Bed O’Cobs 1/8”, Andersons
Lab Bedding, Maumee, OH). Fifteen glass marbles were placed in a grid pattern
formed by five rows of three marbles, evenly spaced throughout the cage (See
schematic below). A single mouse was placed in the center of the cage and video
recorded (Samsung SC-MX20L/XAA) for 30 min. Afterwards, photos of each testing
environment were collected and the number of marbles buried at least two-thirds of
the way with bedding were tallied.
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Figure 4.2 – Marble burying schematic

Marble burying schematic illustrating placement of 15 marbles at the start of testing.
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Tail Suspension
Tail suspension apparatus was comprised from a metal ring stand rod
suspended approximately 18 in from the bench top between two rings stands. All
mice were habituated to the behavior room one hr prior to testing. Prior to taping the
mouse’s tail, a one-inch clear plastic tube was threaded over the tail and placed at
the base of each mouse’s rear to prevent it from climbing its tail during testing. Mice
were suspended by their tails using 15 cm of standard laboratory tape (Thermo
Fisher Scientific, Waltham, MA) in which 2.5 – 3 cm of one end was used to secure
the tail, and the opposing end secured to the bar. Mice were suspended for six min
and video recorded (Samsung SC-MX20L/XAA). Videos were played back and
scored, unbiased, for the amount of time mice spent immobile or helpless. Immobility
was defined by a lack of movement of the forelimbs, hind limbs, and head, but not
whiskers. Pendulum swinging in the absence of limb movement was also evaluated
as time immobile. Total time spent immobile was recorded as time out of 360 sec.
Sucrose Preference
Sucrose preference testing was carried out in a polycarbonate cage (26.67 X
48.26 x 15.56 cm3, Ancare, Bellmore, NY) and spanned a total of eight days. All
mice were individually housed during the testing period and given one nestlet (2 X 2
in, Ancare, Bellmore, NY). During habituation (days 1 – 4), mice were acclimated to
the presence of two dual bearing sipper tube bottles (Lixit #QLCSA-5, Petsmart,
Phoenix, AZ) containing water. Following habituation, one water bottle solution was
replaced with a 2 % sucrose solution for remaining testing days. To avoid a side
preference, the location of the sucrose solution was counterbalanced during sucrose

118

testing days (days 5 – 8). Measurements, based on weight difference, were
calculated daily for total water, sucrose solution, and food consumption before
replenishing. The density of a 2 % sucrose solution is 1.0060 g / cm3 and is
negligible to the density of water (1 g / cm3). Mice were given 40 grams of rodent
chow daily (#5001, LabDiet, St. Louis MO) and 100 milliliters of fluid in each sipper
bottle, whether water or sucrose. After testing, mice were returned to group housing.
To prevent fighting between males, nestlets were collected every other day from
males originally residing in the same home cage, intermixed, divided evenly, and
returned.
Barnes Maze
All mice were habituated to the behavior room one hr prior to testing. The
Barnes maze was constructed from a circular, white plexiglass (91.4 cm diameter)
with twenty holes (5 cm) positioned equidistance from each other and 2 cm from the
outer edge (FT Plastics, Oak Park, MI). Located beneath one hole was a removable,
sliding black box that served as the goal location. A mesh step was placed inside the
black box to aid descending mice. Visual cues adorned the walls or were native to
the testing room: a solid black circle, a solid black line, camera stand, experimenter,
and trolley. Cues remained constant and unchanged throughout all testing days.
Habituation (day 1): Mice are placed directly in front of the goal hole,
enclosed in a glass beaker (Pyrex, Thermo Fisher Scientific, Waltham, MA) placed
upside – down. Habituation lasts for five min and mice are allowed to directly explore
the goal hole, goal box, and its surrounding environment. If the mouse has not
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entered the goal hole after five min, the mouse is gently placed inside, the entrance
covered, and remains for 30 sec. One hr later, acquisition training can begin.
Acquisition Training (days 1 – 4): Acquisition training lasts five min, three
trials per day, one hr between trials. Mice are placed onto the center of the maze,
facing a chosen wall used throughout testing. Latency to find the goal hole, enter the
hole, and the number or errors are recorded. If a mouse finds and subsequently
enters the goal hole before five min time is up, the training trial can be stopped. If the
mouse has not entered the goal hole after five min, the mouse is gently placed
inside, the entrance covered, and remains for 30 sec. The location of the goal hole
remains constant throughout training. All training trials are video recorded (Samsung
SC-MX20L/XAA).
Acquisition Probe (day 5): Before beginning, the goal box is removed and the
Barnes maze table is rotate 90 degrees counterclockwise from the training location.
Acquisition probe lasts for a single trial, five min in length. Mice are released onto
the center of the maze as in prior days and allowed to explore for the full five min.
The probe trial is video recorded and post – processed using Ethovision software
(version 8.5, Noldus, Leesburg, VA).
Acquisition Retraining (day 6): The goal box is replaced and the location of
the goal hole is set up identical to training days 1 – 4. Mice undergo three training
trials, one hr apart. If a mouse finds and subsequently enters the goal hole before
five min time is up, the training trial can be stopped. If the mouse has not entered the
goal hole after five min, the mouse is gently placed inside, the entrance covered,
and remains for 30 sec.
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Curtain Probe (day 7): Before beginning, the goal box is removed and the
maze rotated 90 degrees counterclockwise from training locations. Additionally,
bench coat paper is used to surround the maze in two levels, blocking all visual cues.
The purpose of the curtain surrounding the maze was to determine if mice were
using non-visual intra maze cues or the visual extra maze cues to help them locate
the goal hole during training exercises. Mice are then release onto the center of the
maze and allowed to explore for five min. Probe trials are video recorded and post –
analyzed using Ethovision.
Acquisition Retraining (day 8): The goal box is replaced and the location of
the goal hole is set up identical to training days 1 – 4 and day 6. Mice undergo three
training trials, one hr apart. If a mouse finds and subsequently enters the goal hole
before five min time is up, the training trial can be stopped. If the mouse has not
entered the goal hole after five min, the mouse is gently placed inside, the entrance
covered, and remains for 30 sec.
Reversal Training (day 9): Similar to acquisition training days, however the
location of the goal hole is now 180 degrees from all previous training days. Mice
undergo three training trials, one hr apart. If a mouse finds and subsequently enters
the goal hole before five min time is up, the training trial can be stopped. If the
mouse has not entered the goal hole after five min, the mouse is gently placed
inside, the entrance covered, and remains for 30 sec.
Reversal Probe (day 10): Before beginning, the goal box is removed and the
maze rotated 90 degrees counterclockwise from reversal training location. Mice are
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then release onto the center of the maze and allowed to explore for five min. Probe
trials are video recorded and post – analyzed using Ethovision.
During all phases of the Barnes maze, a number of factors are recorded
(manually during the test, confirmed via video) including latency to the goal hole,
time to enter the goal hole, number of errors pre-hole, and number of errors post –
hole. During probe days (days 5, 7, and 10) Ethovision software was used confirm
latencies and errors, as well as measure time spent in zones drawn around the goal
hole mice were trained to locate, and the actually hole where the box can hook-in at
(90 degrees counterclockwise). The number of acquisition training days was
determined prior to testing with separate groups of mice. It was concluded that four
days of acquisition training was adequate for mice to learn the location of the goal
hole, ascend into the goal box, and retain that information.
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Figure 4.3 – Barnes maze schematic

(A) Overview of zone boundaries surrounding the trained goal hole (Goal Hole) or
the hole where the training box attaches (Hook-in Hole). This schematic was used
for calculating zone analysis for BM probe (day 5) and curtain probe (day 7). (B)
Overview of zone boundaries surrounding the location of the original goal hole (Old
Goal Hole), the location of the re-trained goal hole (Goal Hole), or the hole where the
training box attaches (Hook-in Hole). This schematic was used for calculating zone
analysis for BM reversal probe (Day 10).
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High Resolution Magic Angle Spinning Proton Nuclear Magnetic Resonance
(H1MRS)
Mice were decapitated and brains immediately removed from the skull. Serial
coronal slices (2 mm) were obtained using a mouse anodized aluminum matrice
(BS-AL 5000C, Braintree Scientific, Braintree, MA) beginning at + 2 bregma and
ending at - 8 bregma (see schematic below). Slices were promptly frozen on a block
of dry ice. Once frozen, slices were moved onto a wet ice platform. Intact, bilateral
punches isolating various brain regions were collected using 1.5 mm diameter
disposable biopsy punches (Miltex Inc., Plainsboro, NJ) and stored in 1.7 ml
microcentrifuge tubes (Thermo Fisher Scientific, Waltham, MA) at - 80°C until testing.
For H1NMR analysis, tubes were transferred from - 80°C, one bilateral punch was
extracted, weighed, and promptly placed into a 10 μl Bruker zirconium rotor
containing PAFT buffer (100 mM K2HPO4 / KH2PO4, 200 mM HCOONa, 1 g / L NaN3
diluted 50 % with D2O containing 3 mM trimethylsilyl – propionate (TSP, Sigma
Aldrich, St Louis, MO; pH = 7.4). TSP served as an internal chemical shift reference
(0.00 ppm), formate (8.44 ppm) was used for autophasing, and D2O was used to
lock on the center frequency. The rotor (with sample) was placed into a Bruker
magic angle spinning probe maintained at 4°C in a vertical wide – bore (8.9 cm)
Bruker 11.7 T magnet, controlled with an Avance DRX-500 console (Bruker Biospin
Corp., Billerica, MA, USA). Rotors were spun at 4.2 ± 0.002 kHz at 54.7° relative to
the static magnetic field B0. After a pre – saturation pulse for water suppression,
spectra were acquired with a 1-D Carr–Purcell–Meiboom–Gill pulse sequence (90(τ-180-τ)n-acquisition) with TR = 6210 ms, τ = 0.15 ms, and n = 12 for total echo
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time (TE) of 3.6 ms; spectral bandwidth = 7.0 kHz (14 ppm), 16 k complex data
points, and 256 averages for total acquisition time of 7 min 36 s. Data was acquired
using Bruker-XWINNMR version 3.6 software. Spectra were analyzed with a custom
LCModel version 6.1 – 4, established with a basis set of metabolites over a spectral
range of 1.0 – 4.2 ppm. The precision of the LCModel fit to the spectral data was
estimated with Cramér–Rao bounds, which are typically less than 10 % for the
metabolites reported herein.
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Figure 4.4 – Fresh tissue punch schematic

Illustration of individual 2 mm coronal slices and location the bilateral fresh tissue
punches collected for H1NMR and western blots. Blue punches represent the
relative size (1.5 mm) collected. Coronal mouse brain slices were edited from the
Paxinos mouse atlas.
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Western Blotting
Mice were decapitated and brains immediately removed from the skull. Serial
coronal slices (2 mm) were obtained using a mouse anodized aluminum matrice
(BS-AL 5000C, Braintree Scientific, Braintree, MA) beginning at + 2 bregma and
ending at - 8 bregma (see schematic in H1MRS above). Slices were promptly frozen
on a block of dry ice. Once frozen, slices were moved onto a wet ice platform. Intact,
bilateral punches isolating various brain regions were collected using 1.5 mm
diameter disposable biopsy punches (Miltex Inc., Plainsboro, NJ) and stored in 0.7
ml microcentrifuge tubes (Thermo Fisher Scientific, Waltham, MA) at - 80°C until use.
Tissue punches were sonicated (Fisher Scientific sonic dismembrator Model 500) in
50 μl buffer (tris buffered saline (TBS), 2 mM ethylenediaminetetraacetic acid
(EDTA), 0.5 mM phenylmethylsulfonyl fluoride (PMSF, Thermo Fisher Scientific,
Waltham, MA), 1 % triton X-100 (Thermo Fisher Scientific, Waltham, MA), and
P8340 (Sigma Aldrich, St Louis, MO), and protein concentrations measured via
Bradford assay on a spectrophotometer (Smartspec3000, Biorad, Hercules, CA).
Protein concentrations of 5 – 10 µg per lane were loaded on 6 – 8 % SDS gels,
electrophoresed (SE260, Hoefer, Holliston, MA), and transferred onto nitrocellulose
(Whatman Protran, GE Healthcare via Thermo Fisher Scientific, Waltham, MA).
Membranes were blocked with 5 % nonfat milk (Carnation, Nestle) for one hr,
washed in phosphate buffered saline with 1 % tween20 (PBST), then incubated
overnight with corresponding primary antibody diluted in 2 % nonfat milk with PBST
Membranes were washed of the primary antibody (See Table 4.1) with PBST then
incubated in corresponding HRP conjugated secondary antibody (See Table 4.2) for
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an additional one hr. Once complete, membranes were washed thoroughly with
PBST and protein visualized with enhanced chemiluminescensce (Thermo Fisher
Scientific, Waltham, MA) and exposed on film. Film was scanned (Canon
canoscan9000F) and band intensity quantified using ImageJ software. For proteins
exhibiting multiple bands, intensities were combined.
Lysis solution: TBS, 2 mM EDTA pH 8.0, 0.5 mM PMSF (Thermo Fisher
Scientific, Waltham, MA), 1 % triton-100, 0.5 % P8340 (Sigma Aldrich, St Louis, MO).
Sociability
All animals were habituated to the behavioral testing room one hr prior to
testing. Two groups of animals were used: test mice and control or unfamiliar mice.
Control animals were of a similar mixed background strain, similar ages, gender
matched, and housed in a separate room as the test mice. The sociability arena
consisted of a 68.5 cm X 27.2 cm rectangular black plexiglass box (FT Plastics, Oak
Park, MI) in which two wire mesh cups (11.11 cm X 12.86 cm, Walmart, Bentonville,
AR) were turned upside – down in each end (see schematic below). Magnets were
attached to the top of the cups for added weight (#BX0X08DCSPC, K&J Magnetics
Inc, Plumsteadville, PA).
Sociability testing was carried out in three phases: habituation, trial 1, and trial
2. During habituation, mice were placed in the center of the sociability arena and
allowed to explore the arena and empty cups for five min. Afterwards, mice were
returned to their home cage. Thirty min later trial 1 began where a control, or
unfamiliar mouse, was placed underneath one wire cup while the other remained
empty. Test mice were allowed to explore the sociability arena for ten min, then
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Table 4.1 – Western blot primary antibodies
Antibody
Company
Glutamate decarboxylase (GAD)
Santa Cruz
65/67
gamma-Aminobutyric acid A
Santa Cruz
(GABAA) R receptor α1-6(E-8)
gamma- Aminobutyric acid B
Santa Cruz
(GABAB) receptor R1(R300)
Glutaminase (Gls)
Abcam
Glutamine synthetase (GS)
Millipore
4-aminobutyrate aminotransferase
Santa Cruz
(ABAT) (H-161)
beta-Actin
Sigma
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Catalog #

Species

Dilution

sc365180

MsIgG1

1:1000

sc376282

MsIgG1

1:1000

sc14006

Rb

1:1000

ab113509
MAB302

Rb
MsIgG2A

1:1000
1:1000

sc366534

Rb

1:1000

A1978

MsIgG1

1:1000

Table 4.2 – Western blot secondary antibodies
Antibody
Conjugation
Company
Gt α MsIgG1
HRP
Southern Biotech
Gt α MsIgG2A
HRP
Southern Biotech
Gt α Rb
HRP
Cell Signaling
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Catalog #
1070-05
1080-05
7074

Dilution
1:2000
1:2000
1:2000

returned promptly to their home cage. Thirty min later trial 2 began. The same
control mouse was placed underneath the same wire cup as before, but this time an
additional unfamiliar, now novel mouse, was placed underneath the previously
empty cup. Control and novel animals were counterbalanced for side of arena and
role as control or novel throughout the study between genotypes. Furthermore,
control animals were habituated to residing underneath the wire cups.
All phases of sociability were video recorded (Samsung SC-MX20L/XAA) and
the center point of the mouse tracked using Ethovision software (version 8.5, Noldus,
Leesburg, VA). Videos were analyzed for total distance traveled, average velocity,
time spent in a 3.75 cm perimeter circle (half a mouse length or 1.68 X cup
diameter) or 5.56 cm perimeter (three-fourths a mouse length, or 2 X cup diameter)
around each cup, each zone (left, right, middle), and manual scored for grooming
time and location.

131

Figure 4.5 – Sociability schematic

Sociability schematic illustrating the three-chambered arena designating left, middle,
and right segments. Zone analyses calculating time spent in the immediate vicinity of
the wire cups (black girds) are depicted in blue (1.68 X) and green (2 X) circles
representing half and three-fourths a mouse body lengths away from the perimeter
of the wire cups. The arena is drawn to scale with respect to the mouse in the top
left corner.
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RESULTS
Initial behavioral screens suggest Cldn11-/-Tg+/- mice have a reduced anxietylike phenotype
Initial interactions with Cldn11-/-Tg+/- mice in their home cage suggested that
they may exhibit a behavioral abnormality. When lifting the cage top of a large cage
of mice, most scattered to the edge, while a few remained in the center. When
genotypes of these mice were checked, they were most often Cldn11-/-Tg+/- mice. To
quantify this anecdotal observation, we investigated the relative anxiety levels in
these mice and littermate controls using behavioral paradigms.
Two behavioral tests were considered, open field (OF) and marble burying
(MB). Each test examines anxiety by eliciting a response in a novel or a familiar
environment. In the OF paradigm, anxiety level is measured by determining the
amount of time rodents spend in the center of a novel open arena (Figure 4.1).
Using t-tests to compare total time, Cldn11-/-Tg+/- mice at 6 – 8 M of age spent twice
as much time in various sized center squares (32, 48, 66, and 83 %) as controls
(Figure 4.6, Table 4.3). To determine if this abnormal phenotype was present at
younger ages, we examined a separate cohort of 2 and 4 M Cldn11+/-Tg+/- and
Cldn11-/-Tg+/- mice in the OF paradigm. No significant differences were observed for
any of the center square dimensions tested (Figure 4.6, Table 4.3). These data
suggest that at 6 – 8 M of age, Cldn11-/-Tg+/- mice exhibit a less anxious phenotype
compared to controls that is not detected in the mutants at younger ages.
The validity of behavioral testing depends heavily on control parameters
specific to each test. For instance, the OF paradigm relies on a mouse’s ability to
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Figure 4.6 – Cldn11-/-Tg+/- mice spend significantly more time in center squares
of an open field arena, indicating a decreased anxiety-like phenotype

Time spent in concentric center squares of an open field arena reveals that Cldn11-/Tg+/- were evident for center squares (A) 32 %, (B) 48 %, (C) 66 %, and (D) 83 %.
Center square percentages were based on the average mouse body length away
from the periphery of the arena: half (83 %), one (66 %), one and a half (48 %), and
two (32 %) body lengths. Data values are plotted as mean + SD, 9 ≤ n ≤ 10, *p < .05,
**p < .01.
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Table 4.3 – Tabulated p values comparing the amount of time Cldn11+/-Tg+/- and
Cldn11-/-Tg+/- mice spent in differing CS of the open field arena (Figure 4.6)
6–8M
Center Square (%)
t17
p
32
2.483
0.0237
48
2.747
0.0138
66
3.067
0.0070
83
2.545
0.0209
4M
t18
p
32
0.3584
0.7242
48
0.3020
0.7661
66
0.2509
0.8047
83
0.2205
0.8280
2M
t18
p
32
0.1371
0.8925
48
0.3874
0.7030
66
0.5750
0.5724
83
1.158
0.2618
A t-test was used to identify statistically significant differences (bold, italicized).
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explore an unfamiliar, lit arena. The overall interpretation of CS activity can be
influenced by two key factors: the speed a mouse travels and the total distance
traversed. Appendix D.1 shows the total distance traveled (A) and the average
velocity (B) of Cldn11+/-Tg+/- and Cldn11-/-Tg+/- mice at 2, 4, and 6 – 8 M of age. Both
groups of mice traverse a similar distance at 2 (t18 = 0.2729, p = 0.7880), 4 (t18 =
1.1063, p = 0.3021), and 6 – 8 (t17 = 1.413, p = 0.1756) M of age. Similarly, when we
investigated the average speed of the mice, we find no significant difference at 2 (t18
= 0.2887, p = 0.7765), 4 (t18 = 1.128, p = 0.2739), and 6 – 8 M (t17 = 1.335, p =
0.1996).
Additionally, because ambient lighting is a major contributing factor to anxiety
in the OF test, we wanted to verify that differential illumination, if present, did not
influence the results. We divided the square arena into four quadrants (Figure 4.1)
and performed a quadrant analysis in which the average amount of time spent in
each was compared between genotypes within each age group (Appendix D.2). A
one-way ANOVA did not detect significant differences for time spent in any quadrant
for mice at 2 M of age (F7, 72 = 1.330, p =0.2486). Significant overall F values were
obtained at 4 (F7,
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= 2.497, p = 0.0235) and 6 – 8 M of age (F7,68 = 3.248, p

=0.0049), however, Bonferroni post hoc tests comparing individual quadrants
between genotypes were not significant. Taken together, the lack of differences
between any of the control parameters validates our initial interpretation of the OF
data that Cldn11-/-Tg+/- mice appear to have a less anxious phenotype.
Behavioral testing aims to quantify anthropomorphic emotional responses in
rodents and relate them to multifaceted and complex human behaviors. The
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interpretation of behavioral phenotypes based on a single test may be misleading,
and therefore, a secondary behavioral test is always recommended (Ramos, 2008).
Because the OF paradigm induces anxiety-like responses through a novel
environment, we wanted a second test that could be implemented in a more native,
less aversive setting: a home cage. To achieve this, we chose to perform marble
burying (MB) analysis.
Marble burying is designed to measure the anxiety-like response of rodents
by comparing the number of marbles buried over a designated time period. We
analyzed the number of marbles buried for the same cohort of mice that underwent
OF testing. Significant differences between Cldn11+/-Tg+/- and Cldn11-/-Tg+/- mice
were seen at 6 – 8 M of age (Figure 4.7). Cldn11-/-Tg+/- mice buried significantly
fewer marbles as compared to controls, t17 = 2.723, p = 0.0145, on average about
half as many. At 2 and 4 M of age, Cldn11+/-Tg+/- and Cldn11-/-Tg+/- mice buried a
similar amount of marbles: t18 = 1.935, p = 0.0689 and t18 = 1.306, p = 0.2080
respectively. These data mirror the OF paradigm, supporting the idea that Cldn11-/Tg+/- mice have decreased anxiety-like phenotype at 6 – 8 M of age.
Cldn11-/-Tg+/- mice do not exhibit depression-like symptoms
Behavioral abnormalities are common in white matter diseases, and can be
the most debilitating feature of the disease. Changes in anxiety state are frequently
comorbid with changes in depression (major depression, major depressive disorder,
unipolar depression, clinical depression). A number of behavioral experiments have
been developed for studying depression-like behaviors in animal models (Porsolt et
al., 1977; Porsolt et al., 1987). Because we observed an altered anxiety-like
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Figure 4.7 – Marble burying test reveals Cldn11-/-Tg+/- mice have decreased
anxiety-like phenotype compared to controls

Using a Student’s t-tests by age, Cldn11-/-Tg+/- mice buried significantly fewer
marbles than controls at 6 – 8M of age. At 2M or 4M, there is no significant
difference in the number of marbles. Data values are plotted as mean + SD, 9 ≤ n ≤
10, *p < .05.
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phenotype in the Cldn11-/-Tg+/- mice, we next asked if changes in depression were
also present. We employed two behavioral tests, the tail suspension test (TST) and
the sucrose preference test (SPT). These tests emphasize distinct facets of
depression, despair and anhedonia respectively.
In a comparable template to anxiety testing, these tests investigate
depression-like phenotypes via different strategies. The TST paradigm has been
widely used to screen the effectiveness of antidepressant drugs for their ability to
increase mobility time (Cryan et al., 2005; Perrault et al., 1992; Steru et al., 1987;
Steru et al., 1985). We calculated the amount of time Cldn11+/-Tg+/- and Cldn11-/Tg+/- mice spent immobile over a 360 sec period at 2, 4, and 6 – 8 M of age (Figure
4.8). The average time spent immobility was approximately 220 sec for mice at 2
and 6 – 8 M of age, and 250 sec for mice at 4 M of age. Regardless of age, there
was no significant difference in the amount of time spent immobile between Cldn11+/Tg+/- and Cldn11-/-Tg+/- mice at 2 (t18 = 1.736, p = 0.0996), 4 (t18 = 0.1603, p =
0.8745), or 6 – 8 M (t18 = 0.5067, p = 0.6185). These data suggests a lack of
despair-like phenotype in the Cldn11-/-Tg+/- mice.
Eliminating the aversive stimulus, we tested anhedonia-like behavior in an
unobtrusive setting using the SPT. Mice have a propensity for sweeter substances
and when given the choice, preferentially drink the sugary option. A sucrose
preference percentage was calculated (sucrose liquid consumed / total liquid
consumed [water + sucrose]) for each test day and compared between genotypes.
Figure 4.9 illustrates the average sucrose preference percentage for Cldn11+/-Tg+/and Cldn11-/-Tg+/- mice at 2, 4, and 6 – 8 M of age. On any given test day, mice
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Figure 4.8 – The tail suspension test suggests a lack of a depression-like
phenotype in Cldn11-/-Tg+/- mice

Student’s unpaired t-test at 2, 4, and 6 – 8M of age reveal both Cldn11+/-Tg+/- and
Cldn11-/-Tg+/- mice spend a similar amount of time immobile during tail suspension,
suggesting a lack of anhedonia. Data values are plotted as mean + SD. 9 ≤ n ≤ 10.
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drank approximately 55 – 70 % sucrose solution compared to water. Using a
repeated measures (RM) two-way ANOVA, no significant differences were
calculated for preference percentage between genotypes at 2, 4, or 6 – 8 M of age:
F1,18 = 0.04, p = 0.8536; F1,18 = 0.94, p = 0.3445; and F1,18 = 0.76, p = 0.3943
respectively. The preference percentages calculated for Cldn11+/-Tg+/- and Cldn11-/Tg+/- mice is similar to published values for mice with our background strain
performance (Pothion et al., 2004).
The amount of sucrose solution consumed can be influenced by a number of
variables, such as weight of the mouse, total liquid consumed, and the amount of
food eaten. Each control parameter was monitored during testing, both during
acclimation (1 – 4) and testing days (5 – 8) (Appendix D.3). The weight of each
animal was normalized to weight on day 1, neutralizing the influence of gender
(Appendix D.3, A). Using a RM ANOVA for mice at 2, 4, or 6 – 8 M of age, no
significant differences in weight fluctuations was seen (2M: F1,16 = 0.15 , p = 0.6991;
4M: F1,18 = 0.01, p = 0.9287; and 6 – 8 M: F1,18 = 0.58, p = 0.4576).
Next, we examined total liquid consumed, regardless of type, across the
testing period (Appendix D.3, B). For any given age, mice consumed approximately
5 – 10 ml of liquid over a 24 – hr period. A RM ANOVA revealed no significant
influence of genotype on liquid volume consumed at 2 (F1,16 = 0.17 , p = 0.6858) and
6 – 8 M (F1,18 = 0.92, p = 0.3493) of age, however, a significant F value was
calculated for mice at 4 M of age (F1,18 = 6.19, p = 0.0229). Bonferroni post hoc tests
comparing genotype versus each test day indicates a lack of significance. The final
control parameter monitored was total food intake during SP testing (Appendix D.3,
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Figure 4.9 – Sucrose preference testing demonstrates a lack of anhedonia in
Cldn11-/-Tg+/- mice

Using a RM two-way ANOVA, it was determined that both Cldn11+/-Tg+/- and Cldn11/Tg+/- mice have a similar level of preference for a sucrose solution at 2, 4, and 6 – 8
M of age. Data values are plotted as mean + SD, n = 9 at 2 M, n = 10 at 4 and 6 – 8
M. Cldn11-/- values are shifted about the abscissa for clarification.
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C). In general, mice of all ages consumed approximately 4 – 6 g of food, regardless
of phase (acclimation or testing). A RM ANOVA was preformed for each age group
and we did not observe significant effects of genotype on food consumed at 2 or 6 –
8 M of age (F

1,16

= 0.43, p = 0.5196 and F

1,18

= 0.59, p = 0.4510 respectively).

Once more, the overall F values showed a significant difference at 4 M of age (F1,18
= 3.21, p = 0.0898), but Bonferroni post hoc tests comparing genotype versus day
was not significant. These data suggest that each constraint was neutral and did not
influence the overall results of sucrose preference.
A more complex analysis for the breakdown of liquid consumption must be
completed, acknowledging the presentation of two sipper bottles and potential effect
placement has on total liquid consumption. Appendix D.4, A shows the culmination
of liquid drank during acclimation when water is present in both sipper bottles. In our
arrangement, the left sipper tube is closest to the long wall of the cage and the right
sipper tube is more towards the center. The purpose of examining the differential
liquid drank from the left and right side is to determine if one side has preferentially
influenced testing, especially given the inherent tendency for Cldn11-/-Tg+/- mice to
spend more time in the center. To prevent a side preference while drinking, sipper
bottle locations were counterbalanced throughout testing: half of the mice received
sucrose beginning in the left sipper bottle, while others started with sucrose on the
right. Sipper bottle placement was alternated each day and side preference was
computed for acclimation (Appendix D.4, A) and sucrose testing (Appendix D.4, B).
During acclimation (days 1 – 4), a two-way RM ANOVA, shows no significant
difference between Cldn11+/-Tg+/- and Cldn11-/-Tg+/- mice at 2 M (2M: F1,16 = 0.4213,
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p = 0.68). The overall ANOVA comparing left versus right sipper bottle does yield a
statistically significant F value (F1,16 = 0.4213, p = 0.68), however, Bonferroni post
hoc comparing Cldn11+/-Tg+/- versus Cldn11-/-Tg+/- is not statistically significant. At 4
M of age, statistically significant F values were tabulated for a placement difference
between left and right (F1,18 = 11.09, p = 0.0037), as well as genotype (F1,18 = 5.09, p
= 0.0367). Bonferroni post hoc tests indicate the only significant finding is between
the left and right sipper bottles for both genotypes: both Cldn11+/-Tg+/- and Cldn11-/Tg+/- mice drank significantly more from the right sipper bottles. With respect to 6 – 8
M animals, there was no statistically significant difference between genotype (F1,18 =
1.66, p = 0.2141), but significance in left versus right side preference (F1,18 = 25.09,
p = <0.0001). Both Cldn11+/-Tg+/- and Cldn11-/-Tg+/- mice preferentially drank more
liquid from the right sipper bottle.
Throughout SP testing days (days 5 – 8), one sipper bottle contained a 2 %
sucrose solution. To account for a side preference, two-way RM ANOVAs were
performed in a similar fashion as the acclimation phase. At 2 M of age, no significant
differences were seen for left versus right liquid preference (F1,16 = 4.25, p = 0.0533),
or between genotypes (F1,16 = 0.41, p = 0.5292). At 4 M of age, no significant
difference were seen for liquid drank from left versus right sipper bottles (F1,18 = 1.66,
p = 0.2144), however comparing genotypes yielded a statistically significant F value
(F1,18 = 6.48, p = 0.0203). Performing a Bonferroni post hoc contrasting Cldn11+/Tg+/- versus Cldn11-/-Tg+/- revealed no significant difference. And finally, at 6 – 8 M of
age, a two-way RM ANOVA indicated a statistically significant difference for left
versus right preference (F1,18 = 8.71, p = 0.0086). A Bonferroni post hoc test

144

revealed that Cldn11+/-Tg+/- mice drank significantly more liquid from the right side,
as compared to the left. No significant difference was seen between genotype (F1,18
= 0.48, p = 0.4962). In summary, the patterning of liquid intake was similar between
Cldn11+/-Tg+/- and Cldn11-/-Tg+/- mice, indicating side preference did not influence the
overall sucrose preference results.
Combining results from TS and SP, these data indicate a lack of depressionlike phenotype in Cldn11-/-Tg+/- mice. The various subcategories of depression
examined, despair and anhedonia-like responses, are similar between Cldn11+/-Tg+/and Cldn11-/-Tg+/- mice. Analyses of confounding variables indicate negligible
differences, strongly suggesting a lack of influence of depression-like characteristics
in Cldn11-/-Tg+/- mice.
Cognitive learning and memory is similar between Cldn11+/-Tg+/- and Cldn11-/Tg+/- mice
One of the most distressing symptoms of white matter diseases, despite the
probable change in mood, is the loss of cognitive function. Increasing association
between white matter dysfunction and cognitive decline / dysfunction is vastly noted
throughout the literature, not only in normal aging patients (Gunning-Dixon and Raz,
2000; Hedden and Gabrieli, 2004), but diseases with a predominantly white matter
pathology. In multiple sclerosis (MS), for example, cognitive dysfunction is a frequent
and often devastating symptom that, arguably, is the most debilitating feature of the
disease (Jongen et al., 2012; Lovera and Kovner, 2012).
To determine if our mouse model of dysfunctional myelin exhibited similar
deficits, we assessed cognitive learning and memory ability using the Barnes maze
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(BM). For this test, a circular platform containing 20 holes along the perimeter is
used to assess a mouse’s ability to learn and remember the location of a target goal
box located underneath a single hole (Figure 4.3). Mice are trained to locate the
correct goal hole and the latency is computed for training, as well as probe days
(Barnes, 1979). Using a RM ANOVA comparing the effect of genotype on latency to
locate the goal hole throughout testing, no significant difference was discerned at 2
(F1,17 = 1.48, p = 0.2399), 4 (F1,15 = 0.12, p = 0.7293), or 6 – 8 M of age (F1,18 = 4.03,
p = 0.0601) (Figure 4.10). These data indicate similar cognitive learning and memory
ability of Cldn11+/-Tg+/- and Cldn11-/-Tg+/- mice.
During BM testing, three probe days are performed to evaluate a mouse’s
learning and memory ability under different scenarios. For each, the goal
compartment is removed, eliminating reinforcement of a correct selection. Because
there is no compartment for a mouse to enter, time spent in various zones
surrounding the trained goal hole is analyzed. Zone 0 represents the immediate
circular vicinity around the trained goal hole, twice its diameter. Zone 1 is designated
as the wedge-shaped portion of maze surrounding the trained goal hole, demarcated
by one neighboring hole on each side. Zone 2 is designated as the wedge-shaped
section surrounding the goal hole, encompassing Zone 1 and expanding the
boundary to two holes flanking the trained goal hole (see Methods for clarification).
The first scenario is a simple probe day (day 5) to test the mouse’s ability to
remember the location of the trained goal hole (Appendix D.5). Employing Student’s
t-tests to compare time spent in various zones around the trained goal hole, we
observe no significant differences at 2, 4, or 6 – 8 M of age for time spent in Zone 0,
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Figure 4.10 – Latency to find trained goal hole throughout Barnes maze testing
is comparable between Cldn11+/-Tg+/- and Cldn11-/-Tg+/- mice demonstrating
indistinguishable spatial learning and memory ability

A two-way RM ANOVA comparing genotype by day confirms similar latency for
Cldn11+/-Tg+/- and Cldn11-/-Tg+/- mice to reach the learned goal hole across Barnes
maze testing at 2, 4, and 6 – 8 M of age. Data values are plotted as mean + SD; 2
M: 9 ≤	
 n ≤ 10, 4 M: 7 ≤	
 n ≤ 10, 6 – 8 M: 9 ≤	
 n ≤ 11. See Methods section for zone
illustration. Cldn11-/-Tg+/- values are shifted about the abscissa for clarification; red
numbers indicate probe days.
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1, or 2 around the trained goal hole (Table 4.4). These data suggest that both
Cldn11+/-Tg+/- and Cldn11-/-Tg+/- mice not only found the goal hole is a similar amount
of time, but spend equal time in the zone located immediately around the trained
hole.
The second scenario tested was a curtain probe (day 7). In a similar fashion
to probe day, time spent in the aforementioned zones was investigated (Appendix
D.6). For Cldn11+/-Tg+/- and Cldn11-/-Tg+/- mice at 2 M of age, a comparable amount
of time was spent in Zone 0, 1 and 2. The cohort of mice at 4 M of age spent a
similar amount of time in Zone 0 and 1, however, Cldn11-/-Tg+/- mice spent
significantly more time in Zone 2, about 30 % more, as compared to Cldn11+/-Tg+/mice. At 6 – 8 M of age, no significant differences were seen for time spent in any
zone examined (Table 4.5).
The final scenario examined during BM testing was a reversal probe (day 10).
The reversal probe was conducted in a similar format as the probe day (day 5), and
the time spent in the aforementioned zones was analyzed for the newly trained hole
(Appendix D.7). At 2 M of age, Cldn11+/-Tg+/- mice spent significantly more time in
Zone 0 (t18 = 1.314, p = 0.0334), a similar amount of time in Zone 1 (t18 = 1.944, p =
0.0687) and significantly less time in Zone 2 (t18 = 2.118, p = 0.0492) around the
newly trained reversal hole. For the cohort at 4 M of age, no significant differences
were seen for the amount of time spent in any zone: Zone 0 (t16 = 0.6839, p =
0.5045), Zone 1 (t16 = 0.1958, p = 0.8474), or Zone 2 (t16 = 0.0665, p = 0.9478).
Similarly, at 6 – 8 M of age, no significant differences were observed (Zone 0: t17 =
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Table 4.4 – Tabulated p values comparing the amount of time Cldn11+/-Tg+/- and
Cldn11-/-Tg+/- mice spent in differing sized zones around the goal hole during
BM probe day 5 (Appendix D.5).
6–8M
Zone
t17
p
0
0.1903
0.8513
1
0.4176
0.6815
2
0.6297
0.5373
4M
t16
p
0
0.8154
0.4268
1
0.3620
0.7221
2
0.0155
0.9878
2M
t18
p
0
0.72
0.4808
1
0.9633
0.3482
2
1.062
0.3022
A t-test was used to identify statistically significant differences (bold, italicized).
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Table 4.5 – Tabulated p values comparing the amount of time Cldn11+/-Tg+/- and
Cldn11-/-Tg+/- mice spent in differing sized zones around the goal hole during
BM curtain probe day 7 (Appendix D.6).
6–8M
Zone
t17
p
0
0.7320
0.4376
1
0.1658
0.8701
2
0.0165
0.9870
4M
t16
p
0
1.178
0.2560
1
1.819
0.0877
2
2.236
0.04
2M
t18
p
0
0.7701
0.4518
1
0.1132
0.9199
2
0.0309
0.9757
A t-test was used to identify statistically significant differences (bold, italicized).
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0.4643, p = 0.6480; Zone 1: t17 = 0.5227, p = 0.6075; and Zone 2: t17 = 1.063, p =
0.3019).
To account for undetectable intra-maze discrepancies, the maze was rotated
90O clockwise on all probe days, ensuring that a hole aligned identically with trained
location. To determine the presence of cues, zones were drawn around the hole
where the box attaches, the hook-in hole (now at a different location), and zone
analysis for time spent was completed. Appendix D.8 shows the zone analysis for
probe day for 2, 4, and 6 – 8 M mice. Student’s t-tests revealed no significant
differences in the amount of time Cldn11+/-Tg+/- and Cldn11-/-Tg+/- mice spent
around the hook-in hole for Zone0, Zone1, or Zone2 at any age (Table 4.6). Appendix
D.9 diagrams time spent in each zone around the hook-in hole during curtain probe.
Mice at 2 and 6 – 8 M of age spent an indistinguishable amount of time in each
region surrounding the hook-in hole, whereas at 4 M of age, Cldn11+/-Tg+/- animals
spent significantly more time in every zone surrounding the hook-in hole (Table 4.7).
On the final probe day, reversal probe, both groups of animals spent a similar
amount of time in the regions around the hook-in hole (Appendix D.10, Table 4.8).
In general, cognitive learning and memory ability of Cldn11-/-Tg+/- mice is
indistinguishable from controls at 2, 4, and 6 – 8 M of age. Barnes maze testing
indicates that both genotypes could be trained to locate and remember a target goal
hole promptly. The curtain probe trial reveals the use of distal visual cues to be
unlikely, and presumably, mice employed a remembered motor reflex to guide them
to the target. Introducing a new target location during reversal training and
subsequent probe day indicates that both Cldn11+/-Tg+/- and Cldn11-/-Tg+/- mice have
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Table 4.6 – Tabulated p values comparing the amount of time Cldn11+/-Tg+/- and
Cldn11-/-Tg+/- mice spent in differing sized zones around the hook-in hole
during BM probe day 5 (Appendix D.8).
6–8M
Zone
t17
p
0
0.5273
0.6048
1
0.5307
0.6025
2
0.3143
0.7571
4M
t16
p
0
0.00009
0.9993
1
0.8202
0.4242
2
0.4174
0.6820
2M
t18
p
0
2.406
0.0271
1
0.04365
0.9657
2
0.1523
0.8806
A t-test was used to identify statistically significant differences (bold, italicized).
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Table 4.7 – Tabulated p values comparing the amount of time Cldn11+/-Tg+/- and
Cldn11-/-Tg+/- mice spent in differing sized zones around the hook-in hole
during BM curtain probe day 7 (Appendix D.9).
6–8M
Zone
t17
p
0
0.3207
0.7521
1
0.2527
0.8034
2
0.3207
0.7521
4M
t16
p
0
5.733
<0.0001
1
3.788
0.0016
2
4.639
0.0003
2M
t18
p
0
1.785
0.0921
1
0.1690
0.8678
2
0.3035
0.7652
A t-test was used to identify statistically significant differences (bold, italicized).
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Table 4.8 – Tabulated p values comparing the amount of time Cldn11+/-Tg+/- and
Cldn11-/-Tg+/- mice spent in differing sized zones around the hook-in hole
during BM reversal probe day 10 (Appendix D.10).
6–8M
Zone
t17
p
0
1.425
0.1712
1
0.3416
0.7366
2
0.6429
0.5284
4M
t16
p
0
0.7512
0.4642
1
0.9394
0.3624
2
1.149
0.2687
2M
t18
p
0
0.0753
0.9409
1
0.2331
0.8184
2
0.2369
0.8156
A t-test was used to identify statistically significant differences (bold, italicized).
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similar short-term memory ability and can focus on a new challenge. This extensive
testing and analysis advocates for a lack of cognitive differences between the two
groups of animals, for any age examined.
Neurochemical alterations in the brain of Cldn11-/-Tg+/- mice may be
responsible for behavioral changes observed
Because we observed abnormal behavior within Cldn11-/-Tg+/- mice, we
wanted to determine if neurochemical alterations were present, which could
conceivably drive the decreased anxiety we observe. From the same 6 – 8 M
animals in which a decreased anxiety-like phenotype was detected, we collected ex
vivo tissue punches and analyzed the neurochemical composition using high
resolution magic angle spinning proton magnetic resolution (magic angle H1 NMR)
(Table 4.9, Figure 4.11). Of importance were brain regions relating to the
development of anxiety. Using t-tests to compare individual brain regions, Cldn11-/Tg+/- mice had significantly increased levels of the main neurotransmitter gammaaminobutryic acid (GABA) in the VHC, but not the DHC, or ACC (Figure 4.11A):
VHC: t9 = 2.502, p = 0.0338; DHC: t9 = 0.4875, p = 0.6378; ACC: t9 = 0.1117, p =
0.9138. Contrasting inhibitory changes, we examined the levels of the principal
excitatory neurotransmitter, glutamate, in the VHC, DHC, and ACC, however no
significant differences were seen (Figure 4.11B): VHC: t9 = 1.359, p = 0.2073; DHC:
t9 = 0.0365, p = 0.9717; ACC: t9 = 2.302, p = 0.0503.
To ascertain the mechanism by which increased levels of GABA could arise,
we focused on the metabolic enzymes responsible for synthesizing and breaking
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Figure 4.11– Proton Magnetic Resonance Spectroscopy quantification for various
brain regions reveals increased GABA levels in the ventral hippocampus of Cldn11-/Tg+/- mice

(A) gamma-aminobutryic acid (GABA) levels in select brain regions of Cldn11+/-Tg+/and Cldn11-/- mice. Student’s t-test for select regions indicates that Cldn11-/-Tg+/mice have significantly increased GABA levels in the ventral hippocampus (VHC),
however comparable amount in the dorsal hippocampus (DHC) and anterior
cingulate cortex (ACC). (B) Glutamate (Glu) levels in select brain regions of
Cldn11+/-Tg+/- and Cldn11-/- mice. Student’s t-test for select regions indicates that
Cldn11+/-Tg+/- and Cldn11-/-Tg+/- mice have similar glutamate levels in the VHC, DHC,
and ACC. Data values are plotted as mean + SD; 5 ≤	
 n ≤ 6; *p < .05.
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Table 4.9 – List of brain regions collected and neurotransmitters analyzable with
H1MRS
Generalized Brain Region
Neurochemical
ACC
Anterior Cingulate Cortex
Act
Acetate
AMC
Anterior Motor Cortex
Ala
Alanine
AST
Anterior Striatum
Asp
Aspartate
AUD
Auditory Cortex
Bet
Betaine
BS
Brainstem
Cre
Creatine
CB
Cerebellum
Cho
Cholines
DHC
Dorsal Hippocampus
GABA
Gamma-aminobutryic acid
DPST
Dorsal Posterior Striatum
Gln
Glutamine
MidB
Midbrain
Glu
Glutamate
NAC
Nucleus Accumbens
GPC
Glycerophosphocholine
PCC
Posterior Cingulate Cortex
GSH
Glutathione
PMC
Posterior Motor Cortex
Ins
Inositol
SOC
Superior Olivary Complex
Lac
Lactate
THAL
Thalamus
NAA
N-Acetlyaspartate
VHC
Ventral Hippocampus
NAAG N-Acetlyaspartatylglutamate
VPST
Ventral Posterior Striatum
PEA
Phenylethylamine
PCh
Phosphocholine
Suc
Succinate
Tau
Taurine

157

down GABA: glutamic acid decarboxylase 65 / 67 (GAD 65 / 67) and 4aminobutyrate aminotransferase (ABAT) respectively, as well as post-synaptic
receptors. Using t-tests comparing genotype and individual brain region, no
significant differences were seen for the either GABAA or GABAB receptor, nor the
synthesizing enzyme GAD 65 / 67 (Figure 4.12, Table 4.10). Interestingly, when we
compared the protein level of ABAT, a significant increase was seen in the VHC of
Cldn11-/-Tg+/- mice (t8 = 2.570, p = 0.0331), but not the DHC (t8 = 0.8287, p =
0.4313), or ACC (t8 = 0.9267, p = 0.3849).
We detected neurochemical alterations at 6 – 8 M of age, correlating with the
measureable behavior phenotype, however we wanted to evaluate if this alterations
were present in younger animals, preceding a quantifiable behavioral phenotype.
Fresh tissue punches were collected from 4 M animals and an abbreviated
neurochemical assessment was completed prioritizing the VHC. Appendix D.11
shows GABA and glutamate levels normalized to creatine levels within a given
punch. No significant changes were observed within the VHC (GABA: t12 = 0.7879, p
= 0.4460; Glu: t12 = 0.1128, p = 0.9120) or DHC (GABA: t15 = 0.0865, p = 0.9322;
Glu: t15 = 1.337, p = 0.2011). These data support the idea that a neurochemical
change may not precede the onset of a detectable behavioral phenotype.
Repeat behavioral analyses of Cldn11-/-Tg+/- mice suggest an undetectable
behavioral phenotype
After the initial finding of a decreased anxiety-like phenotype and
corresponding increase in GABA level within the VHC of Cldn11-/-Tg+/- mice, we
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Figure 4.12 – Western blot analysis of key brain regions associated with an
anxiety-like phenotype is similar between Cldn11+/-Tg+/- and Cldn11-/-Tg+/- mice

(A) Student’s t-test comparing GABA’s synthesizing protein, GAD 65 / 67, in select
brain regions from Cldn11+/-Tg+/- and Cldn11-/-Tg+/- mice at 6 – 8 M of age suggests
no difference in protein concentration. (B) Student’s t-test comparing protein
concentrations of ABAT, the enzyme responsible for recycling GABA. A significant
increase is seen in the ventral hippocampus (VHC) of Cldn11-/-Tg+/- mice, but not in
the dorsal hippocampus (DHC) or anterior cingulate cortex (ACC). (C) Student’s ttest comparing GABAA receptor in select brain regions from Cldn11+/-Tg+/- and
Cldn11-/-Tg+/- mice at 6 – 8 M of age indicates a lack of difference in protein
concentration. (D) Student’s t-test comparing GABAB receptor in select brain regions
suggests no difference in protein concentration between genotypes. Representative
western blot images are shown below each bar graph. Data values are plotted as
mean + SD; 4 ≤	
 n ≤ 6.
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Table 4.10 – Tabulated p values comparing the protein level of select
metabolic enzymes from fresh tissue punches from Cldn11+/-Tg+/- and Cldn11-/Tg+/- mice (Figure 4.12).
GABAA
Punch Location
t4
p
VHC
0.3299
0.7580
DHC
0.3340
0.7551
ACC
0.3698
0.7303
GABAB
t4
p
VHC
1.114
0.3276
DHC
1.286
0.2677
ACC
2.361
0.0776
GAD 65/67
t9
p
VHC
1.577
0.1458
DHC
0.5337
0.6065
ACC
0.4957
0.6320
A t-test was used to identify statistically significant differences (bold, italicized).
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hypothesized that excess GABA levels may have originated from dysregulation of
metabolizing enzymes; either an increase in synthesis or a decrease in recycling.
Examination of the amygdala would have been preferable, however, heavy
reciprocal connections are formed between the AMYG and VHC (O'Donnell and
Grace, 1995; Pikkarainen et al., 1999). Recent data has uncovered the ability of the
AMYG – VHC connection to modulate anxiety-related behaviors, as well as the
social nature of rodents, termed sociability (Felix-Ortiz et al., 2013; Felix-Ortiz and
Tye, 2014; Moy et al., 2004). By inhibiting AMYG output via pyramidal cells of the
basolateral nucleus (BLA) to the VHC, increased social behavior of mice was
observed (Felix-Ortiz and Tye, 2014).
Interestingly, the AMYG and VHC have a bidirectional, reciprocal connections
thought to modulate social behavior. To ascertain if Cldn11-/-Tg+/- mice have a deficit
in social behavior, we preformed a sociability assay on a third cohort of mice 6 – 8 M
in age (Figure 4.13). During habituation when both wire cups in the arena remain
empty, we find that Cldn11+/-Tg+/- and Cldn11-/-Tg+/- mice spend a similar amount of
time in the zones immediately surrounding each cup, as well as each chamber
containing a cup (two-way ANOVA; 1.68 X: F1,10 = 0.64, p = 0.4428; 2 X: F1,10 = 1.20,
p = 0.2948; chamber: F1,10 = 0.70, p = 0.4208). During trial 1, an unfamiliar mouse is
placed underneath one wire cup and we observe that both Cldn11+/-Tg+/- and
Cldn11-/-Tg+/- mice spend an indistinguishable amount of time around the empty cup,
the cup housing an unfamiliar mouse, and in each arena chamber containing a cup
(two-way ANOVA; 1.68X: F1,10 = 1.91, p = 0.1970; 2X: F1,10 = 3.01, p = 0.1133;
chamber: F1,10 = 0.29, p = 0.6026).
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During the final assessment (trial 2) when mice are underneath both wire
cups (now familiar mouse and novel mouse) we find a similar amount of time is
spent immediately around each cup and in each chamber, regardless of mouse
familiarity (two-way ANOVA; 1.68X: F1,10 = 0, p = 0.9856; 2X: F1,10 = 0.02, p =
0.8856; chamber: F1,10 = 0.02, p = 0.8856). These data suggest that the social
nature of Cldn11-/-Tg+/- mice is comparable to controls.
Examining the motor ability of Cldn11+/-Tg+/- and Cldn11-/-Tg+/- mice during sociability
testing further supports these results. Appendix D.12 shows the total distance
(Appendix D.12, A), average velocity traveled (Appendix D.12, B) and the time spent
in each chamber of the sociability arena (Appendix D.12, C). Each parameter was
monitored to ensure similarity, eliminating potential influence on time spent in each
chamber of the sociability arena. The total distance traveled was proportional
between Cldn11+/-Tg+/- and Cldn11-/-Tg+/- animals during habituation (t10 = 1.40, p =
0.3229), trial 1 (t10 = 0.9836, p = 0.3485), and trial 2 (t10 = 0.3858, p = 0.7086). In
addition, the average velocity traversed was similar between Cldn11+/-Tg+/- and
Cldn11-/-Tg+/- mice during habituation (t10 = 1.024, p = 0.33), trial 1 (t10 = 0.9141, p =
0.3822), and trial 2 (t10 = 0.3106, p = 0.7632).
The last motor parameter examined was the total amount of time spent in
each chamber of the sociability arena: left, center, and right. Using a one-way
ANOVA to analyze each phase of testing, we find an overall statistically significant F
value for habituation (F5,30 = 5,704, p = <0.001), trial 1 (F5,30 = 23.18, p = <0.0001)
and trial 2 (F5,30 = 9.622, p = <0.0001), however, Bonferroni post hoc tests
comparing genotype versus chamber is not statistically significant for any of the
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Figure 4.13 – Time spent in various zones of the sociability arena is similar between
Cldn11+/-Tg+/- and Cldn11-/-Tg+/- mice

(A) The average amount of time Cldn11+/-Tg+/- and Cldn11-/-Tg+/- mice spend within
half a body length (1.68X) around each wire cup is similar throughout each phase of
sociability testing: habituation, trial 1, and trial 2. (B) The average amount of time
mice spend within a body length (2X) of each wire cup is indistinguishable between
genotypes. (C) The amount of time Cldn11+/-Tg+/- and Cldn11-/-Tg+/- mice spend in
each chamber of the sociability arena during each phase is not statistically different
between genotypes. Data values are plotted as mean + SD, n = 6. THM to house
mouse; TBE to be empty; M mouse; E empty; FM familiar mouse; NM novel mouse
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phases. Together, these data suggest that the social nature of Cldn11-/-Tg+/- mice is
comparable to controls and uninfluenced by motor ability or arena bias.
Sociability testing involves examining the exploratory preference, and other
quantifiable behaviors such as grooming, in the presence of familiar and novel mice
(Kaidanovich-Beilin et al., 2011). A secondary analysis was completed on the
location and length of grooming behaviors. The amount of time and location of
grooming events indicates changes in stress and anxiety levels, differential
grooming during various phases of testing could indicate preferential changes in
anxiety-like behavior (Kalueff and Tuohimaa, 2005; Moyaho et al., 1995; Moyaho
and Valencia, 2002).
Appendix D.13, A diagrams the total time spent grooming for Cldn11+/-Tg+/and Cldn11-/-Tg+/- mice. No statistically significant differences are observed between
genotypes during habituation (t = 1.447, p = 0.1785), trial 1 (t = 1.309, p = 0.22), or
trial 2 (t = 1.299, p = 0.2231). We evaluated the proportion of grooming time spent in
each chamber of the sociability arena more extensively during trials 1 and 2 because
of the added variable (additional mice) and increased overall grooming (Appendix
D.13, B). Total grooming time during trial 1 was separated into the fraction of total
time spent grooming in the empty chamber, the middle chamber, and the chamber
that housed a mouse.
A one-way ANOVA revealed a statistically significant difference in the amount
of time spent grooming (F5,30 = 1.040, p = <0.0001) and post hoc testing indicated
that both Cldn11+/-Tg+/- and Cldn11-/-Tg+/- mice spent significantly more time
grooming in the empty chamber as compared to the chamber that housed a mouse
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or the middle portion, however, there was no main effect of genotype on location.
Total grooming during trial 2 was separated in a similar fashion, but the empty
chamber now housed a novel mouse. An ANOVA for time spent in each location
was not statistically significant (F5,30 = 0.2113, p = 0.5921), suggesting both
genotypes groomed for a similar amount of time in all locations.
The persistence of a decreased anxiety-like phenotype was also investigated
by repeating the OF and MB paradigms with the third cohort of mice. To determine if
the native testing environment can alter anxiety state, we conducted repeat OF
testing in two difference locations. During the repeat OF test in location 1, Cldn11+/Tg+/- and Cldn11-/-Tg+/- mice spent a similar amount of time in each of center square
designation (Figure 4.14, Location 1): 32 % (t18 = 0.2850, p = 0.7940), 48 % (t18 =
0.3314, p = 0.7441), 66 % (t18 = 0.6956, p = 0.4956), and 83 % (t18 = 0.0774, p =
0.9391). Control parameters, including total distance traveled, average velocity, and
time spent in each quadrant was similar between genotypes (traveled t18 = 1.703, p
= 0.1058; t18 = 1.647, p = 0.1169; and F1,18 = 0.03, p = 0.8709 respectively)
(Appendix D.15, A).
Likewise, when mice were evaluated for open field activity in a different
environment, location 2, Cldn11+/-Tg+/- and Cldn11-/-Tg+/- spent an indistinguishable
amount of time in each center square designations (Figure 4.14, Location 2): 32 %
(t11 = 0.5755, p = 0.5766), 48 % (t11 = 1.109, p = 0.2910), 66 % (t11 = 1.467, p =
0.1702), and 83 % (t11 = 1.466, p = 0.1707). Control variables were not statistically
different between genotypes: total distance traveled: t11 = 0.4911, p = 0.6330,
average velocity: t11 = 0.4131, p = 0.875, and quadrant analysis: F1,11 = 3.79, p =
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0.0776 (Appendix D.14, B). These data suggest it was irrelevant which environment
mice were tested in; there was no detectable difference in the anxiety state between
mice, uninfluenced by motor ability or exploration constants.
With a lack of significant difference discerned by repeating the OF test, we
conducted MB to further investigate this new conclusion (Figure 4.15). Using a
Student’s t-test, we find Cldn11+/-Tg+/- and Cldn11-/-Tg+/- mice bury a similar number
of marbles (t18 = 1.036, p = 0.3140). The same cohort of OF mice completed the MB
task, and results indicate a similar number of marbles buried between Cldn11+/-Tg+/and Cldn11-/-Tg+/- mice. If we compare the MB averages from the original cohort
(Figure 4.7) to the repeated cohort of mice, we notice that Cldn11+/-Tg+/- animals
buried, on average, slightly fewer marbles, while Cldn11-/-Tg+/- mice buried slightly
more marbles. Thus the averages are closer together, eliminating significance, and
confirming the OF results of an inability to detect the less anxious phenotype in
Cldn11-/-Tg+/- mice.
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Figure 4.14 – Repeat analyses of open field center square percentages from two
different locations suggest Cldn11-/-Tg+/- mice and controls are similar

Repeat open field center square analyses for 6 – 8 M Cldn11+/-Tg+/- and Cldn11-/Tg+/- mice. Student’s t-tests indicate similar amount of time spent in (A) 32 %, (B)
48 %, (C) 66 %, and (D) 83 % center squares, irrespective of location. Data values
are plotted at mean + SD; Location 1: n = 10, Location 2: 6 ≤	
 n ≤ 7.
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Figure 4.15 – Repeat marble burying paradigm indicates Cldn11+/-Tg+/- and Cldn11-/Tg+/- mice bury a similar amount of marbles

Marble burying analysis was repeated for an additional cohort of Cldn11+/-Tg+/- and
Cldn11-/-Tg+/- mice. Using a Student’s t-test comparing the number of marbles buried,
no significant differences were seen. Data values are plotted as mean + SD; n = 10.
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Our initial neurochemical data demonstrating GABA alterations was
compelling, and a pilot study was conducted to more precisely determine, where
GABA changes emanated from in the brains of Cldn11-/-Tg+/- mice. For this analysis,
1 mm coronal brain slices were generated spanning the brain segment of interest
(bregma - 1 to - 5), and bilateral punch structures were pooled for magic angle
H1MRS (Figure 4.16A). GABA level was controlled for tissue weight and normalized
to the internal control, creatine. Analysis revealed stark different amount of GABA for
all segments analyzed (Figure 4.16B): - 1 to - 2, - 2 to - 3, - 3 to - 4, and - 4 to - 5
bregma. Given the pilot study contained only one animal from each genotype, it
negates the possibility of statistical analysis, however, we can still discern an
increased level of GABA for all slices, regardless of genotype. In addition, the GABA
level for the Cldn11-/-Tg+/- mouse in the first two slices was greater than the Cldn11+/Tg+/-, but decreased within the last two slices.
One momentous question remains, what happened to the behavioral
phenotype of the Cldn11-/-Tg+/- mice? Our recent assessment of Cldn11-/-Tg+/- mice
reveals our inability to detect a behavioral phenotype or neurochemical alteration
within these animals. The aforementioned studies were conducted throughout
several years and a number of variables could account for our inability to detect
significant differences.
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Figure 4.16 – Pilot neurochemical investigation to resolve location of altered GABA
points to dissimilarity from original data set

One Cldn11+/-Tg+/- and one Cldn11-/-Tg+/- mouse (age 6 – 8 M) were used to
determine precise location for increased GABA expression. (A) Coronal slices were
generated (1 mm) and bilateral region of interest (blue circles) were collected and
analyzed via magic angle H1MRS. (B) GABA expression was quantified, adjusted for
tissue weight, then normalized to the internal control marker, creatine.
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DISCUSSION
The concept that dysfunctional myelin can lead to behavioral abnormalities
has been alluded to throughout the myelin literature. Evidence in clinical literature
suggests that myelin may pose an as alternative mechanism for the etiology of
behavioral abnormalities. In white matter diseases such as leukodystrophies and
multiple sclerosis (MS), the acknowledged component is dysfunctional myelin,
however the prominent features are the accompanying behavioral abnormalities.
Direct evidence supporting dysfunctional myelin as a causative component for
behavioral abnormalities is difficult to obtain due to the compound nature of
neurological illnesses and the challenge of separating dysfunctional myelin to
disease etiology from behavior. Our Cldn11-/-Tg+/- mouse model is ideal for
partitioning dysfunctional myelin from a complex disease state to investigate its
contribution to manifestation of behavioral abnormalities.
Dysfunctional myelin has the ability to generate behavioral abnormalities
The etiology of behavioral abnormalities is hypothesized to emanate from a
disconnection between neural circuits. As stated in the disconnection hypothesis:
behavior is the result of temporal integration of sensory signals; abnormal behavior
results when there is a disconnection between brain regions or neural circuits
(Friston, 1998, 1999). Chapter 3 of this dissertation demonstrates that dysfunctional
myelin alters signal integration and neural processing within the auditory brainstem.
If we extrapolating those findings and apply them to higher-order brain networks, we
envisage a similar deficit is present. Higher-order cortical networks contain a vast
network of small diameter, myelinated fibers, that transmit sensory information to
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various integration centers within the brain. If integration of sensory signals becomes
altered, a behavioral abnormality will arise. This chapter proposes evidence in favor
of dysfunctional myelin as an etiology for manifestation of abnormal behavior
Chronicling the behavioral abnormalities of Cldn11-/-Tg+/- mice
Initial behavioral analyses of 2, 4, and 6 – 8 M Cldn11+/-Tg+/- and Cldn11-/Tg+/- mice reveals a distinct abnormality resulting from dysfunctional myelin.
Irrespective of the inability to detect a phenotype in subsequent cohorts of animals,
(see below), Cldn11-/-Tg+/- mice have a less anxious phenotype at 6 – 8 M. This
reduced anxiety-like phenotype is not detectable at younger ages, 2 or 4 M. This
robust finding is supported by two technically distinct behavioral tests eliciting
anxiety-like responses from different methods: OF and MB. While Cldn11-/-Tg+/- mice
have no apparent change in depressive-like phenotype based on tests of anhedonia
and depressive-like (TST and SPT respectively), or differences in cognitive ability,
an alteration in anxiety state is still noteworthy. Furthermore, throughout all
behavioral tests require motor activity, we did not detect difference in distance
traveled or velocity of Cldn11-/-Tg+/- mice, negating the known hind limb weakness
(Gow et al., 1999). A number of mutant myelin mouse models have been generated
and studied for abnormal phenotypes under a similar battery of behavioral analyses.
Alternative mouse models of dysfunctional myelin emanate behavioral
abnormalities
Proteolipid protein (PLP) is a major myelin protein constituting about half of
total protein within the myelin sheath. Several different mouse strains of mutated
PLP have been generated to study potential behavioral abnormalities via gene
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knockout (PLP1) and overexpression (Boison and Stoffel, 1994; Inoue et al., 1996;
Readhead et al., 1994). Studies involving overexpression of PLP indicate abnormal
anxiety-like phenotype; interestingly, an increase in anxiety is seen when evoked
with the light / dark transition test, while a decrease is identified by the elevated plus
maze. In addition, decreased spatial learning and memory is noted using the Barnes
maze test (Tanaka et al., 2009). In contrast, knocking out PLP causes an increase in
anxiety-like behavior in mice (Boison and Stoffel, 1994).
The second major protein found within myelin sheaths is myelin basic protein
(MBP). Mutant mice harboring genetic alterations to the MBP gene have also been
studied for behavioral abnormalities (Privat et al., 1979; Rosenbluth, 1980).
Variations in protein expression cause severe tremors and seizures, as well as a
decrease learning ability via the T-maze test (Inagawa et al., 1988).
A direct comparison between our dysfunctional myelin mutant and those is
complex. When altered, each of these proteins (PLP and MBP) cause changes in
the ultrastructure of the myelin membrane, along with a neurodegenerative
phenotypes. Also pronounced are the varying degrees of shakes and tremors
exhibited by mutant animals and premature death in MBP mutants (Kirschner and
Ganser, 1980; Klugmann et al., 1997; Privat et al., 1979; Readhead et al., 1994).
Consequently, these myelin mutants do not have the ability to separate out
compounding structural and disease-causing phenotypes. It is implausible to
separate out the contribution of dysfunctional myelin on behavioral abnormalities
with additional variables present. These data attempt to illustrate the idea that
dysfunctional myelin leads to behavioral abnormalities, however our data is the first
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to show definitive evidence. The Cldn11-/- mice lack any ultrastructure abnormalities
or neurodegenerative component at older time points; leaving a straightforward
model to directly study the behavioral ramifications of dysfunctional myelin (Gow et
al., 1999).
Dysfunctional myelin causes neurochemical alterations
The leading hypothesis for the etiology of behavioral abnormalities is largely
based on altered neurochemical levels present in the brain. Variations include an
increase or decrease in amount, as well as modifications in the quanta released at a
synapse, inherently causing an imbalance and the physical manifestation of
abnormal behavior (Sarter et al., 2007). Pharmaceutical companies have taken
advantage of this hypothesis and developed drugs to counteract the incorrect levels
for various illnesses including anxiety and depression. However, about 30 % of
patients actively being treated relapse during treatment, suggesting an alternative
explanation for the etiology must exist.
Anxiety, like many emotion based feelings, are generated from a complex
network of brain regions and their connections, known as the limbic system.
Consisting of the hypothalamus, amygdala, hippocampus and limbic cortex, the
limbic system is responsible for processing emotional and motivational behaviors
(LeDoux, 2003; Morgane et al., 2005). Alterations in the neurochemical composition
of certain brain regions has been connected to anxiety (Hoehn-Saric, 1982; Hyman,
1998; Pratt, 1992) including increased norepinephrine, increased serotonin (Graeff,
1993) and altered GABA levels (Depino et al., 2008; Hoehn-Saric, 1982).
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While the amygdala was not analyzed, the VHC plays a critical role in
regulation of anxiety-like phenotypes. Notably, the analyzed VHC punch is
composed of roughly 40 % subiculum, which contains a large population of
GABAergic neurons that perhaps account for the measured increase. The subiculum
is the major output structure of the VHC, sending projections to cortical and
subcortical targets such as thalamic nuclei (O'Mara, 2005; O'Mara et al., 2001;
Witter and Groenewegen, 1990). A unique feature of the subiculum is the presence
of long-range projection GABAergic neurons. Typically, GABAergic neurons are
small interneurons that regulate local neural circuitry within a nucleus, however the
subiculum is one of few nuclei in the brain containing GABAergic projection neurons
(Buzsaki and Chrobak, 1995; Jinno et al., 2007). The target of these GABAergic
projections is the cortical limbic system, imposing inhibition on the hypothalamicpituitary-adrenal (HPA) axis, which in turn, dampens the HPAs response to stress
(Lowry, 2002). Coming full circle, there are extensive reciprocal connections
between the AMYG and VHC regions; thus, the increase in the less anxious
phenotype we observed is still related to the neurochemical alterations in the VHC
punch.
Analysis of ex vivo tissue punches indicates that Cldn11-/-Tg+/- mice have
significantly increased GABA levels, about 20 %, in the VHC region (Figure 4.11 and
Table 4.11). In patients suffering from anxiety disorders, a similar significant
increase within the AMYG is noted throughout the published literature (Lydiard,
2003; Nemeroff, 2003; Nutt and Malizia, 2001). An increase of GABA by 20 % in the
VHC is not only statistically significant, but suggestive of being biologically relevant.
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Evidence in the literature establishes a 10 % change in GABA levels in the AMYG is
sufficient to cause altered detectable anxiety-like phenotype (Ackermann et al.,
2008; Sherif and Oreland, 1995). Further support has been shown when excess
GABA remains in the synaptic cleft in the absence of GABA transporters or
receptors (Liu et al., 2007; Sur et al., 2001). The function of inhibitory interneurons,
and discernably GABA, is to modulate and alter the excitability of neural circuitry
(Bloom et al., 1995). Excess neurotransmitters, whether excitatory, or in this case
inhibitory, can have dramatic effects on overall neural circuitry, leading to
dysregulation and the manifestation of a behavioral abnormality.
These data support the hypothesis that dysfunctional myelin within Cldn11-/mice generates detectable alterations in neurotransmitter levels. They suggest that
dysfunctional myelin may be an important etiology for behavioral abnormalities
because it can generate the types of neurotransmitter alterations that are found in
patients and are commonly targeted by pharmaceutical companies. However, it
remains to be determined what proportion of the disease burden might be
associated with this etiology.
The vanishing phenotype of Cldn11-/-Tg+/- mice
Initial behavioral experiments describe a consistent story and reveal novel
findings attributable to dysfunctional myelin. A decrease in anxiety level correlated
with increased inhibitory GABA levels present in the VHC of Cldn11-/-Tg+/- mice at 6
– 8 M of age. These data suggested, for the first time, that dysfunctional myelin
plays a critical role in the etiology of behavioral abnormalities, as well as causes
alterations in neurotransmitter levels. Undermining these findings are the ensuing
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experiments attempting to formulate a mechanism by which an increase in GABA
originates.
Performing longitudinal studies on the same group of mice would have
introduced a potential learned behavior, failing to reflect genuine behavioral
abnormalities (Bailey et al., 2006; Bolivar et al., 2000; Voikar et al., 2004). This
necessitates the need for separate cohorts of mice to age, replicate behavioral
testing, and tissue collected for protein analysis to determine mechanism of GABA
increase. The time to complete a second round of experiments can take upwards of
a year, pending optimal breeding. During this time frame, several infections occurred,
modifying the perspective of data collected.

Second, throughout behavioral testing data collection, several infections
occurred in the vivarium. With each ailment and subsequent management regime,
the possibility arises that treatment could affect the behavior of both Cldn11+/-Tg+/and Cldn11-/-Tg+/- mice. Most notable was the presence of pinworms (Syphacia
muris and Aspiculuris tetraplera) and treatment with Ivermectin (MediGel IVR gel
cups). The anthelmintic ivermectin, from the superfamily avermectin, exerts its
antiparasitic effect by activating glutamate-gated chloride channels receptors
(GluClRs) present exclusively in the invertebrate nervous system (Cully et al., 1994).
Recently, our understanding of the precise location where ivermectin binds and how
it modulates cys-loop ion channels has expanded with publication of the crystal
structure of ivermectin bound to the C.elegans GluClR (Hibbs and Gouaux, 2011).
Ivemectin binds at the transmembrane domain between two adjacent subunits
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forming hydrogen bonds and van der Waals interactions with select amino acids
within the channel’s transmembrane domain. The binding of ivermectin between
subunits has been suggested to wedge open the pore, permitting the passing of
chloride ions, cause hyperpolarization of the neurons, paralysis, and ultimate demise
of the pinworm species (Fisher and Mrozik, 1992; Martin, 1997). Nevertheless, it has
been demonstrated that ivermectin can bind to and alter glycine receptors (GlyRs),
as well as GABAA receptors (GABAAR) in vertebrate animals (Dawson et al., 2000;
Shan et al., 2001).
While there may be no overt signs of a pinworm infection, such as hair loss or
weight fluctuation, altering internal receptor modulation could influence behavioral
outcomes in the host species, in our case the mice. It has been demonstrated that
the mere presence of an active pinworm infection can modify the behavior of mice,
decreasing exploration during OF testing. Likewise, treatment with ivermectin has
been shown to have the opposite result, increasing exploration of an OF arena
during pinworm treatment (Davis et al., 1999; McNair and Timmons, 1977).
Consequently, if the mice became infected and behavioral analyses performed; data
would be difficult to interpret. No behavioral test was carried out while pinworm
treatment was in effect, however it is unknown at what point mice contracted the
illness before being detected. Furthermore, the perpetual effect of treating animals
with ivermectin has not been investigated. Thus, we do not know what lasting effects
ivermectin may have on host GlyR and GABAAR.
In spite of the difficulties with this project, our data, in part, suggests that
dysfunctional myelin is associated with behavioral abnormalities and alters
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neurotransmitter levels. Data collected from the initial cohorts of Cldn11+/-Tg+/- and
Cldn11-/-Tg+/- mice is robust and experiments were conducted within a short time
frame, so we do not expect technical difficulties such as infections to have
confounded the data. These studies await re-examination using mice that have not
been exposed to ivermectin and we plan to use a new inducible Cldn11-/- colony of
mice currently being generated at Baylor School of Medicine.
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APPENDIX A – Abbreviation
aa
ABAT
ABR
ACC
aCSF
Act
AEP
Ala
AMC
AMYG
ANOVA
Asp
AST
AUD
AVCN
Bet
BIC
BLA
BS
CAP
CB
CH
Cho
Cldn
cm
CN
CNS
Cre
CS
dB
DCM
DCN
DPST
DTI
EE
EEG
EI
fMRI
GABA
GAD
Gln
Glu
GPC
GSH

amino acid
4 – aminobutyrate aminotransferase
auditory brainstem response
anterior cingulate cortex
artificial cerebral spinal fluid
acetate
auditory evoked potential
alanine
anterior motor cortex
amygdala
analysis of variance
aspartate
anterior striatum
auditory cortex
anteroventral cochlear nucleus
betaine
binaural interaction component
basolateral amygdala
brainstem
compound action potential
cerebellum
chloral hydrate
cholines
claudin
centimeter
cochlear nucleus
central nervous system
creatine
center square
decibel
double cable model
dorsal cochlear nucleus
dorsal posterior striatum
diffusion tensor imaging
excitatory-excitatory
electroencephalography
excitatory-inhibitory
functional magnetic resonance imaging
gamma-aminobutryic acid
glutamic acid decarboxylase
glutamine
glutamate
gycerophosphocholine
glutathione
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H1MRS
HC
HC
HPA
i.p.
IC
ILD
in
Ins
IPL
ITD
JP
kg
kHz
Lac
LL
LLR
LNTB
LSO
M
MAG
MB
MidB
MBP
MDL
mg
MGN
min
ml
MLR
MNTB
MS
msec
MSO
NAA
NAAG
NAC
OF
PBS
PCC
PCh
PDZ
PEA
PET
PLP
PMC

proton magnetic resonance spectroscopy
hippocampus
hippocampus
hypothalamic pituitary adrenal
intraperiotoneal
inferior colliculus
interaural level delay
inch
Inositol
intraperiod line
interaural time delay
juxtaparanode
kilogram
kilo Hertz
lactate
lateral lemniscus
late / long latency response
lateral nucleus of the trapezoid body
lateral superior olive
month
myelin associated glycoprotein
marble burying
midbrain
myelin basic protein
major dense line
milligram
medial geniculate nucleus
minute
milliliter
middle latency response
medial nucleus of the trapezoid body
multiple sclerosis
millisecond
medial superior olive
N-acetlyaspartate
N-acetlyaspartatylglutamate
nucleus accumbens
open field
phosphate buffered saline
posterior cingulate cortex
phosphocholine
PSD95 / Dlgs / ZO-1
phenylethylamine
positron emission tomography
proteolipid protein
posterior motor cortex
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ppm
PVCN
sec
SEP
SL
SNR
SOC
SP
SPL
Suc
SZ
Tau
TBE
TBSGBA
THAL
TJM
TS
TSP
VEP
VHC
VPST
ZO
µm
µsec
µV

parts per million
posteroventral cochlear nucleus
second
somatosensory evoked potential
sensation level
signal to noise ratio
superior olivary complex
sucrose preference
sound pressure level
succinate
Schizophrenia
taurine
2,2,2 – tribromoethanol
tris buffered saline, goat serum, bovine albumin
thalamus
tight junction model
tail suspension
trimethyl silyl – propionate
visual evoked potential
ventral hippocampus
ventral posterior striatum
zonula occludens
micron
microsecond
microvolt
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APPENDIX B – Chapter 2 Supplemental Figures
Appendix B.1 – Sensation level for Wave III amplitudes is highly variable

Normalized Wave III amplitudes are plotted as a function of time for calculated
sensation level at 80 dB SPL (A), 70 dB SPL (B), 60 dB SPL (C) 50 dB SPL (D) 40
dB SPL (E) and 30 dB SPL (F). Data for each mouse are normalized to amplitude at
50 min and the average linear regression line constrained at (50,1) is shown (solid
line) ± 95 % CI (dashed lines).
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Appendix B.2 – Sensation level for Wave V amplitudes is highly variable

Normalized Wave V amplitudes are plotted as a function of time for calculated
sensation level at 80 dB SPL (A), 70 dB SPL (B), 60 dB SPL (C) 50 dB SPL (D) 40
dB SPL (E) and 30 dB SPL (F). Data for each mouse are normalized to amplitude at
50 min and the average linear regression line constrained at (50,1) is shown (solid
line) ± 95 % CI (dashed lines).
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APPENDIX C – Chapter 3 Supplemental Figures
Appendix C.1 – Raw DN1 latency occurs between latencies of Waves IV and V

(A) Raw latencies plotted for Wave IV and V, as well as the calculated DN1 trough,
as a function of the various intensity differences (ΔdB SPL) tested for Cldn11+/-Tg+/Cldn11+/-Tg+/- mice. (B) Raw latencies are plotted for Wave IV and V, as well as the
calculated DN1 trough at the various intensity differences tested (ΔdB SPL) for
Cldn11-/-Tg+/- mice. Data values are plotted as mean + SD; 10 ≤	
 n ≤ 12.
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Appendix C.2 – Raw DN1 latency and amplitude for Cldn11+/-Tg+/- and Cldn11-/Tg+/- mice

(A) Raw DN1 trough latency plotted as a function of intensity difference (ΔdB SPL)
for Cldn11+/-Tg+/- and Cldn11-/-Tg+/- mice. (B) Raw DN1 amplitude plotted as a
function of intensity difference (ΔdB SPL) for Cldn11+/-Tg+/- and Cldn11-/-Tg+/- mice.
Data values are plotted as mean + SD; 10 ≤	
 n ≤ 12
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Appendix C.3 – Proportion of myelinated fibers in trapezoid body fiber tract

Percentage of myelinated fibers traversing through the trapezoid body tract are
displayed. Negative sign indicates sagittal cryostat section medial to the MNTB,
whereas the plus sign indicates slides in which posses MNTB principle cells. Data
are plotted as mean + SD; n = 3 fields / slide; ~ 100 axons / slide.
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APPENDIX D – Chapter 4 Supplemental Figures
Appendix D.1 – Cldn11+/-Tg+/- and Cldn11-/-Tg+/- mice travel a similar distance
and velocity during the open field paradigm

(A) The total distance traveled during the open field test was similar between
Cldn11+/-Tg+/- and Cldn11-/-Tg+/- mice at 2, 4, and 6 – 8 M of age. (B) Similarly, the
average velocity was indistinguishable between genotypes at 2, 4, and 6 – 8 M. Data
values are plotted as mean + SD, 9 ≤ n ≤ 10.
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Appendix D.2 –Time spent in each quadrant of the open field arena is similar
between Cldn11+/-Tg+/- and Cldn11-/-Tg+/- mice

The average time spent in each quadrant of the OF arena (Figure 4.1) was similar
between Cldn11+/-Tg+/- and Cldn11-/- mice at 2, 4, and 6 – 8 M of age. Data values
are plotted as mean + SD, 9 ≤ n ≤ 10.
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Appendix D.3 – Standard sucrose testing variables including weight
fluctuation, food consumed and liquid drank are indistinguishable between
Cldn11+/-Tg+/- and Cldn11-/-Tg+/- mice

(A) Normalized weight fluctuation for Cldn11+/-Tg+/- and Cldn11-/-Tg+/- mice during the
eight days of sucrose preference testing at 2, 4, and 6 – 8 M of age. A mouse’s
weight was normalized to its starting weight before the testing period began to
control for gender differences. (B) Total liquid intake during the eight days of sucrose
preference testing at 2, 4, and 6 – 8 M of age. (C) Total amount of food consumed
during the eight days of sucrose preference testing for 2, 4, and 6 – 8 M of age mice.
Using repeated measures ANOVAs, no statistically significant differences were seen
for any variable, at any age tested. Shaded portion of graphs reflects portion of test
when a sucrose solution was present. All data values are plotted as mean + SD, n =
9 at 2 M, n = 10 at 4 and 6 – 8 M. Cldn11-/-Tg+/- values are shifted about the
abscissa for clarification.
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Appendix D.4 – Side preference for liquid consumption during sucrose
preference testing is similar for Cldn11+/-Tg+/- and Cldn11-/-Tg+/- mice

(A) Acclimation phase (days 1 – 4) during sucrose preference testing when water is
present in both the L and R sipper tubes. Using a two-way repeated measures
ANOVA, the average amount of liquid (water) drank on either the L or R side, or
between sides within a genotype, is indistinguishable between Cldn11+/-Tg+/- and
Cldn11-/-Tg+/- mice at 2 M of age. At 4 and 6 – 8 M of age, both Cldn11+/-Tg+/- and
Cldn11-/-Tg+/- mice drink a similar amount of liquid (water) from either the L or R
sipper tubes, however, within a genotype, both groups drink significantly more from
the R sipper tube. (B) Sucrose phase (days 5 – 8) of testing when one sucrose and
one water sipper tube was present each day, counterbalanced by day. Employing a
two-way repeated measures ANOVA, the average amount of liquid drank,
irrespective of type, was similar between Cldn11+/-Tg+/- and Cldn11-/-Tg+/- mice at 2
and 4 M of age. At 6 – 8 M, there was no significant difference between the amount
of liquid drank from either the L or R sipper tubes between genotypes; however,
within genotypes, the Cldn11+/-Tg+/- animals drank significantly more liquid from the
R sipper tube, than L, as compared to Cldn11-/-Tg+/-. All data values are plotted as
mean + SD, n = 9 at 2 M, n = 10 at 4 and 6 – 8 M; **p < .01, ****p < 0.0001.
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Appendix D.5 – Zone analysis of Barnes probe trial (day 5) conveys similar
time is spent in various sections around the goal hole

Student’s unpaired t-tests reveal that at 2, 4, and 6 – 8 M of age, Cldn11+/-Tg+/- and
Cldn11-/-Tg+/- mice spend a similar amount of time in (A) ‘Zone 0,’ (B) ‘Zone 1,’ and
(C) ‘Zone 2’ during Barnes probe trial (day 5). Data values are plotted as mean +
SD; 2 M: 9 ≤	
 n ≤ 10, 4 M: 7 ≤	
 n ≤ 10, 6 – 8 M: 9 ≤	
 n ≤ 11. See Methods section for
zone illustration.
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Appendix D.6 – Zone analysis of Barnes curtain trial (day 7) conveys similar
time is spent in various sections around the goal hole

Student’s unpaired t-tests reveal that at 2, 4, and 6 – 8 M of age, Cldn11+/-Tg+/- and
Cldn11-/-Tg+/- mice spend a similar amount of time in (A) ‘Zone 0’ and (B) ‘Zone 1’
during Barnes curtain trial (day 7). Time spent in (C) ‘Zone 2’ is similar at 2 and 6 – 8
M of age, however, 4 M analyses of time reveals that Cldn11-/-Tg+/- mice spend
significantly more time in ‘Zone 2’ than controls. Data values are plotted as mean +
SD; 2 M: 9 ≤	
 n ≤ 10, 4 M: 7 ≤	
 n ≤ 10, 6 – 8 M: 9 ≤	
 n ≤ 11; *p < .05. See Methods for
zone illustration.
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Appendix D.7 – Zone analysis of Barnes reversal trial (day 10) reveals
comparable time spent in various sections around the newly learned goal hole

Student’s unpaired t-tests indicate that time spent in (A) ‘Zone 0,’ (B) ‘Zone 1,’ and
(C) ‘Zone 2’ is similar between Cldn11+/-Tg+/- and Cldn11-/-Tg+/- mice at 4 and 6 – 8
M of age. Of note, 2 M animals spend similar amount of time in ‘Zone 1,’ however
controls spend significantly more time in ‘Zone 0’ and Cldn11-/-Tg+/- mice spend
significantly more time in ‘Zone 2.’ Data values are plotted as mean + SD; 2M: 9 ≤	
 n
≤ 10, 4M: 7 ≤	
 n ≤ 10, 6 – 8M: 9 ≤	
 n ≤ 11; *p < .05. See Methods section for zone
illustration.
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Appendix D.8 – Zone analysis of Barnes probe trial (day 5) conveys similar
time spent in various sections around the hook-in hole

Student’s unpaired t-tests reveal that at 2, 4, and 6 – 8 M of age, Cldn11+/-Tg+/- and
Cldn11-/-Tg+/- mice spend a similar amount of time in (A) Zone0, (B) Zone1, and (C)
Zone2 surrounding the hook-in hole during the probe trial. Data values are plotted as
mean + SD; 2 M: 9 ≤	
 n ≤ 10, 4 M: 7 ≤	
 n ≤ 10, 6 – 8 M: 9 ≤	
 n ≤ 11. See Methods for
zone illustration.
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Appendix D.9 – Zone analysis of Barnes curtain probe (day 7) conveys
Cldn11+/-Tg+/- mice spent more time around the in zones surrounding the hookin hole

Student’s unpaired t-tests reveal that at 2 and 6 – 8 M of age, Cldn11+/-Tg+/- and
Cldn11-/-Tg+/- mice spend a similar amount of time in (A) Zone0, (B) Zone1, and (C)
Zone2 surrounding the hook-in hole during the curtain probe trial. At 4 M of age,
Cldn11+/-Tg+/- mice spent significantly more time in each zone surrounding the hookin hole. Data values are plotted as mean + SD; 2 M: 9 ≤	
 n ≤ 10, 4 M: 7 ≤	
 n ≤ 10, 6 –
8 M: 9 ≤	
 n ≤ 11; **p < .01, ***p < .001, ****p <.0001. See Methods for zone
illustration.
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Appendix D.10 – Zone analysis of Barnes reversal trial (day 10) conveys
similar time spent in various sections around the hook-in hole

Student’s unpaired t-tests reveal that at 2, 4, and 6 – 8 M of age, Cldn11+/-Tg+/- and
Cldn11-/-Tg+/- mice spend a similar amount of time in (A) Zone0, (B) Zone1, and (C)
Zone2 surrounding the hook-in hole during the reversal probe trial. Data values are
plotted as mean + SD; 2 M: 9 ≤	
 n ≤ 10, 4 M: 7 ≤	
 n ≤ 10, 6 – 8 M: 9 ≤	
 n ≤ 11. See
Methods for zone illustration.
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Appendix D.11 – Concentration of GABA and glutamate within select brain
regions of 4 M Cldn11+/-Tg+/- and Cldn11-/-Tg+/- mice reveals similar levels

(A) gamma-aminobutryic acid (GABA) levels in the ventral and dorsal hippocampus
of 4 M Cldn11+/-Tg+/- and Cldn11-/-Tg+/- mice. Student’s t-test for select regions
indicates no significant difference in concentration for either brain regions. (B)
Glutamate (Glu) levels in the ventral and dorsal hippocampus of 4 M Cldn11+/-Tg+/and Cldn11-/-Tg+/- mice. Student’s t-tests indicate both groups have similar glutamate
levels. Data values are plotted as mean + SD; 6 ≤	
 n ≤ 8.
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Appendix D.12 – Sociability testing control parameters do not influence overall
results

(A) Using a t-test, the average distance traveled during each phase of sociability
testing (habituation, trial 1, and trial 2) is similar between Cldn11+/-Tg+/- and Cldn11-/Tg+/- mice. (B) Similar to average distance, the average velocity of the mice is alike
between genotypes during each phase of testing. (C) A one -way ANOVA comparing
total time spent each chamber of the sociability arena during habituation, trial 1, and
trial 2 is equivalent between Cldn11+/-Tg+/- and Cldn11-/-Tg+/- mice. Data values are
plotted as mean + SD; n = 6.
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Appendix D.13 – Grooming during sociability testing reveals similar anxietylike behaviors

(A) Individual t-tests by session (habituation, trial 1, and trial 2) disclose similar total
grooming time between Cldn11+/-Tg+/- and Cldn11-/-Tg+/- mice. (B) Using a one – way
ANOVA comparing genotype versus compartment, the fraction of time mice spend
grooming is not different during trial 1 or trial 2. Individual Bonferroni post – hoc
testing indicates select differences within a genotype between various compartments.
Data values are plotted as mean + SD; n = 6; *p < .05, ***p < .001, ****p <.0001. H
habituation, T1 trial 1, T2 trial 2, M mouse, E empty, Mid middle, FM familiar mouse,
NM novel mouse
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Appendix D.14 – Control variables during repeat open field test reveals
parameters do not influence center square activity

(A) A Student’s t-test comparing average distance traveled and velocity was similar
between Cldn11+/-Tg+/- and Cldn11-/-Tg+/- mice in Location 1. A two – way ANOVA
comparing time spent in each quadrant of the open field was also indistinguishable
between genotypes. (B) A Student’s t-test comparing average distance traveled and
velocity was similar between Cldn11+/-Tg+/- and Cldn11-/-Tg+/- mice in Location 2. A
two -way ANOVA comparing time spent in each quadrant of the open field was also
indistinguishable between genotypes. Data values are plotted as mean + SD;
Location 1 n = 10, Location 2 6 ≤	
 n ≤ 7.
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ABSTRACT
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In the current study, we have generated mutant mice that lack Claudin 11
(Cldn11) tight junctions in CNS myelin sheaths. In myelin sheaths, Cldn11 forms
tight junctions located along the outer and inner edges of the membrane spiral,
preventing ions and small molecules from entering the intramyelinic space. The
function of Cldn11 tight junctions is to improve the passive properties of the myelin
membrane, by increasing membrane resistance and reducing capacitance, thereby
improving the speed of saltatory conduction. In the absence of Cldn11, conduction
velocity is slowed, most dramatically in small diameter myelinated fibers, somewhat
analogous to reducing myelin thickness. Notably, the absence of Cldn11 is without
degenerative myelin pathology, enabling direct study on the impact of dysfunctional
myelin on neural processing.
Undoubtedly, slowed conduction velocity along myelinated axons increases
temporal dispersion and, consequently, degrades information transfer between
neural circuits. Herein, this dissertation work explores the impact of dysfunctional
myelin on neural processing in the conserved integration circuit of the auditory
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brainstem. We find that dysfunctional myelin alters neural processing, generating an
inability to lateralize sound sources on the azimuth plane. Extrapolating this
information to higher order circuitry within the cortex, we find that dysfunctional
myelin generates a disconnection between brain regions, manifesting in behavioral
abnormalities and alteration in neurotransmitter levels.
Together, these data demonstrate that non-degenerative changes in myelin
membrane passive properties can lead to neurochemistry changes that perturb
behavior/perception. Second, they have important implications for the etiology of
behavioral disorders in general, and more specifically for the behavioral components
of hypomyelinating and demyelinating diseases like multiple sclerosis.
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